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Background: Cardiorespiratory instability (CRI) in noninvasively monitored step-down unit 
(SDU) patients has a variety of etiologies, and therefore likely manifests in different patterns of 
vital signs (VS) changes.  
Objective: We sought to describe differences in admission characteristics and outcomes between 
patients with and without CRI. We explored use of clustering techniques to identify VS patterns 
within initial CRI epoch (CRI1) and assessed inter-cluster differences in admission 
characteristics, outcomes and medications. 
Methods:  Admission characteristics and continuous monitoring data (frequency 1/20 Hz) were 
recorded in 307 patients. Vital sign (VS) deviations beyond local instability trigger criteria for 3 
consecutive minutes or for 4 out of a 5 minute moving window were classified as CRI events. 
We identified CRI1 in 133 patients, derived statistical features of CRI1 epoch and employed 
hierarchical and k-means clustering techniques. We tested several clustering solutions and used 
10-fold cross validation and ANOVA to establish best solution. Inter-cluster differences in 
admission characteristics, outcomes and medications were assessed. 
Main Results: Patients transferred to the SDU from units with higher monitoring capability 
were more likely to develop CRI (n=133, CRI 44% vs no CRI n=174, 31%, p=.042). Patients 
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with at least one event of CRI had longer hospital length of stay (CRI 11.3 + 10.2 days vs no 
CRI 7.8 + 9.2, p=.001) and SDU unit stay (CRI 6.1 + 4.9 days vs no CRI 3.5 + 2.9, p< .001). 
Four main clusters(C) were derived. Clusters were significantly different based on age (p=0.001; 
younger patients in C1 and older in C2), number of comorbidities (p<0.01; more C2 patients had 
≥2), and admission source (p=0.008; more C1 and C4 patients transferred in from a higher 
intensity monitoring unit). Patients with CRI differed significantly (p<.05) from those without 
CRI based on medication categories.  
Conclusions: CRI1 was associated with prolonged hospital and SDU length of stay. Patients 
transferred from a higher level of care were more likely to develop CRI, suggesting that they are 
sicker. Future study will be needed to determine if there are common physiologic underpinnings 
of VS clusters which might inform monitoring practices and clinical decision-making when CRI 
first manifests. 
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1.0  INTRODUCTION 
Patients are placed in step-down units (SDUs) because their presumed risk for cardiorespiratory 
instability (CRI) necessitates a higher level of monitoring than is available in general hospital 
units (Hravnak et al., 2008). In the SDU, patient physiology is either continuously or 
intermittently monitored using non-invasive vital sign (VS) monitoring devices. These generally 
include the use of the electrocardiogram (ECG) leads for monitoring vital signs of heart rate 
(HR) and respiratory rate (RR), as well as plethysmographic monitoring of peripheral capillary 
oxygen saturation (SpO2). Each of the vital signs (VS) are expected to be within certain 
predefined “normal” threshold limits, based on normal human physiology, with non-invasive 
monitors preset to normal limits but also providing in-built capabilities of user-input threshold 
set limits. While varying criteria for thresholds exist, normal monitoring threshold parameter 
values include HR between 40 and 140, RR between 8 and 36 and SpO2>85%, with deviations 
from any of these normal values, while being monitored, considered either as artifact or as 
potential CRI (Hravnak, DeVita, et al., 2011; Hravnak et al., 2008). Nevertheless, such generic 
threshold parameters denote instability far into its course. Generic thresholds also do not account 
for differences in the various pathophysiologic reasons which drive CRI. For example, possibly 
CRI due to acute onset respiratory failure may present in a different sequence of VS 
abnormalities than CRI due to hypovolemia or acute onset arrhythmia. Such a variety in 
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processes and manifestations may make it difficult for clinicians to be certain of the CRI state 
until well into its course. 
Non-invasive monitoring of VS in SDUs are performed to assess patient departure from a 
stable state and prevent complications. Complications are undesirable outcomes (due to adverse 
physiologic events) developed by a patient during the course of their hospital stay. Hravnak et al. 
monitored 326 patients using an electronically integrated continuous monitoring system and 
reported that patients on SDUs became unstable as long as 6 hours prior to a medical emergency 
team (MET) call (Hravnak, DeVita, et al., 2011). The underlying theory supporting  this project 
is the concept of  Failure to Rescue (FTR), first proposed by Silber et al. (Silber, Williams, 
Krakauer, & Schwartz, 1992). Failing to notice instability onset and rescue a deteriorating patient 
promptly and appropriately can lead to negative patient outcomes including increased morbidity 
and mortality, increased requirement for intensive care,  and elevated costs (Hravnak, Schmid, 
Ott, & Pinsky, 2011). The premise for this study is that failure to identify these complications 
quickly, by noticing the impending pattern changes prior to overt CRI, can contribute to FTR. 
CRI is generally a process that occurs over minutes to hours, and offers numerous subtle warning 
signs and symptoms that could be identified from non-invasive monitoring prior to a patient ever 
crossing a CRI VS threshold. The hypothesis for this study is that early identification and 
accurate characterization of the patterns of physiological deviations that lead to overt CRI may 
aid existing monitoring technologies in earlier detection, thus improving patient outcomes and 
preventing FTR.  
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1.1 SPECIFIC AIMS 
Purpose: Current physiologic monitoring tools in SDU patients use simultaneous continuous 
monitoring of individual VS, but do not characterize inter-temporal patterns in multiple VS 
during the time of overt CRI (CRI epoch). 
The proposed study on adult SDU patients has the following specific aims  
1. Identify and compare the admission characteristics of patients who develop overt CRI 
(unstable) with patients who do not develop CRI (stable)  
2. For the unstable patient’s first occurrence of CRI (CRI1)--characterize the first VS over 
stability threshold, extract numeric features within CRI1 epoch, and use clustering to 
study interaction of other VS within each cluster.  
3. Explore inter-cluster differences based on admission characteristics and whether various 
CRI1 patterns are linked to specific disease states.  
1.1.1 Definition of Terms 
CRI: VS excursions beyond local criteria for instability concern (HR< 40 or > 140, RR< 8 or > 
36, SpO2< 85%) not due to artifact were defined as CRI if they persisted for a minimum duration 
of 3 minutes, or for 4 minutes out of a 5-minute moving window (80% duty cycle) with or 
without changes in other VS. 
CRI epoch: Defined as the first time a VS exceeded normality thresholds and continues until the 
time the VS returns to normality. 
CRI1: The patient’s first instance of CRI epoch not caused by artifactual VS cross of threshold. 
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CRI1 Driver: The first VS to cross the CRI stability thresholds within CRI1 epoch. 
1.2 CURRENT BACKGROUND AND REVIEW OF LITERATURE 
1.2.1 MET Teams to prevent FTR 
Within hospitals, medical emergency teams (METs) are typically composed of medical, nursing, 
and respiratory therapy staff who can be summoned immediately at any time for prompt 
evaluation, triage, and treatment of patients with signs of impending clinical deterioration at a 
much earlier stage in the development of CRI (Chan, Jain, Nallmothu, Berg, & Sasson, 2010). 
Hravnak et al. recorded 111 MET activation criteria events caused by CRI in 59 patients, but 
MET activation for this cause occurred in only 7 patients (Hravnak et al., 2008). Schmid-
Mazzoccoli et al. have reported that there was a delay in activation of the MET by > 30 minutes 
with greater delays occurring often during the night shift.(Schmid-Mazzoccoli, Hoffman, Wolf, 
Happ, & Devita, 2008). The exact reason for such delay in MET activations remains unclear but 
appears to be multifocal. Ludikhuize et al. identified that the delay could be due to differences in 
personal perceptions about how nurses, resident physicians and medical specialists and experts 
judged deteriorating patients and their VS patterns on medical wards, and that there was a wide 
difference in personal perceptions and a lack of clarity among the various care providers 
(Ludikhuize et al., 2012). Thus METs can be deployed only when bedside clinicians notice overt 
CRI. A better approach would be to assist clinicians to notice overt CRI, and even more 
importantly, become aware of evolving changes in VS prior to CRI manifestation. Such an 
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approach could assist clinicians to not only treat CRI earlier, but target therapy to a specific 
disease etiology if CRI patterns unique to pathophysiologic disease processes can be determined. 
1.2.2 Early warning scores for early identification of CRI 
Many different techniques of early identification of at-risk patients using charted VS, both of 
single VS abnormalities (Cretikos et al., 2007; Lee, Bishop, Hillman, & Daffurn, 1995; G. B. 
Smith, Prytherch, Schmidt, Featherstone, & Higgins, 2008)  as well as multiple simultaneous 
abnormalities (Bleyer et al., 2011; G. B. Smith, Prytherch, Schmidt, & Featherstone, 2008; 
Subbe, Kruger, Rutherford, & Gemmel, 2001) have been explored in an effort to identify overt 
CRI earlier. Still others have developed aggregate weighted systems (Gao et al., 2007; Paterson 
et al., 2006) by categorizing VS deviations  into step-wise  degrees of physiological abnormality 
based on expert-opinion, prior literature and trial and error, and then computing a score for each 
of the variables used within the system. However, most of the studies in this area are based upon 
a single discrete point in time (e.g.: NEWS, MEWS etc.) and treat CRI as a homogenous entity, 
with no differentiation between the different types of physiologic processes which occur prior to 
overt CRI. We have anecdotally observed that CRI is an evolving process in time and not an 
event, and further manifests as  different patterns leading up to different CRI etiologies. This 
study seeks to confirm those observations. These observations are supported by the literature 
regarding instability physiology and known patterns. 
 19 
 
1.2.3 Characteristics other than VS that impact CRI  
Previous studies have shown that mortality prediction models which include demographic 
and clinical diagnoses besides only the monitored VS, after development of CRI, were able to 
achieve better prediction capabilities. Smith et al. (G. B. Smith, Prytherch, Schmidt, 
Featherstone, Kellett, et al., 2008) ) showed that adding age to a single-VS CRI model (RR<5 or 
> 36, HR<40 or > 140, systolic blood pressure < 90 mm Hg, sudden decrease in consciousness) 
or intermittently determined MEWS improved mortality prediction. Higher age also increased 
mortality prediction as MEWS score increased. Yousef et al. used a multivariable logistic 
regression model on static variables (age, race, gender etc. ) and demonstrated that using the 
Charlson Comorbidity Index (CCI) could differentiate between patients with and without CRI 
with high specificity (97%)  (Yousef, Pinsky, DeVita, Sereika, & Hravnak, 2012).  
1.2.4 Instability physiology and known patterns 
1.2.4.1 Low pulse oximetry as an input signal to CRI in SDU patients 
Peripheral pulse oximetry is aimed at detecting changes in oxygen saturation of peripheral 
arterial blood noninvasively (SpO2), and is utilized as a marker for hypoxemia and therefore 
CRI. The pulse oximeter probe used on patients in the SDU is designed to target the pulsatile 
flow arising from the arterial bed, causing signal changes in the waveform via plethysmography. 
The “order” in which low SpO2 manifests itself relative to other VS changes might provide clues 
to the reason for hypoxemia. For example, if a patient becomes overly sedated, one would expect 
to see a low RR (the CRI ‘driver”) precede decreased oxygen uptake which then manifests as 
 20 
 
low SpO2. Conversely, if a patient develops lung atelectasis and diminished alveolar surface 
area, a lower SpO2 might be the first manifestation of decreased oxygen uptake, followed in 
short order by increased RR and HR to increase circulation and therefore oxygen delivery to 
compensate for the oxygen uptake shortfall.  
Nevertheless, peripheral pulse oximetry is subject to error. Peripheral hypoperfusion from 
hypothermia, low cardiac output or vasoconstrictive drugs usually prolong the detection time for 
a hypoxic event due to reduced perfusion at the site of measurement (Jubran, 1999). Bradycardia 
and its accompanying low perfusion state (low cardiac output) as well as motion artifacts are the 
main sources of varying patterns in the plethysmographic signal, with usually a very low SpO2 
value in such states. Motion artifacts also imitate low pulse oximetry states and typically, in SDU 
patients, can be caused due to shivering, agitation or twitching. Peripheral hypoperfusion due to 
bradycardia and thus a low cardiac output as well as artifact related low perfusion produce lower 
than normal values and a waveform pattern that appears with very little variation in the signal. 
Oscillatory patterns of the SpO2 signal, with corresponding oscillatory changes in the HR and 
the RR suggest a “real” CRI with lesser suspicion of an artifact. Weak signal strength is 
indicated by a decrease in the amplitude of the waveform with prolonged “real” low value 
leading up to potential CRI.  
1.2.4.2 Tachycardia and bradycardia as CRI inputs in SDU patients 
Tachycardia is defined as heart rate > 100 beats per minute (bpm). Sinus tachycardia is the most 
common dysrhythmia encountered in SDU patient population, which often occurs as a response 
to any sympathetic stimulus (e.g.: hypoxia, pain, dehydration or hyperthyroidism)(M. P. Fink, 
Abraham, Vincent, & Kochanek, 2005). The signal patterns seen in this dysrhythmia include 
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normal threshold deviations which could last from a few seconds to several hours. In post-
surgical patients, tachycardia could be a secondary compensatory physiological sign of bleeding 
and/or hypovolemia. Sinus tachycardia in the presence of an elevated blood pressure could be 
manifestations from opioid withdrawal. With a higher prevalence of the older population 
(age>65 yrs.), atrial fibrillation and atrial flutter with either the presence or absence of structural 
heart diseases could also lead to tachycardic rhythms (Nattel, 2011). Prolonged tachycardia has 
been shown to be a major risk factor for cardiac arrests in monitored patients (Sander, Welters, 
Foëx, & Sear, 2005) as well as in post-operative patients (Landesberg et al., 1993) and could 
portend impending CRI.  
Bradycardia is defined as heart rate < 60 bpm. Frequent causes of bradycardia in SDU 
patients include but are not limited to degeneration of heart tissue due to aging, damage of heart 
tissue due to heart attack or heart diseases, hypertension, hypothyroidism, imbalance of 
electrolytes (especially potassium) contributing to arrhythmogenesis (Miura et al., 2012), 
obstructive sleep apnea, inflammatory diseases such as lupus and some of the commonly used 
medications such as beta blockers or calcium channel blockers (Kwon et al., 2012). Signal 
patterns in such states usually show slower rhythms close to the lower normal thresholds, with a 
decreasing trend and low signal variability. Patients with any or all of the above physiologic 
abnormalities and signal patterns are more prone to developing CRI, with varying physiologic 
causes producing different types of monitoring patterns prior to CRI.  
1.2.4.3 Tachypnea and bradypnea as CRI inputs in SDU patients 
Abnormal RR has shown in numerous studies to be an important predictor leading up to serious 
cardiac arrest or transfer to an intensive care unit (escalation of care). (Cretikos et al., 2007; 
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Fieselmann, Hendryx, Helms, & Wakefield, 1993; Goldhill, McNarry, Mandersloot, & 
McGinley, 2005; Hodgetts, Kenward, Vlachonikolis, Payne, & Castle, 2002; Subbe, Davies, 
Williams, Rutherford, & Gemmell, 2003). Subbe et al. noted that in unstable patients (defined as 
patients who were dying, suffering cardiac arrest or being admitted to critical care) relative 
changes in RR were much greater than changes in HR or systolic blood pressure, and that RR 
was likely to be a better means of discriminating between stable patients and unstable patients. 
(Subbe et al., 2003). Pathologic conditions which cause metabolic acidosis (ketosis, uremia, 
salicylates, methanol, alcohol, lactic acidosis) lead to increased hydrogen ion concentrations, 
which in turn lead to increased CO2 production thus increasing the tidal volume and RR. 
Furthermore, pathologic conditions which cause hypercarbia (COPD, asthma, MG, ALS etc.) or 
hypoxia (pulmonary edema, severe ARDS etc.) also increase alveolar ventilation. Besides the 
above, hypoxia and hypercarbia in SDU patients could also occur from the use of opiate 
medications (for pain control) which depress the RR. Signal patterns in tachypnea can be either 
regular or irregular above threshold limits, or with a progressively increasing trend, while 
bradypnea is usually maintained as a slow RR that is deep (larger amplitude) with a regular 
rhythm. Cretikos et al, in a prospective case-control study reported that RR might be the VS with 
the best combination of sensitivity and specificity for the prediction of major adverse events 
leading up to CRI in hospitalized ward patients (Cretikos et al., 2007). Changes in RR (tachy or 
brady) is an indicator of abnormality in several body systems, as well as acid-base status and is 
an important precursor to impending CRI, albeit due to a variety of pathophysiologic causes as 
described above.  
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1.2.5 Compensatory hemodynamic mechanisms 
There are a number of compensatory feedback mechanisms in the human body with a variety of 
“sensors” to detect slight changes either in the pH of the blood (chemoreceptors) or the pressure 
of the blood flow (baroreceptors).  
1.2.5.1 Chemoreceptors 
The control of the respiratory activity in the body is carefully regulated by the central or 
medullary chemoreceptors and peripheral chemoreceptors (present in the aortic arch and carotid 
bodies) and a constant interaction between the central and peripheral chemoreceptors. 
Ventilation to the alveoli of the lungs is regulated chemically by the partial pressure of carbon 
dioxide (PaCO2) as well as the partial pressure of oxygen (PaO2), with PaCO2 being the primary 
driver of RR. Alveolar ventilation (VA) is a product of the RR and tidal volume, as  
V=VA+ VD = VT * f 
where VA = alveolar minute ventilation, VD = dead space volume, VT = tidal volume and f = 
respiratory rate. The conditions of hypoxemia (↓ PaO2) and hypercarbia (↑ PaCO2) are corrected 
by increasing both the tidal volume as well as the respiratory rate. Chemoreceptors detect the 
levels of carbon dioxide in the blood. In order to do this, they monitor the concentration of 
hydrogen ions in the blood, which cause a decrease in the pH of the blood due to increasing 
PaCO2. The physiologic response is that the respiratory center located in the medulla sends 
nervous impulses to the external intercostal muscles and the diaphragm, to increase breathing 
rate (increasing trend in the signal pattern) to blow off the excessive accumulating CO2. While 
the response to stimulation of chemoreceptors on the HR is complicated and obscure, stimulation 
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of peripheral chemoreceptors usually directly activates the medullary vagal center and slows the 
HR, triggering a surge of catecholamines to increase HR (Levy & Pappano, 2007). Figure 1 
illustrates the case of a SDU patient who developed CRI due to SpO2, (in the CRI epoch) but 
prior to it, had developed a decrease in RR, with a compensatory change of increase in HR, 
within 2 minutes. 
 
 
Figure 1. Tableau plot of compensatory changes—decreasing RR, causes increase in HR 
1.2.5.2 Baroreceptors 
Baroreceptors detect the amount of stretch of the blood vessel walls, and send the signal to the 
nervous system. Arterial baroreceptors are stretch receptors that are stimulated by changes in 
both the mean blood pressure as well as the rate of change in the pressure with each arterial 
pulse. This signal is then transmitted to the nucleus tractus solitarii in the brainstem, which then 
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through autonomic neurons trigger increases or decreases in HR. If blood pressure (BP) falls, 
such as in orthostatic hypotension or in various types of shock states (Bose, Hravnak & Pinsky, 
2014) (see preliminary work 13.1) baroreceptor reflexes act to help restore blood pressure by 
increasing HR.  
Thus, when patients become unstable and develop CRI, physiologic changes occur with 
deviations from normal threshold values or the patient’s baseline values, and the compensatory 
changes would be interactive within the three VS of HR, RR and SpO2.  
1.2.6 MET Syndromes—MET calls due to Different Etiologies 
MET calls are placed after a patient has developed overt CRI and has been recognized from the 
monitored variables by the bedside clinicians. While there is an abundance of literature on before 
and after studies of METs within hospitals (DeVita et al., 2006; Hillman et al., 2005; Lee et al., 
1995), a few studies have also attempted to document that there are different causes of MET 
calls, with differing approaches to the management of the causes. Lee and colleagues, in the 
original study on METs (Lee et al., 1995), discovered that out of the 522 MET calls, the most 
common causes were acute respiratory failure, status epilepticus, coma and severe drug 
overdose. Kenward et al., in a study of 136 MET calls over a 12-month period, discovered that 
altered consciousness, hypoxia, tachypnea, hypotension and tachycardia were the most common 
causes of MET calls (Kenward, Castle, Hodgetts, & Shaikh, 2004). Jones et al. studied 400 MET 
calls and found that the underlying reasons for initiating MET calls were hypoxia (41%), 
hypotension (28%), altered consciousness (23%), tachycardia (19%), tachypnea (14%) and 
oliguria (Daryl Jones et al., 2006). He termed these etiologies for MET calls as “MET 
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syndromes.” Jones et al. further elaborated that the accompanying physiological causes for such 
aberrations included infections, pulmonary edema and arrhythmias. Jones et al. were the first to 
suggest in literature that if there are differing causes for MET calls, there must be differing 
patterns in the monitored variables for CRI. However, no studies to date have analyzed the 
patterns of CRI from the monitored variables of HR, RR and SpO2.  
1.2.7 CRI is a process and not an event 
Goldhill et al. (Goldhill & McNarry, 2004) showed that  84% of in-hospital cardiorespiratory 
arrests are preceded by slow deterioration in vital signs. Buist et al. (Buist, Bernard, Nguyen, 
Moore, & Anderson, 2004) found that in 76% of adverse events occurring in non-ICU patients, 
CRI was present for more than one hour before the event with a median duration of 6.5 hours. In 
one third of these adverse events, documented instability had continued for more than 24 hours. 
Although CRI is occasionally instantaneously and unmistakably apparent (lethal arrhythmia, 
massive pulmonary embolism, severe hemorrhage pathologies), it more often evolves over time, 
with an emerging constellation of subtle abnormality in one or more vital signs as shown in 
Figure 2. Patients repeatedly display physiologic compensation before compensatory 
mechanisms are exhausted. Therefore, when CRI occurs it is usually a process and not an event. 
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Figure 2. Graph to show the emerging constellation of subtle abnormality in one or more VS and 
that CRI is an evolving process in time as opposed to an event  
1.2.8 The need for Time Series approaches to studying CRI retrospectively 
However, the problem of recognizing evolving patterns in overt CRI, or the changes in VS 
leading up to CRI, requires an approach which accounts for identifying changes over real time. 
Therefore, time series analytic approaches are necessary. 
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 A time series of HR for a particular patient is a sequence of HR values measured 
typically at successive points in time, and spaced at uniform time intervals. Time series models 
are increasingly being used in the field of medicine for analyses of beat-to-beat variability in HR 
in order to discriminate between survivors and non-survivors (Stein et al., 2008) and have been 
shown to be effective for retrospective analysis of physiological variables in the field of intensive 
care medicine (M Imhoff & Bauer, 1996; Michael Imhoff, Bauer, Gather, & Löhlein, 1998). A 
univariate analysis of HR, for instance, provides information about the range of heart rates and 
its distribution, and a multivariate analysis of HR as a predictor variable provides an 
understanding of how HR relates to RR or SpO2. However, a time series analysis, with its 
associated properties of autoregression and moving average, provide an understanding of how 
HR changes over time. Time series data points are assumed to correlate to adjacent data points, 
providing information about how a variable relates to itself in time over a defined period 
(autocorrelation), thus providing a paradigm to evaluate the dynamic state of a variable over 
multiple points in time. Since time series are repeated measures of the same variable over time, it 
also allows the study of patterns, called trends. Furthermore, time series can be split into 
different window periods, or intervals, and allow for computations of the slopes, intercepts, 
means and variances so as to compare one interval with the next.  
 
Time series analysis Autoregressive (AR) models are models in which the value of a 
variable in one period is related to its values in previous periods. AR (p) is an autoregressive 
model with p lags: yt = y t = μ + + εt  , where µ is a constant, and γp is the 
coefficient for the lagged variable in time t-p. An AR (1) process is expressed as:  
 29 
 
yt  = µ + 𝛾𝛾yt-1+Et  = µ + y(Lyt)+ Et  or (1- 𝛾𝛾L)yt  = µ + Et 
Moving average (MA) models account for the possibility of a relationship between a variable 
and the residuals from previous periods. MA(q) is a moving average model with q lags is  
 yt = µ + Et +  
where  q is the coefficient for the lagged error term in t-q. For instance, MA(1) model is 
expressed as: yt = µ + Et + Et-1. Autoregressive moving average (ARMA) models combine 
both p autoregressive terms and q moving average terms, also called ARMA(p,q).   
  
εt-i 
Since the development of CRI is a process and develops over a period of time, time series 
modeling approaches incorporating the AR and MA parts can be applied to retrospectively 
analyze patterns within the variables prior to the overt instance of CRI (CRI epoch).  
Based on the properties of a continuously monitored signal’s characteristics, instead of 
accounting for an instantaneous deviation from normal thresholds as being a case of CRI (when 
in actuality, it could be an artifact), two additional time series properties can be imposed, referred 
to as the duty cycle and tolerance. For a pre-defined window period (P) of monitoring, if (T) be 
the time the signal persists in a particular state, duty cycle is defined by the 
relationship . 
1.2.9 Time series modeling approaches and the use of ARIMA and VAR 
The AutoRegressive Integrated Moving Average (ARIMA) model uses the lag and shift of 
historical information (AR and MA) in order to develop a mathematical model on an existing 
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univariate time series to provide great detail and precision. First proposed in 1976 by Box and 
Jenkins (Box, Jenkins, & Reinsel, 2013), ARIMA time series intervention analysis has been used 
widely for prediction and early warning analysis of infectious diseases (Luz, Mendes, Codeço, 
Struchiner, & Galvani, 2008; Reichert et al., 2004; Yi, Du, Wang, & Liu, 2007). ARIMA (AR, 
D, MA) models make use of previous observations to make predictions of future values using 
lagged variable values. While the advantage of the ARIMA is that it can parsimoniously model a 
given variable, requiring only the prior data of the variable, building models to study CRI 
patterns has to be done individually on a patient-by-patient basis and mostly on a univariate 
basis. This makes the approach computationally inefficient to find the “best” generalizable 
model to study patterns among the variables in large datasets involving multiple patients and 
their corresponding time series variables. Furthermore, in preliminary study, we have tried to 
implement the use of the ARIMA model after applying a T4253 data smoothing procedure for 
artifacts on a small subset of this study’s SDU patients. We were able to forecast univariately, 
after several iterations of deciding the parameter values and best fit, based on information criteria 
(AIC and BIC). However, we could not identify specific patterns common to this set of patients, 
owing to numerous individual differences in the time series of each of the variables from patient 
to patient. It remains unclear if this was due to the imputation procedure, the smoothing, the lack 
of uniformity of the time series, or the iterative nature of ARIMA modeling to arrive at a best fit 
model, without overfitting, to study signal patterns prior to CRI. 
The Vector autoregression (VAR) model extends the univariate autoregressive model in 
order to describe not only how the values of a particular variable at time, t,  depend linearly on 
the past values but also include the past values of the other variables as input for modeling (Wild 
et al., 2010).  The general VAR (p) model is  
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yt = c + A1yt-1+ A2yt-2+…….+ Apyt-p+et  where 
 
VAR models have been used in medicine receiving wide-spread acceptance. This is 
because they are not only capable of analyzing time series variables multivariately, but also 
provide an environment for testing Granger causality, a common method used for the 
investigation of dynamic interrelationships in multivariate time series  (e,g. increase in HR, 
causes a decrease in RR within a particular period etc.) (Goebel, Roebroeck, Kim, & Formisano, 
2003; Roebroeck, Formisano, & Goebel, 2005). Granger causality is based on the common-sense 
concept that causes precede their effects in time. Such temporal ordering implies that if there are 
two time series represented generally as X and Y, the past and present values of the series X 
should help to predict future values of series Y (Barnett & Seth, 2014).  
The VAR framework allows all variables to be treated as if the variables have equal 
influence on each of the other variables--allowing for feedback relationships within the variables. 
In preliminary study, we have previously implemented the VAR model in a small subset of the 
data, multivariately, using HR, RR and SPO2 to study the inter-relationships among the variables 
as well as the Granger causal dynamics among the variables leading up to CRI. For instance, in 
our cases as shown in Preliminary Study Section 13.5, SpO2 falling below threshold was the first 
indicator of CRI. However, SpO2 itself was generally not the cause for changed RR or HR, but 
rather RR and HR tended to be the cause for the SpO2, suggesting that SpO2 is a later VS 
change, and is led by more subtle changes in other VS as causative. Our preliminary study also 
demonstrated that building a VAR model (being an iterative approach) to explain the causal 
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patterns among the variables, with the sheer number of coefficients (as high as 273) which 
needed to be estimated, led to greater room for modeling errors and over fitting and at times not 
being achieve a stable VAR model. The VAR model, if well implemented, is quite rich in 
capturing the temporal dynamics made possible by adjusting the model order (max lag), but has 
also been criticized in medical literature since it tends to be a simplified characterization of 
highly complex hemodynamic response (Gorrostieta, Ombao, Bédard, & Sanes, 2012) and is 
open to confounding from unmeasured relationships, as are most other statistical procedures 
(Thompson & Siegle, 2009). Thus, while CRI is a process with evolving patterns prior to overt 
CRI, better approaches besides ARIMA and VAR models to study inter-relationships among the 
variables and their patterns are needed. 
1.2.10 Machine Learning 
1.2.10.1 Definition and Benefits 
Machine learning, the science of learning from data, automates mathematical and statistical 
analyses of time series datasets in order to learn from the data and extract important patterns and 
trends (Goodwin, VanDyne, Lin, & Talbert, 2003; Lucas, 2004). In a type of machine learning 
called unsupervised machine learning, the outcome is not specified or known, and the goal is to 
provide a training sample data in order to identify inter-relationships among the time series 
variables and to then detect emerging patterns. The resulting model may assume the form of a set 
of rules or descriptions that lead to the outcome (CRI) which can then be tested on a validation 
data set, not exposed to prior training. Small changes in multi-parameter time series of 
physiologic data (HR, RR, SpO2) encompass subtle patterns that may seem random or of low 
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certainty upon visual monitoring of the time series, but could in fact be early signatures of 
impending CRI (Lynn & Curry, 2011) and as such, lend themselves to machine learning 
algorithms (Crump et al., 2009), which are better than standard time series approaches in terms 
of their performance of identifying patterns.    
1.2.10.2 Unsupervised machine learning—clustering approach to pattern recognition 
In machine learning, the problem of unsupervised learning is that of trying to find hidden 
structure in unlabeled data. Unsupervised learning methods have commonly been used in 
bioinformatics for sequence analysis and genetic clustering; in data mining for sequence and 
pattern mining; and in medical imaging for image segmentation (Gupta, Saul, & Gilbertson, 
2004) Unsupervised learning algorithms try to find correlations without any external inputs (i.e. 
labeled data) other than the raw data itself. As such, the training data consists solely of a set of 
input vectors X without any corresponding target values. The goal in such unsupervised learning 
problems is to discover potential regions where there may be groups of similar kinds within the 
data. These advanced computational algorithms decide on how to group the sample into clusters 
which share similar properties. The most common unsupervised learning method is cluster 
analysis, which is used for exploratory data analysis to find hidden patterns or grouping in data. 
The clusters are modeled using a measure of similarity which is defined upon metrics such as 
Euclidean or probabilistic distance.  
1.2.10.3 Clustering Approaches to pattern recognition 
The clustering problem is defined as a problem of classifying a group of data points into a 
number of clusters without any prior knowledge about data structure, to produce a concise 
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representation of the data. It is a fundamental means for multivariate data analysis widely used in 
numerous applications, especially in pattern recognition. Clustering, as an unsupervised machine 
learning technique aims to explore the unknown nature of data through the separation of a 
defined dataset, with no ground truth, into a finite set of “natural” data structures (Jain & Dubes, 
1988; Xu & Wunsch, 2008; Xu & Wunsch, 2005). Clustering algorithms have been employed 
extensively in biomedical research (Andreopoulos, An, Wang, & Schroeder, 2009) with 
particular focus in areas involving gene expression data analysis, genomic sequence analysis and 
MRI data analysis.  
Given a set of data objects (entities, input patterns, instances, observances, units), the 
objective of clustering is to partition them into a certain number of clusters (groups or subsets) 
in order to explore the underlying structure and provide useful insights for further analyses. The 
operational definition of a cluster is that it is a set of data objects which are similar to each other, 
with data objects pertaining to different clusters different from one another (Everitt, Landau, & 
Leese, 2001). Two of the most commonly employed types of clustering procedures include—
hierarchical and partitional (eg: K-means) clustering.  
1.2.11 Hierarchical Clustering 
Hierarchical clustering (HC) is an unsupervised machine learning method of cluster analysis 
which seeks to build a hierarchy of clusters. Common strategies for hierarchical clustering 
include agglomerative (“bottom up”) approach where each observation starts within its own 
cluster and pairs of clusters merged moving up in the hierarchy (as shown in Figure 3). The 
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divisive (“top down”) approach starts with clumping all the observations into a single cluster and 
then performs a recursive splitting moving down in the hierarchy (as shown in Figure 4).  
 
Figure 3. “Bottom up” clustering approach   
 
Figure 4.  “Top down” clustering approach 
Both agglomerative and divisive clustering algorithms organize data objects into a hierarchical 
structure based on the proximity matrix. The results of hierarchical clustering are usually 
depicted by a dendrogram as shown in Figure 5.  
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Figure 5. Dendrogram showing the implementation of hierarchical clustering on a dataset. 
The root node of the dendrogram represents the entire data set, and each leaf node is 
regarded as a data object. The intermediate nodes describe the extent to which the objects are 
proximal to each other, and the height of the dendrogram expresses the distance between each 
pair of data objects or clusters, or a data object and a cluster. The ultimate clustering results can 
be obtained by cutting the dendrogram at different levels (the dashed line in Fig. 5).  
This representation provides very informative descriptions and a visualization of the 
potential data clustering patterns, especially when real hierarchical relations exist in the data, 
such as the data in medicine, physiology and biology (Jain & Dubes, 1988; Kaufman & 
Rousseeuw, 2009; Theodoridis & Koutroumbas, 2008). Agglomerative clustering, which starts 
with exactly one data object, is often preferred as compared to the divisive approach which is 
computationally much more intensive (Kaufman & Rousseeuw, 2009).  
Hierarchical clustering approaches have been employed for gene clustering providing 
useful insights into annotating functionally unknown genes through annotated genes which 
exhibit similar expression patterns (Iyer et al., 1999; Moreau, De Smet, Thijs, Marchal, & De 
Moor, 2002). It has been employed in gene profiles for fingerprinting diseases such as cancer, 
providing new approaches for diagnosis and drug development (Alon et al., 1999; Scherf et al., 
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2000). Garber et al. applied hierarchical clustering to data from 67 different lung tumors from 
four different types—squamous, large cell, small cell and adenocarcinoma and identified that 
adenocarcinomas exhibited more heterogeneity in terms of its patterns while the others remained 
within their own clusters (Garber et al., 2001). Alizadeh et al. successfully implemented 
hierarchical clustering to distinguish between the patterns of two molecularly distinct subtypes of 
diffuse B-cell lymphomas, providing molecularly relevant criteria for therapy and drug selection 
(Alizadeh et al., 2000).  
1.2.12 K-means clustering 
The K-Means method is another type of unsupervised machine learning clustering approach 
which can be used to generate globular clusters—i.e. clusters with non-convoluted boundaries, 
bearing some resemblance to the mean of the cluster. Clusters produced in this manner are non-
hierarchical and do not overlap. The general procedure of the K-means algorithmic approach 
begins by partitioning the data set into K clusters and the data points are randomly assigned to 
the clusters resulting in clusters that roughly have the same number of data points. For each and 
every data point, a distance measure is calculated from the data point to each cluster and if the 
data point is closest to its own cluster, it remains in the cluster it started with, but if not, then it is 
moved to the closest cluster. The process is repeated until a complete sweep through of all the 
existing data points, results in no data point moving from one cluster to another, thus ending the 
clustering process (Jain, 2010). An example of a graph derived after such a procedure is shown 
in Fig 6. K-means has commonly been employed in the medical literature because it has the 
advantage of being computationally faster than hierarchical clustering and produces tighter 
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globular clusters, especially with a large number of data points. Heuristic algorithms employed 
by K-means are efficient in converging quickly to a local optimum, so as to 
 
Figure 6. K-means clustering illustration.  
 
terminate the process. However, automatically determining the final number of clusters has been 
a challenging problem in this type of clustering procedure, with the general procedure being to 
implement different values of K. Although there are a number of predefined criterion established 
(Figueiredo, Cheng, & Murino, 2007; Hansen & Yu, 2001), the commonly employed criteria 
include the AIC and BIC and minimal values of the sum of squares of error. The main 
assumption is that the division of the clusters will produce an optimum number of patterns with a 
type of partitioning that is resilient to random change in values within the system (Jain, 2010).  
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1.3 CONCEPTUAL FRAMEWORK 
Physiologic alterations, in most hospitalized patients are preceded by changes in monitored 
parameters and a period of cardiorespiratory instability (CRI) that is either unrecognized or 
improperly detected.  In clinical practice, vital sign monitoring and early detection of easily 
discernible physiological alterations are the key to detecting CRI, identifying it appropriately, 
and applying appropriate interventions to prevent negative patient outcomes that result in failure 
to rescue (FTR) or death of the patient. The proposed study, which aims to identify and compare 
the admission characteristics of patients who develop overt CRI (unstable) with patients who do 
not develop CRI, characterize the first vital sign (VS) over stability threshold and use clustering 
to study interaction among other VS within each cluster, and explore whether the various CRI 
patterns are linked to specific disease states was guided by the conceptual framework shown 
below.  
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Figure 7. Theoretical/Conceptual Framework  
There are both dynamic (continuously changing with time) and static patient-level factors 
that contribute to create CRI. Dynamic physiologic patient changes responsible for a patient’s 
CRI include traditionally measured parameters, e.g., vital signs. For the purposes of the proposed 
study, heart rate (HR), respiratory rate (RR) and oxygen saturation (SpO2) were used to identify 
dynamic patient changes. We analyzed both single parameter (i.e. each of the parameters 
individually) as well as multiparameter trends of change in these variables. Static patient-level 
factors long known to contribute to the mortality of hospitalized patients (generally incorporated 
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in a variety of acuity-scoring systems) were also analyzed for the purposes of our study. 
Examples include age, gender, race, type of service (medical/surgical), hospital admission 
diagnosis, medical history and Charlson Comorbidity Index (CCI) score for patients on whom 
physiological information was obtained. Although, these static characteristics cannot 
independently be used for CRI surveillance, they could be valuable when used in combination 
with dynamic patient changes for patterns of physiologic alterations. Thus, both dynamic patient 
changes and static patient characteristics were used for pattern analysis of CRI.  
The proposed study was based on the belief that the earlier the physiological alterations 
are recognized and acted upon, the less negative impact that their occurrence will have on the 
patient’s outcome. Hence, early detection of physiologic alterations could prevent negative 
patient outcomes or even death during hospitalization, while not doing so will lead to FTR or 
death. Since CRI does not happen without some alteration in either single parameter or multi-
parameter trends of change, early detection of physiological alterations could be analyzed using 
unsupervised machine learning algorithms. If vital decision-making information obtained from 
these patterns can be used to guide therapeutic interventions, then hopefully negative 
consequences or death during hospitalization could be averted.  
1.4 SIGNIFICANCE OF RESEACH STUDY FOR NURSING 
Existing monitoring systems hold the promise of both detecting and predicting patient 
deterioration at the time of its occurrence. However, current monitoring tools in SDU patients do 
not characterize inter-temporal patterns in multiple VS during the time of overt CRI. Pattern 
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recognition of CRI even from its very first occurrence, prior to the occurrence of an adverse 
event carries with it the possibility of targeted interventions to avert an impending adverse event. 
Such studies will provide direction to augment existing monitoring efforts for improved and 
early prediction capabilities in order to shift nursing focus on CRI from a reactive approach to a 
preemptive one. Eventually, monitoring systems can be integrated to generate databases which 
will enable improved risk prediction models (DeVita et al., 2009). Such data can also be used for 
improved critical incident review and contribute to quality improvement thereby serving as better 
tools in avoiding negative patient outcomes or death, while being extremely beneficial for 
clinicians and bedside nurses.  
Acuity of patients transferred from the intensive care units to step-down units (SDUs) or 
wards is increasing, making cardiorespiratory instability (CRI) an increasingly common 
occurrence on these units. Although multiple vital signs (VS) are continuously monitored, alerts 
are provided to staff only when individual parameters exceed presumed thresholds of stability, 
without relationship to each other. To better inform clinical decision-making, it would be helpful 
to know if VS changes manifest in unique clusters, and are related to certain patient 
characteristics or pathophysiologic etiologies.  
 Initial exploration of the potential of grouping patient deterioration according to VS 
change patterns was motivated by the emergence of medical emergency teams (MET).(Buist et 
al., 2002) The emergence of MET prompted evaluation of their benefit in improving patient 
outcomes(Bellomo et al., 2003; Bristow et al., 2000; Buist et al., 2002; DeVita et al., 2004; 
Hillman et al., 2005), and critical analysis of events preceding a MET call for help(Downey et 
al., 2008; Jones, Bates, et al., 2006; Jones, Duke, et al., 2006). Jones et al.(Jones, Duke, et al., 
2006) studied 400 MET calls in intensive care unit (ICU) settings and found the underlying 
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reasons for initiating calls were hypoxia (41%), hypotension (28%), altered consciousness 
(23%), tachycardia (19%), tachypnea (14%) and oliguria. They termed these etiologies “MET 
syndromes.” In their study, infections (especially pneumonia), cardiogenic shock or pulmonary 
edema and arrhythmias were responsible for 53% of all MET calls. Jones et al. were the first to 
suggest that, if there are differing causes for MET calls, there must be differing patterns in 
monitored variables that precede the unstable state. If so, they suggested there might be different 
approaches to managing CRI based on MET syndrome. We were unable to identify any studies 
that attempted to analyze patterns of CRI using commonly monitored variables, e.g., heart rate 
(HR), respiratory rate (RR) and peripheral oxygen saturation (SpO2) prior to instability that was 
sufficiently severe to prompt MET activation. Having such information prior to a MET need 
might help clinicians recognize the syndrome, or instability pattern, earlier in its course and 
provide more targeted supportive or preventative measures to avert the crisis. 
1.5 PRELIMINARY STUDIES 
The following sections demonstrate the candidate’s development of knowledge and skills to 
support doctoral work. 
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1.5.1 Understanding of the Pathophysiologic Underpinnings of Hemodynamics, CRI and 
Patterns of Shock 
The candidate developed two manuscripts, now published, to demonstrate his evolving 
understanding of the pathophysiologic underpinnings of hemodynamics, CRI, and shock 
evolution.  
The first paper (Appendix A) described the physiology of cardiac output, and the various 
parameters and technologies used to assess volume status and cardiac output, The candidate was 
first author on this paper published in the Oxford Textbook of Cardiology,  Fall 2012. In 
summary, this paper demonstrated that there was no such thing as a “normal” cardiac output but 
rather the question was whether cardiac output is either adequate or inadequate to meet the 
metabolic needs of the body. As such, choices for hemodynamic monitoring should always 
reflect the necessity for information that might alter patient management based on preload 
responsiveness. This paper demonstrated theoretically that the diagnostic accuracy of preload 
responsiveness is markedly improved by the use of arterial pulse pressure or stroke volume 
variation, within the context of their physiological limitations. Most importantly, the paper 
showed that the accuracy of absolute values may be less important at a given point in time, rather 
it is important to follow the trends of monitored variables to track the short-term effects of 
therapies, such as fluid loading, for improvements in cardiac output. Finally, the authors pointed 
out that it is not monitoring of hemodynamic variables that can improve outcomes, instead it is 
the changes in therapy guided by the patterns of the data and appropriate treatments based on that 
data that can improve patient outcomes.  
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The second paper (Appendix B) has been published as a refereed book chapter in 
Monitoring Technologies in Acute Care, Spring 2014 where the candidate was the first author. 
This paper focuses on the interface between monitoring and physiology at the bedside. In 
summary, the authors showed that hemodynamic instability (used instead of CRI, since it was 
described from a pathophysiological perspective instead of thresholds) as a clinical state 
represents either a perfusion failure with clinical manifestations of circulatory shock and/or heart 
failure. Different types of circulatory shock etiologies—hypovolemic, cardiogenic, obstructive 
and distributive shock-- require different types of treatment modalities making distinctions 
among them important. Diagnostic approaches or therapies based on data derived from 
hemodynamic monitoring assume that specific patterns of derangements reflect specific disease 
processes, which will respond to appropriate interventions. This paper further described the 
physiologic underpinnings of various forms of shock (hypovolemic, obstructive, distributive, 
cardiogenic) and demonstrated how shock patterns can be recognized based upon manifestation 
of monitored parameters. Finally, this paper pointed out that hemodynamic monitoring at the 
bedside improves patient outcomes, however treatment decisions and pharmacological 
management should be directed at the right time, ensuring that the patterns are monitored for 
patients experiencing hemodynamic instability.  
These two papers above demonstrate the development of the candidates understanding of 
the physiologic and pathophysiologic underpinnings of CRI and its assessment, and the ability to 
describe and disseminate this information.  
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1.5.2 Baseline Characteristics Contributing to CRI Propensity 
The candidate also examined mechanisms to evaluate characteristics other than VS as they 
contribute to CRI, specifically co-morbid conditions. The first study was a psychometric analysis 
of the Charlson Comorbidity Index (CCI) Deyo Method (an indicator of comorbidity extracted 
from administrative databases, and a variable in the parent study Appendix C. This work was 
presented as a poster at the Society of Critical Care Medicine Scientific Congress, Spring 2013. 
Since CCI items were originally empirically derived, this study sought to provide psychometric 
information about the CCI Deyo through exploratory factor analysis (EFA) to expose factor 
structure of the items and construct validity. This study used the entire sample of patients who 
will be used for dissertation purposes, but used their admission characteristics of age, gender, 
race and CCI to apply EFA. In summary, EFA revealed multiple comorbidity groupings within 
the list of CCI disease states. However, this abstract also showed that the CCI as a scoring 
mechanism had a poor construct validity.   
In addition, the candidate conducted a study to examine the internal structure of the CCI 
Appendix D. In this study, principal component analysis (PCA) was utilized to investigate the 
internal structure and identify subscales. In summary, this manuscript submitted to the Journal of 
Nursing Measurement, Spring 2015, using PCA revealed co-occurrence of certain disease items, 
indicating common underlying pathologic mechanisms, as well as propensity of multiple 
comorbidity groupings. The study findings of a multidimensional internal structure of the CCI 
implied that subscale scores could provide more detailed information on patient comorbidities 
than an overall index. 
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These two (a poster and a paper) demonstrated the candidate’s development of skills in 
implementing a modified version of a type of dimensionality reduction approach called PCA. 
Some studies (Honda, Notsu, & Ichihashi, 2010; Su & Dy, 2004) have shown that PCA  could be 
used initially prior to the implementation of other clustering approaches such as K-means as a 
way of reducing computations for K-means. Performing PCA before implementing clustering 
procedures is done sometimes as an optional step for efficiency purposes. The skills acquired by 
the candidate in implementing PCA approach were useful for decisions to be made during K-
means clustering for finding optimal solutions. 
 
 
1.5.3 Dissertation Topic Evolution 
The candidate developed a doctoral dissertation approach abstract which was accepted for 
presentation of a poster at the Eastern Nursing Research Society, Boston, MA, Summer 2012.  
This poster outlined the initial background, purpose and aims for the current study, which has 
since been further refined. This poster is in Appendix E.  
This poster demonstrated the candidate’s progress in developing an initial research proposal, 
formulating preliminary studies and necessary course work required in planning to accomplish 
its aims and mathematical, statistical and computer skills required to implement machine 
learning approaches. It also demonstrated the change in the nature of the methodological 
approaches which must be implemented, based on actually working with the dataset. 
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1.5.4 Temporal Variation in CRI 
The candidate also conducted a study examining temporal variation in CRI onset. He reported 
this study in a poster for presentation at the Rapid Response Systems International Society 
Conference in Spring 2014 (Appendix F). In summary, hypothesizing that real VS variations 
indicating CRI occur throughout the clock, unlike MET calls which are made more frequently 
during mid-day hours, we proceeded to test our hypothesis. We discovered that patients became 
unstable throughout the clock without specific clustering relative to time of day thus concluding 
that better methods to improve clinician’s detection of patient instability were needed. 
This poster demonstrated skills learned in using a count/tallying approach of the number of alerts 
based on each hour of the day for the entire group of patients within a 24 hour period. It also 
demonstrated the ability to calculate the probability values of the alerts per hour for the entire 
day. The project also clearly demonstrated the propensity of patient’s developing CRI throughout 
the clock, thus highlighting the importance of our future dissertation in that that, just as CRI 
develops around the clock, patterns of CRI develop prior to overt CRI also develop and are 
evolving in time. Thus, approaches to preemptively recognize the patterns are needed. 
1.5.5 Time-Series Analysis using Vector Autoregressive (VAR) model 
The candidate also examined the use of a time-series modeling approach called VAR to study 
Granger causal dynamics among the variables of HR, RR and SpO2. The first study was VAR 
model for studying causal dynamics of CRI (Appendix G). This work was submitted to the 
upcoming Society of Critical Care Medicine conference, Spring 2015. Since vital signs of HR, 
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RR and SpO2 undergo inter-related changes in situations of stress, from a physiologic 
perspective, we hypothesized that VAR model could explore the inter-related Granger causal 
dynamics among the variables prior to CRI. In summary, VAR modeling indicated that, HR 
changes seemed to occur before those in RR, within the examined sample of patients.  
 In addition, the candidate also worked on a paper, Vector Autoregressive (VAR) 
Environment For Assessing Granger Causal Dynamics Of Vital Sign Time-Series In Step-Down 
Unit (SDU) Patients With Cardiorespiratory Instability, which was submitted to Nursing 
Research, a publication of the Eastern Nursing Research Society, in Summer 2015 (Appendix 
H). This study was the first of its kind in the literature to use VAR modeling approach with HR, 
RR and SpO2 in order to apply Granger causality in SDU patients. We found out that within the 
study sample, SpO2 itself was generally not the cause for changed RR or HR, but rather RR and 
HR tended to be the cause for the SpO2. This suggested that SpO2 was a later VS change, and 
was led by more subtle changes in other VS as causative. In summary, even though it was an 
iterative and lengthy computational procedure to build patient-specific VAR models, these 
models in certain cases could reveal Granger causal inter-relationships among the three variables 
of HR, RR and SpO2.  
These two (an abstract and a paper) demonstrate the candidate’s development of skills in 
implementing time-series modeling approaches as well as a working knowledge of time-series 
related concepts such as lags, autocorrelation etc. and other time-series related concepts. We 
were able to build a few stable patient-specific VAR models to study Granger causality. 
However, there were instances where a stable VAR model could never be developed and as such 
causal dynamics could not be examined. We also discovered that in certain cases, VAR models 
were prone to much over-fitting of the data and as such, with the sheer number of coefficients to 
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be estimated, were erratic and unreliable. With the absence of continuous streaming data for the 
window-period examined, there were instances where, after rendering the time series uniform, 
we had to impute missing values. It was unclear if the models were erratic due to imputation 
procedures, artifacts or both. Accordingly, we decided to switch to better approaches to study 
patterns. However, basic skills of working with time-series data were acquired. 
1.5.6 Monitoring Cardiorespiratory Instability-Current status and implications for 
nursing practice 
The candidate developed a manuscript which was submitted to Intensive and Critical Care 
Nursing in Summer 2015 and is currently under review. This manuscript was a literature review 
on other existing options to identify in-hospital patient instability such as telemedicine, rapid 
response teams and technology-enabled early warning scores. Although existing monitoring 
systems hold the promise of better detection and recognition of CRI, nursing surveillance still 
remains the key to reliable early detection. Research directed towards improving nursing 
surveillance and facilitating decision-making is needed to ensure safe patient outcomes and 
prevent CRI. 
This manuscript in Appendix I demonstrated the development of the candidates broad 
understanding of the various approaches currently being extensively studied and implemented to 
better detect CRI, along with their strengths and shortcomings.  
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2.0  RESEARCH DESIGN AND METHODS 
2.1 STUDY DESIGN 
This study was conducted under the domain of the ongoing NIH R01-NR013912. The study 
design was descriptive and utilized a convenience sample of non-randomized self-controlled 
cohorts to identify and compare the characteristics of step-down unit (SDU) patients who 
develop true cardiorespiratory instability (CRI) (unstable) with patients who never develop CRI 
(stable), identify inter-relatedness of the other VS within and prior to the CRI1 epoch, and 
explore whether CRI1 patterns are linked to specific disease states. 
2.2 SAMPLE AND SETTING 
The study was approved by the University of Pittsburgh Institutional Review Board (IRB) 
(PRO13030536). This research study utilized data from patients between 11/06-8/07 who have 
been discharged in the 7-8 years since, using only archived medical records and physiologic data 
of patients. The sample for the study was recruited from a 24-bed trauma step-down unit (SDU), 
located in a tertiary academic medical center. For the proposed study, data were extracted from 
the input obtained from beside monitors (model M1204, Philips Medical, Bothell, WA). The 
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standard of monitoring care on the SDU is that all patients undergo physiologic noninvasive 
monitoring of continuous HR (3-lead ECG), RR (bioimpedance signal), and peripheral blood 
oxygen saturation (SpO2) plethysmographic signal (model M1191B, Phillips Medical Systems). 
Nurse to patient ratios in this SDU ranged from 1:4 to 1:6 during the study period and depended 
on the number of patients in the unit and the acuity of the patients’ conditions. Data were 
collected during a sequential 8-week time period. There were 307 admissions with 22,588 total 
patient-hours of monitoring data (81 mean monitoring hours/patient).  
2.3 ENTRY/EXCLUSION CRITERIA 
Patient entry criteria for the study were : 1) admitted to a monitored bed on Unit 9G, and 2) age 
>21 years during the study period (11/06-8/07; 8 weeks). All patients were admitted to the study 
unit according to the usual standard of care for monitored bed admission and utilization. There 
were no special efforts to direct patient admissions to the SDU. Patients remained in the study 
sample until their discharge to another unit or from the hospital. If they were readmitted to the 
SDU, they were treated as another admission. These criteria yielded a convenience sample of 
307 patients during the study time period. The total census of patients on the study unit was 
included in the sample, with only patients ≤ 21 years of age excluded. 
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2.4 DEFINITION OF CARDIORESPIRATORY INSTABILITY AND COHORT 
ASSIGNMENT 
During the study continuously monitored vital signs were recorded and then the data were 
downloaded from the bedside monitors (See 2.7 for data frequency, format, and storage). Data 
streams were then analyzed to determine if any of the VS variables measured violated the  
thresholds deemed to constitute normality, and thereby defined as CRI: HR between 40-140 
beats per minute, RR between 8 and 36 breaths per minute, and SpO2 > 85%, with additional 
persistence requirements and artifact elimination as in 2.7. Patients’ status was classified as 
unstable if their continuously monitored and recorded vital signs had even once exceeded any of 
the normality thresholds during their SDU stay, and as stable if their continuously recorded vital 
signs had never exceeded any of the thresholds (excluding artifact). A CRI epoch is defined as 
the first time a VS exceeded normality thresholds, and continues until the time at which all VS 
return to normality. The patient’s first instance of CRI not caused by artifactual VS cross of 
threshold is assigned as CRI1. The CRI driver is defined as the VS first to cross the CRI stability 
thresholds in the CRI1 epoch. 
2.5 SAMPLE SIZE 
The sample size is limited to that of the parent study. For this proposed study, 307 patients were 
included and yielded 22,588 hours of continuous VS monitoring data.  
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2.6 SAMPLE SIZE JUSTIFICATION 
The sample size is a subset of the data obtained in the parent study. Based on our previous 
studies which indicate CRI prevalence of about 25%, we projected that our total sample of 307 
patients would yield 25% unstable (~77 patients) and 75% stable patients. However, there were 
more unstable patients (n=133) than were initially anticipated. Since Aim 1 of our study was to 
only provide a baseline assessment of identifying whether any of the admission characteristics 
differ between CRI and no CRI patients (a dichotomous outcome), our sample size of 307 
patients was sufficient for exploration purposes. Specific aim 2 of our study related to the use of 
unsupervised learning techniques of hierarchical and K-means clustering on the sample to 
identify potential patterns in CRI manifestation. These procedures were employed only on 
unstable patients (n=133). There are no generally accepted rules regarding minimum sample 
sizes or the relationships between the clustering objects and the number of cluster variables. The 
choice of clustering variables is dependent on the context of the study (CRI from VSTS) with 
clustering algorithms capable of implementing the procedure with any sample sizes. However, 
empirically, studies have shown that hierarchical clustering works best with small sample sizes 
while K-means works best with sample sizes > 100—which was satisfied by the current sample.  
2.7 SDU ADMISSION CHARACTERISTICS 
Clinical and demographic variables present at the time patients were admitted to the SDU were 
collected from the patients’ clinical records and the hospital’s electronic databases. The 
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following are the admission characteristics that were used—age (continuous), gender 
(dichotomous M/F), race (categorical), type of medical care service (categorical), hospital 
admission diagnosis (categorical), medical history (categorical), SDU intake admission source 
and Charlson comorbidity index (CCI) Deyo Method (cumulative score, 0,1, >2, categorical). 
Outcome variables included hospital length of stay (LOS; continuous), SDU LOS (continuous) 
and transfer from SDU to either a higher intensity monitoring unit or lower intensity monitoring 
unit. Lower intensity unit collectively included patients transferred either to a rehabilitation 
center, a long-term hospital, a skilled nursing facility, a home health agency or directly to home. 
These data  collected for the purpose of this research study were assigned a research code 
number and any obvious patient identifiers (name, SSN, hospital record number) were removed 
from this information using De-ID software ™ (Gupta et al., 2004) prior to entry into the study 
database. De-ID™ is recognized as being appropriate for this use by the University of Pittsburgh 
IRB. These data were extracted for the entire 307 patient dataset and placed in a .csv file for 
study purposes. All dates in this file (admission time and date, LOS, etc.) have been converted to 
Coordinated Universal Time (UTC) to ensure congruence of time stamps across years and 
seasonal time changes. 
2.7.1 Continuous vital sign monitoring data 
The time stamped analog data for HR, RR and SpO2 (at 1/20 Hz freq.) was downloaded from 
every bedside onto external drives during the retrospective study interval.  All time stamps of the 
VS data were also converted to UTC time. These time-stamped data were stored as continuous 
data streams and were identified only according to the bed space monitoring device from which 
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they were obtained, with no patient identifiers. These data were then placed on the study secure 
server in .csv file format. To parse the bedside VS data streams in order to assign them to 
specific patients, an IRB honest broker, Ms. Saul,  provided the research team with the patient 
Study IDs (no identifiers) and their associated times of admission and discharge from each Unit 
9G bed space. Each bed space was then correlated to individual patients by using the Study ID 
only. Once collected, these data were entered into a research database containing no protected 
health information (PHI) and only included a study-ID to uniquely identify each patient and 
his/her data stream. The linkage file which was automatically generated by the De-ID software 
was in an encrypted format and was retained only by Ms. Saul. 
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3.0  STATISTICAL MANAGEMENT PLAN 
3.1 SPECIFIC AIM 1 
Hospital admission characteristics consisted of age, gender, race, type of service, medical 
history, type of service, and Charlson-Deyo comorbidity Index (0,1,> 2).(Deyo, Cherkin, & Ciol, 
1992) “Type of Service” was classified as surgical if patients were assigned to the general 
surgery service on admission to the hospital, irrespective of whether their hospital course 
warranted a surgical procedure or not. Medical patients were assigned to services such as 
cardiology, critical care medicine, family medicine, internal medicine, haematology, 
orthopaedics, otorhinolaryngology, pulmonary and vascular. We also recorded the admission 
diagnosis as based on the ICD-9 classification code assigned at hospital admission. ICD-9 codes 
were grouped into 14 categories according to the classification system reported by Brown et 
al.(Brown, Terrence, Vasquez, Bates, & Zimlichman, 2014) and then reduced to 4 categories 
based on the majority of codes. The resulting 4 categories were: trauma, diseases of circulatory 
system, diseases of digestive system and all other diagnoses. We also recorded SDU admission 
intake source (transfer from higher intensity monitoring, direct SDU admission or transfer from 
lower intensity unit). Outcomes were total hospital length of stay (LOS) in days, SDU LOS, and 
discharge disposition from the SDU (transfer to a higher or lower intensity monitoring unit) and 
mortality. 
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3.1.1 CRI determination.  
Physiologic monitoring data for the 307 patient admissions were available for a mean of 80 
hours and median of 60 hours each. HR, RR, and SpO2 data were recorded at 1/20 Hz frequency 
while systolic blood pressure (SBP) and diastolic blood pressure (DBP) were recorded less 
frequently. VS excursions beyond our local criteria for instability concern (HR< 40 or > 140, 
RR< 8 or > 36, SpO2< 85%, SBP < 80 or > 200, DBP>110) were defined as “CRI events” and 
occurred 271,288 times. Owing to a high incidence of artifacts with pure threshold deviations, 
we additionally required that “events” had to persist for a minimum duration of 3 minutes, either 
continuously or sporadically, for 4 minutes out of a 5-minute moving window (80% duty cycle) 
with or without changes in other VS, to be initially classified as CRI. Events that did not meet 
persistence criteria were termed artifact.  
Of 307 patients, 113 never developed CRI, leaving 194 patients to be considered who 
demonstrated 1582 events (Figure 8). We annotated these events as real CRI (1137 events) or 
artifact (445 events). We created a Gantt chart per patient to record the occurrence of real and 
artifact events in the order that they occurred during a patient’s SDU stay. From that analysis, 61 
patients only had artifact alerts, so they were included in the group who never developed CRI. 
This left a total of 133 (43%) patients who experienced CRI and 174 (57%) who did not.  
The driver of CRI was defined as the first VS to cross a threshold and meet persistence criteria. 
Time to onset of first CRI (CRI1) was the time in days from initial admission to the SDU to 
CRI1, and duration was length of the CRI1 epoch in minutes.  
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Figure 8. Schematic diagram of patients and events.  
The schematic details the process of deriving initial cardiorespiratory instability (CRI1) events 
and the distribution of events due to cardiorespiratory instability drivers - heart rate (HR), 
respiratory rate (RR), pulse oximetry (SpO2) and blood pressure (BP). The resulting sample 
included 133 patients with initial cardiorespiratory instability (CRI1) due to HR, RR or SpO2 
which accounted for 133 CRI1 events. 
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3.1.2 Statistical Analysis 
Data were analyzed using IBM SPSS v22 for descriptive analysis and exploration. The Mann-
Whitney U-test was used to analyze non-parametric differences between groups for continuous 
variables and Chi-square to compare categorical variables. A p< .05 was considered significant. 
3.2 SPECIFIC AIM 2 & 3 
3.2.1 Event Identification (CRI1 determination) 
Continuous bedside physiologic monitoring data were available for a mean of 80 hours per 
patient. HR, RR, and SpO2 data were recorded at 1/20 Hz frequency. VS excursions beyond our 
local criteria for instability concern (HR< 40 or > 140, RR< 8 or > 36, SpO2< 85%) not due to 
artifact were defined as CRI if they persisted for a minimum duration of 3 minutes, or for 4 
minutes out of a 5-minute moving window (80% duty cycle) with or without changes in other 
VS. Of the 307 patients, 133 (43%) experienced CRI and 174 (57%) did not. For this aim, 
analysis of data was restricted to the first CRI event (CRI1). The first vital sign to exceed the 
previously identified thresholds was termed the CRI1 driver. 
3.2.2 Cluster identification 
Steps in preprocessing were feature extraction, standardization, and outlier removal. A 
combination plot of the feature space of all variables was created to facilitate visualization of all 
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possible combinations between VS for each of the features. Hierarchical and k-means clustering 
were then used to complete analysis of the data. 
3.2.2.1 Feature extraction, standardization and outlier removal 
We extracted statistical features (mean, median, mode, minimum, maximum, range, variance and 
standard error of mean) for HR, RR, and SpO2. Since measurement of each VS used a different 
scale, we standardized the variables, thus rendering them scale free. Clustering techniques and k-
means in particular are sensitive to outliers, causing outliers to be selected as initial clusters. Two 
patients with this characteristic were eliminated (|z|> 3.29), leaving 131 patients. 
3.2.2.2 Combination plot of feature space 
Figure 9 shows the combination plot. In this analysis, if a feature for HR exists but RR does not 
exist, it is dark grey colored, indicating missingness. We discovered 13 patients with only HR 
and RR, 7 patients with only HR and SpO2, 5 patients with missing data for HR or SpO2 and 3 
patients with only SpO2. These 28 patients were omitted, leaving 103 patients with complete 
data for cluster analysis. 
3.2.3 Hierarchical clustering—Ward’s linkage procedure 
We next implemented agglomerative hierarchical clustering on the remaining sample. In order to 
form clusters, there must be a criterion for similarity or distance between patients and a criterion 
for determining which clusters are to be linked at successive steps. We used squared Euclidean 
distance, since all variables were continuous, and Ward’s linkage method for determining 
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linkage of clusters. The algorithm began by merging similar clusters, two at a time, at successive 
steps until all cases were complete. Additional cases were then added to the cluster using the 
linkage procedure. 
 
Figure 9. Combination plot of the feature space.  
A combination plot is a visualization of all possible combinations between the feature space and 
the combination of each feature to the next, for all the available patients. The dark grey color 
indicates missingness. There were 13 patients with only heart rate (HR) and respiratory rate 
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(RR), 7 patients with only HR and peripheral pulse oximetry (SpO2), 5 patients with missing 
modes in either HR or SpO2 and 3 patients with only SpO2. 
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The algorithm developed a proximity matrix to calculate the squared Euclidean distance between 
the standardized features for all patients (Jain et al., 1999). Clustering began with each case 
being a cluster unto itself. Next, cases with smaller distances from each other were linked until 
all clusters were completed and means for all variables were calculated for each cluster. The 
squared Euclidean distance to cluster means was calculated and distances summed for all cases. 
At each stage, the two clusters that merged were those that resulted in the smallest increase in the 
overall sum of squares within-cluster distances. A visual representation of the distance at which 
clusters combined was represented by a dendrogram. 
3.2.4 K-means clustering 
The major difference in k-means involves pre-specifying k, which is the number of clusters. By 
visualizing potential cluster solutions from the dendrogram, we chose an initial starting value for 
k at 3. The first step in k-means clustering involved finding k centers. The algorithm started with 
an initial set of means and classified patients based on their distances to the centers. Next, it re-
computed the cluster means using patients that were assigned to the cluster and then reclassified 
all patients based on a new set of means. The steps were then repeated until cluster means 
changed minimally between successive steps. Finally, the algorithm calculated the means of the 
clusters again and assigned patients to their permanent clusters. We tested several clustering 
solutions that entailed using 3 to 5 clusters after visualizing the dendrogram obtained from 
hierarchical clustering. 
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3.2.5 Feature selection 
Following initial identification of clusters, an ANOVA table was constructed to describe F ratios 
per feature within the clusters for a particular solution. If non-significance was observed, it 
indicated that that feature contributed minimally to separation of clusters. From this analysis, we 
discovered that VS range, variance and standard error of mean value were mostly non-significant 
whereas features of mean, median, mode, maximum and minimum always contributed 
significantly to differences between clusters. Hence, we used the latter 5 features per VS for 
further clustering analyses. 
3.2.6 Cross Validation of Cluster Solution 
As the final step, we implemented cross-validation (CV) of each of the cluster solutions. To 
determine the best solution, we performed a commonly used process(McLachlan, Do, & 
Ambroise, 2005) termed a stratified 10-fold CV to each solution. For this analysis, the original 
sample was partitioned into 10 equal sized subsamples. A single subsample was retained as 
validation set for testing the cluster solution with the remaining 9 subsamples used as training 
data and the process repeated 10 times. The advantage of this method is that all observations are 
used for both training and validation, and each observation is used for validation exactly once. 
The performance of a particular clustering solution was assessed by its accuracy, which is the 
number of correctly classified instances. 
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3.2.7 ANOVA Posthoc Bonferroni Test 
To test if there were significant differences between per feature between various clustering 
solutions, we implemented ANOVA posthoc bonferroni test with the dependent variable as the 
feature (eg: HRMedian, HRMode etc), with the fixed factor being the cluster grouping (eg: C3-1, 
C3-2 etc). 
3.2.8 CRI1 driver within each cluster of patients 
Once we identified the best cluster solution, we labeled each cluster based on the general pattern 
of each VS within that particular cluster. We also examined the interaction among VS within that 
cluster and its relationship with the other two VS per patient, using cross correlations of HR with 
RR, HR with SpO2 and RR with SpO2 per patient within each cluster. 
3.2.9 Admission characteristics and outcomes 
Admission characteristics were age, gender, race, type of service (admitted to a medical or 
surgical service, irrespective of whether they had a later surgery or not), medical history, and 
Charlson-Deyo comorbidity Index (0,1,> 2).(Deyo, Cherkin, & Ciol, 1992) We recorded 
admission diagnosis based on the ICD-9 classification code assigned at hospital admission, 
which we first grouped into 14 categories according to the classification system reported by 
Brown et al.(Brown, Terrence, Vasquez, Bates, & Zimlichman, 2014), and further reduced into 4 
categories based on code frequency. The resulting 4 diagnosis categories were: trauma, diseases 
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of circulatory system, diseases of digestive system, and all others. We also recorded SDU 
admission intake source (transfer from a higher intensity monitoring unit, or direct SDU 
admission or transfer from lower intensity unit). Outcomes were hospital length of stay (HLOS) 
in days, SDU length of stay (SDU LOS), and discharge disposition from the SDU (transfer to a 
higher or lower intensity unit). Lower intensity unit collectively included patients transferred 
either to a rehabilitation center, a long-term hospital, a skilled nursing facility, a home health 
agency or directly to home. In our sample, there were no reported deaths for any of the patients. 
3.2.10 Medications per cluster and a control group 
We reviewed the list of medications given 24 hours prior to and after CRI1 epoch, per patient 
within each cluster. Since patients received several types of medications, based on critical care 
expert physician reviews, we pooled medications into seven different categories. The categories 
were AntiInfectives (which included antibacterial, antifungal and antivirals), Cardiovascular 
Drugs, Vitamins/Electrolytes/Hematinics, Fluids, Respiratory Drugs, Narcotics and Sedatives 
and Other (all other drugs besides the other 6 categories).  
The choice for the control group (patients who never developed CRI) was based on the 
following stratified random sampling approach. Within the set of patients used for clustering, the 
breakdown by hospital admission diagnosis was—52.4% Trauma, 15.5% diseases of circulatory 
system, 14.6% diseases of digestive system and 17.5% all other diagnoses. Further, based on the 
driver of CRI1, most CRI1 events occurred on Day 2 of SDU admission. The selection process 
for the control group therefore used Day 2 of the SDU admission for No CRI patients. 
Medications administered on Day 1 (24 hours prior) and Day 3 (24 hours after). Similar to 
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patients with CRI, their medications were also grouped into the same 7 different categories. We 
randomly chose 50 patients from the 174 patients who never developed CRI. However, the 
choice for these 50 patients was based on a stratified random sampling approach of using 
52.4 % of 50 = 26 Trauma patients 
15.5% of 50 = 8 disease of circulatory system patients 
14.6% of 50 = 7 disease of digestive system patients and 
17.5% of 50 = 9 All other diagnoses patients. 
3.2.11 Statistical Analysis 
Data were analyzed using IBM SPSS v22 for descriptive analysis and exploration, WEKA and 
MATLAB R2015a for clustering and cross validation. We also examined the interaction among 
VS within that cluster and its relationship with the other two VS per patient, using cross 
correlations of HR with RR, HR with SpO2 and RR with SpO2 per patient within each cluster. 
One way ANOVA was used to verify if there were inter-cluster differences between age 
(continuous variable), while a Chi-square test was used to verify if there were inter-cluster 
differences based on other categorical variables (gender, race, type of service, hospital admission 
diagnosis, SDU admission source and Charlson Comorbidity Index). A chi-square test was also 
used to verify whether there were differences in the proportion of medications received between 
each of the clusters (1,2,3 and 4) and the control group (Cluster 0) by each medication category. 
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4.0  HUMAN SUBJECTS RESEARCH 
4.1 RESPONSIBLE CONDUCT OF RESEARCH 
All doctoral students are required to complete the University of Pittsburgh Education and 
Certification Program in Research and Practice Fundamentals, an online educational series 
designed to provide training to individuals employed by the University of Pittsburgh, and its 
affiliated institutions. The program consists of both required and optional modules, depending on 
one’s research focus. There are four required modules: 
Module 1—Research Integrity 
Module 2—Human Subjects Research 
Module 6—HIPPA Researchers Privacy Requirements 
Module 14—UPMC HIPPA Staff Security Awareness Training 
Upon completion of this program, a certification is stored in a database and the examinee is able 
to print out a hard copy of this certificate for their records and submission to the Public Health 
Service granting agencies. The PI successfully completed modules 1, 2, 6 and 14. Certificates of 
successful completion are on file. 
Ethical issues related to human subjects’ research are incorporated in doctoral courses including 
Nursing Theory and Research, Research Methods, Qualitative Research, Pilot study, Grant 
writing Practicum, Research Development and others. Areas covered in these courses include 
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ethical issues related to obtaining informed consent, participant confidentiality, conflict of 
interest, research integrity, protection of vulnerable subjects, internal audit procedures, seeking 
IRB approval, and adverse event monitoring. Further instruction was received through the 
various research seminars the PI attended including the Surviving Skills Workshop, Research 
Methodology Series, and Research Progress Update Series available through the School of 
Nursing and the University. 
4.2 PROTECTION OF HUMAN SUBJECTS 
All the data were deidentified and retrieved from a retrospective chart review of existing 
databases and the data will be linked to specific patient identifiers once all the data has been 
collected from the data sources. The University of Pittsburgh Institutional Review Board 
reviewed and approved the study by the expedited review procedure authorized under 45 
CFR46.110 and 21 CFR 56.110. All study data were stored in a locked filing cabinet in the 
School of Nursing. All study data were managed in a secure password protected and encrypted 
database. Research records were maintained for as long (indefinite) as it took to complete this 
research study, as well as the parent study. Research subjects were never identified by name. 
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4.3 WOMEN, MINORITY AND CHILDREN INCLUSION IN RESEARCH 
4.3.1 Inclusion of women and minorities 
The study enrolled both men and women who experienced CRI during the study time frame. The 
current UPMC patient demographic composition by gender, race and ethnicity is 49% female, 
51% male, 1% Hispanic, 99% Non-Hispanic with the non-Hispanic population of 0% American 
Indian/ Alaskan native and Native Hawaiian/Pacific Islander, 5% Asian, 20% African American 
and 75% Caucasian. We anticipated that prevalence of the gender and race of the patients who 
experienced CRI will be consistent with these UPMC—wide patient demographics and noticed 
this to be true in the results. No one was excluded from participation in this study based on race, 
ethnicity or gender. 
4.3.2 Inclusion of Children  
The study setting was an adult tertiary care hospital where the care of children is a rare 
occurrence, however children under 18 years of age who may experience a MET activation were 
excluded from this study due to the unique patterns of instability and surveillance required and 
special training necessary for pediatric care. 
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4.4 DATA SAFETY AND MONITORING PLAN 
Data and safety monitoring was conducted during monthly meetings with the dissertation 
committee. During these meetings any change in exempt status for human research were  
discussed and addressed. We were prepared to report any change of status immediately to the 
IRB, but this was never needed. A summary of these reviews was provided to the IRB at the time 
of the yearly renewal. There was no change in exempt status. 
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5.0  RESEARCH RESULTS AND DISCUSSION: SPECIFIC AIM 1 
5.1 RESULTS FOR SPECIFIC AIM 1 
Hospital admission characteristics of the 307 patients (174 with no CRI and 133 with CRI) are 
related in Table 1. There were no significant differences between CRI and no CRI patients in 
regard to age, gender, race, or admission service. Chronic obstructive pulmonary disease was the 
most common comorbidity (16.6%), but there were no significant differences in comorbidities 
between groups. Slightly more than half (52.1%) had a Charlson Comorbidity index of 0, 
indicating a relatively healthy population; however there were no significant differences between 
CRI and no CRI groups. 
There were significant differences between groups based on SDU intake admission 
source (p=.042) (Table 2). Almost half of CRI patients were admitted to the SDU from an 
intensive care unit (ICU) (44.4%), whereas less than a third (31%) of no-CRI patents were 
admitted from an ICU. CRI patients had a longer hospital LOS (11.3 days [95% CI = 9.6-13.0]) 
than the no-CRI patients (7.8 days [95% CI = 6.4-9.20], p=.001). The mean SDU LOS was also 
longer for CRI patients (6.1 days [95% CI = 5.3-6.9]) than the no-CRI patients (3.5 days [95% 
CI = 3.1-3.9], p<.001). There was no significant difference between groups in terms of discharge 
destination or mortality. 
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Table 1. Hospital admission characteristics in patients with and without one cardiorespiratory 
instability (CRI) event during step-down unit length of stay 
Variable Total 
(N=307) 
No. (%) 
No CRI 
(n = 174) 
No. (%) 
CRI 
(n = 133) 
No. (%) 
p-value 
Age, mean, SD 57.4 + 20.2 55.9 + 20.4 59.28 + 19.9 .146 
Gender, n (%)    .55 
Male 179 (58.3) 104 (59.8) 75 (56.4)  
Female 128 (41.7) 70 (40.2) 58 (43.6)  
Race, n (%)    .136 
White 220 (71.7) 117 (67.2) 103 (77.4)  
Black 43 (14) 29 (16.7) 14 (10.5)  
Other 44 (14.3) 28 (16.1) 16 (12.0)  
Type of Service, n (%)    .54 
Surgical  167 (54.4) 92 (52.9) 75 (56.4)  
Medical 140 (45.6) 82 (47.1) 58 (43.6)  
Hospital Admission Diagnosis    .124 
Trauma 176 (57.3) 106 (60.9) 70 (52.6)  
Diseases of Circulatory System 46 (15) 27 (15.5) 19 (14.3)  
Diseases of Digestive System 34 (11.1) 13 (7.5) 21 (15.8)  
All other diagnoses 51 (16.6) 28 (16.1) 23 (17.3)  
Medical History    .278 
Chronic Obstructive Pulmonary 
Disease 
51 (16.6) 25 (14.4) 26 (19.5)  
Diabetes 50 (16.3) 25 (14.4) 25 (18.8)  
Myocardial Infarction 25 (8.1) 11 (6.3) 14 (10.5)  
Congestive Heart Failure 24 (7.8) 9 (5.2) 15 (11.3)  
Cerebral Vascular Disease 20 (6.5) 12 (6.9) 8 (6)  
Charlson-Deyo Comorbidity Index    .507 
   0 160 (52.1) 94 (54) 66 (49.6)  
   1 76 (24.8) 44 (25.3) 32 (24.1)  
   > 2 71 (23.1) 36 (20.7) 35 (26.3)  
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Table 2. Intake admission source to the step-down unit (SDU), and outcomes in patients with 
and without one cardiorespiratory instability (CRI) event during step-down unit (SDU) length of 
stay 
Variable Total 
N = 307 
 
No CRI 
(n=174) 
No. (%) 
CRI 
(n=133) 
No. (%) 
p-value 
SDU Intake Admission Source    .042 
Higher intensity monitoring unit 113 (36.8) 54 (31) 59 (44.4)  
Direct Admission, or lower 
intensity monitoring unit 
182 (59.3) 109 (62.6) 73 (54.8)  
Unknown 12 (3.9) 11 (6.3) 1 (0.8)  
     
Outcomes     
Hospital LOS, mean days, SD 9.2 + 9.8 7.8 + 9.2 11.3 + 10.2 .001 
SDU LOS, mean, SD 4.7 + 4.2 3.5 + 2.9 6.1 + 4.9 <.001 
Transfer from SDU to a higher 
intensity unit, n (%) 
31 (10.1) 15 (8.6) 16 (12.0) .449 
Died, n (%) 5 (1.6) 5 (2.9) 0  
Key: LOS = length of stay 
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5.1.1 Drivers of CRI 
Of the 133 patients with CRI they had collectively 1071 CRI events (Figure 8), the CRI driver 
for 536 (50%) of these events was RR. SpO2 was the driver for 346 (32%) events, HR for 149 
(14%) and BP for 40 (4%). Although RR was the most common initial cause of CRI events 
overall, for the first 133 CRI events (CRI1), SpO2 was most common (56%), followed by RR 
(33%) and HR (11%) (Figure 10). 
5.1.2 Onset of initial and subsequent CRI Events 
We computed the number of days from SDU admission to the development of CRI1 by driver. 
As shown in Figure 11, CRI1 driven by HR tended to occur between days 1 and 6. CRI1 driven 
by RR varied in presentation between the first 10 days of SDU admission, with 34% developing 
CRI1 on days 1-2. CRI1 driven by SpO2 tended to occur between day 0 and day 6, with 47% 
occurring between days 0 and day 2. As shown in Figure 12, a minority (23%) of patients with 
one CRI1 event never developed a second CRI event, while the remaining 77% of patients 
exhibited an average of 2-5 events each. 
5.1.3 Duration of CRI1 Epoch 
For HR, CRI1 duration lasted between 3-8 minutes, with most lasting 4 minutes. For RR, CRI1 
duration ranged from 3-20 minutes, with 48% of patients having duration of 3 minutes. For 
SpO2, CRI1 duration ranged from 3-56 minutes, with 76% lasting between 3 and 6 minutes.
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Figure 10. Percentage of cardiorespiratory instability (CRI) events and artifacts in 133 patients.  
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The CRI driver was most commonly respiratory rate (RR) while arterial oxygen saturation 
(SpO2) was the cause of most artifacts. SpO2 was also the most common cause of the first 
cardiorespiratory instability event (CRI1).  Heart rate (HR) was a relatively infrequent cause. 
 79 
 
 
Figure 11.  Number of days from admission to development of the first cardiorespiratory 
instability event (CRI1).  
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CRI1 events most commonly occurred in the initial days following step-down unit admission. 
 
 
 
Figure 12. Frequency of further cardiorespiratory instability (CRI) events in patients who 
developed at least one instance of CRI.  
Most events occurred on the first days of step-down unit admission with a progressive decline 
over time.   
 
5.2 DISCUSSION FOR SPECIFIC AIM 1 
The major findings from this study are: 1) There were no demographic differences between 
patients who did and did not develop CRI, except that patients who were admitted from an ICU 
were more likely to become unstable; 2) patients who developed at least one instance of CRI had 
longer lengths of SDU and hospital stays; 3) the driver for most CRI events was RR; and 4) onset 
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of CRI1 differed between drivers, whereas SpO2 was the most common CRI1 driver. While 
CRI1 due to HR and SpO2 tended to occur between the 1st and 6th day, CRI1 due to RR 
occurred later in hospitalization (up to the 10th day); 5) duration of CRI1 due to SpO2 tended to 
last longer, while duration of CRI1 due to HR was short-lived. 
 Patients are admitted to a SDU because they are viewed as potentially unstable and in 
need of closer monitoring for CRI, but knowing which VS to observe more carefully would be 
helpful. Respiratory rate, which has been termed the “neglected sign”,(Cretikos et al., 2008) 
caused more events within our sample than HR or SpO2. Our findings suggest that RR should 
receive greater emphasis as an important component of clinical monitoring. The importance of 
this finding is reinforced by the criteria we used to define RR as a driver of CRI, e.g., a rate that 
was clearly abnormal (<6 and >36 min-1). It is therefore likely that RR is more sensitive and 
may be abnormal before reaching these threshold values. Respiratory rate is altered by numerous 
clinical states commonly seen in SDU patients, such as pain, pre-existing lung disease, infection, 
and opioid use. An increase in RR signals increased work of breathing, which places additional 
stress on the cardiovascular system. Consequently an increase in RR is an important predictor of 
cardiopulmonary arrest.(Hodgetts, Kenward, Vlachonikolis, Payne, & Castle, 2002) Findings of 
our study can be best paired with those of Nurmi et al.(Nurmi, Harjola, Nolan, & Castren, 2005) 
who found the most common medical emergency team trigger criteria was respiratory distress. 
Goldhill et al.(Goldhill & McNarry, 2004) identified RR and HR as the VS most often abnormal 
prior to unexpected death. Despite these known associations, RR is too commonly dismissed as 
an indicator of distress and recorded as an approximate value or consistently recorded as either 
16 or 18(Cooper, Cant, & Sparkes, 2014). Education regarding the importance of proper 
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monitoring and reporting of values which exceed expected norms should become an integral part 
of staff orientation and continuing education.  
 We also found that patients admitted from a higher intensity monitoring unit were more 
likely to develop CRI, a finding that also has implications for practice. Although objective 
criteria exist for determining optimal time for transfer out of the ICU, the decision is often driven 
by a variety of factors, including subjective judgment. (Garland & Connors, 2013) In addition, 
bed availability, both in the ICU and SDU, can influence timing of transfer. (Truog et al., 2006) 
The process of transfer, itself, can lead to increased stress and the potential for instability. Our 
findings suggest that close observation is indicated in the initial hours following transfer and for 
the next several days. In our sample, CRI tended to occur early following SDU admission. 
Notably, 77% of patients who developed one CRI event subsequently developed additional 
events. This suggests the need to monitor patients more closely following SDU admission and 
monitor patients who experience CRI even more closely. Conversely, more than half of our 
sample never became unstable. If models could be developed that could predict patients who 
never become unstable, the ability to predict instability would have implications for patient triage 
and enable clinicians to focus attention on those with greater instability likelihood.(Chen, 
Dubrawski, Hravnak, Clermont, & Pinsky, 2014)  
Patients who developed CRI had increased SDU and hospital length of stay, similar to the 
findings obtained by Fuhrmann et al.(Fuhrmann, Lippert, Perner, & Østergaard, 2008) Lighthall 
et al.(Lighthall et al., 2009) showed that patients with abnormal VS had a LOS twice that of 
“normal”. We also demonstrated that patients with CRI had both hospital LOS and SDU LOS 
that were twice that of the no-CRI patients. The literature reports increased 30-day mortality in 
patients with abnormal VS, (Bell et al., 2006; Fuhrmann et al., 2008; Goldhill & McNarry, 2004) 
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with the greater the number of abnormal VS, the greater the risk of mortality. While it is likely 
that mortality increases with increasing numbers of abnormal VS, in our study mortality between 
patients with and without CRI was not statistically significant, likely due to our small sample 
size. 
5.3 LIMITATION FOR SPECIFIC AIM 1 
The study has several limitations. The sample size was small and our thresholds for abnormality 
were externally set independent of prior physiologic analysis. However, these are the threshold 
values commonly used as medical emergency team trigger criteria. (Hravnak et al., 2011; 
Hravnak et al., 2008; Smith, Prytherch, Schmidt, Featherstone, & Higgins, 2008) Use of lower 
thresholds might have altered our results. Our data apply to the SDU of one Level-1 Trauma 
Center and may not be reflective of other settings or patient populations. Finally, our process of 
identifying events as “real” versus artifact may have misclassified events. 
5.4 CONCLUSION FOR SPECIFIC AIM 1 
Our retrospective analysis of CRI in monitored SDU, shows that patients admitted from a higher 
intensity monitoring setting were more likely to become unstable than those from elsewhere. 
Furthermore, patients who experienced one CRI event were more likely to have additional CRI 
events during their SDU stay and to remain longer in both SDU and hospital. The driver for most 
CRI events was RR although the initial CRI event was more often SpO2. Finally most CRI1 
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occur within the first 72 hours of SDU admission. Interestingly, there were no other demographic 
differences in patients who did and did not develop CRI. Findings suggest the need to more 
closely monitor SDU patients transferred from an ICU and accurately monitor for respiratory 
insufficiency. 
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6.0  RESEARCH RESULTS AND DISCUSSION: SPECIFIC AIMS 2 &3 
6.1 RESULTS SPECIFIC AIM 2 
Of 307 patients, 133 (43.3%) developed CRI1 due to HR, RR or SpO2. In 14 (11%) HR was the 
driver, in 44 (33%) RR was the driver and in 75 (56%) SpO2 was the driver, making SpO2 the 
most prevalent driver. A summary of features extracted from CRI1 epochs per VS is provided in 
Table 3. 
Table 3. Numeric features extracted from initial cardiorespiratory instability (CRI1) epoch by 
vital signs of heart rate (HR), respiratory rate (RR) and arterial pulse oxygenation (SpO2) in 
N=133 patients. 
Feature HR 
Mean + SD 
RR 
Mean + SD 
SpO2 
Mean + SD 
Mean 88.79 + 25.52 17.42 + 8.77 87.17 + 7.39 
Median 88.75 + 25.83 17.46 + 8.9 87.25 + 7.35 
Mode 88.85 + 26.85 17.38 + 8.93 87.28 + 7.59 
Maximum 95.19 + 29.82 21.24 + 10.01 90.07 + 5.99 
Minimum 83.02 + 22.02 13.37 + 7.91 84.18 + 9.41 
Range 12.35 + 15.85 7.87 + 5.53 5.89 + 5.33 
Variance 34.32 + 134.69 7.98 + 11.78 5.48 + 12.09 
Std. error of mean 0.98 + 1.43 0.60 + 0.45 0.45 + 2.63 
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6.1.1 Hierarchical and K-means Clustering 
Results of hierarchical clustering and distribution of the 133 patients into clusters (C) are shown 
for the 3 cluster solution (Figure 13), 4-cluster solution (Figure 14) and 5-cluster solution (Figure 
15). For a 4-cluster solution, results were: C1 24%, C2 61%, C3 8%, and C4 7%. Using this 
information, we tested k-means clustering with k-values set between 3 and 5. The result of a 3-
cluster solution is shown in Figure 16. Since k-means uses a different algorithm compared to 
hierarchical clustering, for k=4 the results were: C1 9%, C2 59%, C3 24% and C4 8% (Figure 
17). With k=5 the results were: C1 24%, C2 7%, C3 31%, C4 8% and C5 30%.(Figure 18). 
 
Figure 13. Dendrogram for 3 cluster solution 
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Figure 14. Dendrogram for 4-cluster solution  
The dendrogram is read from bottom to top, with the vertical lines showing joined clusters. The 
bottom most row contains all N=103 patients. Hierarchical clustering and Ward linkage method 
joined the cases. The figure shows the cut dendrogram to obtain a 4-cluster solution along with 
the breakdown of the cases pie chart. The majority (61%) of cases were in cluster 2. Cluster 
distances are plotted with the dendrogram which is read from bottom to top with the vertical 
lines showing joined clusters. The plot is rescaled to fall within the range of 1 to 25; however the 
ratio of the rescaled distances within the dendrogram is the same as the ratio of the original 
distances. 
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Figure 15. Dendrogram for 5-cluster solution 
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Figure 16. K-Means 3 cluster solution 
 90 
 
 
 
 
Figure 17. K-Means 4 cluster solution  
For a 4-cluster solution, with k=4, there were 9 patients in cluster 1, 61patients in cluster 2, 25 
patients in cluster 3 and 8 patients in cluster 4. The axis contains the standardized values of the 
mean for heart rate (HR), respiratory rate (RR) and arterial pulse oximetry (SpO2). The largest 
cluster is on the bottom of the 3D-graph. The pattern for this group is normal HR, low/normal 
RR and low SpO2. 
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Figure 18. K-Means 5 cluster solution 
 
 
6.1.2 Summary of vital signs with clustering solutions 
A summary of the vital signs for the 3-cluster solution is as shown in Figure 19. While the CRI1 
driver for C3-1 (3 cluster solution, cluster 1) was exactly the same for all the patients in C3-1 and 
C3-3, the driver was unevenly split in C3-2 with HR 47%, RR 41%, SpO2 12%.  
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Figure 19. Summary of VS with 3 cluster solution 
A summary of vital signs for the 4 cluster solution is in Figure 20, while for a 5 cluster solution 
is in Figure 21. 
 
Figure 20. Summary of VS 4 cluster solution 
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Figure 21. Summary of VS 5 cluster solution 
6.1.3 Cross Validation 
For the 3 cluster solution, 93.2% of instances were correctly classified (Figure 22). For the 4 
cluster solution, 89.3% of instances were correctly classified (Figure 23). The precision and 
recall values for each cluster was 1,0.97,0.46,0, while recall was 1,1,0.75,0. We noticed that for 
C1 and C2, recall was accurate. However, the confusion matrix showed that for C3, 2 patients 
were placed into C4, thus causing an error. For C4, the algorithm was performing extremely 
poorly by placing 2 patients in C2 and 7 patients in C3. However, a 5-cluster solution cross-
validation performed more poorly, with only 68.9% of correctly classified instances (Figure 24). 
The precision values for each cluster were (1,0.85,0.77,0.58,0.27) and recall was 
(1,0.65,0.87,0.88,0.25). Thus, a 4-cluster solution performed better than a 5-cluster solution. 
 94 
 
 
Figure 22. 10-fold crossvalidation of 3 cluster solution 
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Figure 23. 10-fold cross-validation of 4 cluster solution   
The confusion matrix shows that for cluster 1 and cluster 2, the recall was accurate. For cluster 3, 
2 patients were placed into cluster 4, thus causing a slight error. For cluster 4, the algorithm was 
performing extremely poorly by placing 2 patients in cluster 2 and 7 patients in cluster 3. 
However, the overall number of correctly classified instances was the highest at 89.32%. 
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Figure 24. 10-fold cross-validation of 5 cluster solution 
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6.1.4 ANOVA Posthoc Bonferroni Test 
As shown in Figure 25, there were more slightly more significant differences (higher percentage) 
between the clusters of a 4 cluster solution (eg: C4-1 vs. C4-2 of a 4 cluster solution) and given 
that with 10-fold cross-validation, a 4-cluster solution achieved higher accuracy, we decided that 
the 4-cluster solution was the best cluster solution. 
 
Figure 25. ANOVA Posthoc Bonferroni test percentage of significant comparisons 
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6.1.5 VS groupings in 4-cluster solution 
In C1, there were 9 patients whose VS grouped into normal HR (70-119 bpm), high RR (32-39 
breaths/min) and normal SpO2 (85-100%) with the driver being either RR or SpO2. In C2 there 
were 61 patients, whose VS grouped into normal HR (55-114 bpm), low to normal RR (3-28 
breaths/min), and low SpO2 (73-85%). Every patient within C2 had SpO2 as the driver. In C3, 
there were 25 patients, and VS grouped as normal HR (48-116 bpm), low RR (5-8 breaths/min), 
and normal SpO2 (89-100%), with the driver for all patients being RR. In C4, there were 8 
patients, whose VS grouped as high HR (142-158 bpm), normal RR (17-25 breaths/min) and 
normal SpO2 (95-100%), while the driver for all patients was HR. Significant cross-correlations 
(p<.05) were observed only between HR with RR. A box plot of the cross-correlations between 
the 4-cluster for HR with RR is shown in Figure 15. In C2 (the majority group), HR and RR had 
a positive cross-correlation indicating synergistic effect—either increasing or decreasing 
simultaneously. For C4, HR and RR had a negative cross-correlation indicating that while that 
HR increased RR decreased, and while RR increased, HR decreased. 
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Figure 26. Box-plot of cross correlations for 4 cluster solution  
This plot shows the cross-correlations between heart rate (HR) with respiratory rate (RR). In 
cluster 2 which was the majority group, HR and RR had a positive cross-correlation indicating 
synergistic effect. For cluster 4, HR and RR had a negative cross-correlation indicating that 
while HR increased RR decreased, and while RR increased, HR decreased. This (HR with RR) 
was the only significant cross-correlation as tested with ANOVA and a posthoc bonferroni test. 
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6.1.6 Admission characteristics and outcomes per cluster 
There were significant differences between clusters in age, SDU admission source and Charlson 
Deyo comorbidity index (Table 4). The outcomes of hospital and SDU LOS did not differ 
between patients by cluster (Table 5).  
6.1.7 Inter-cluster differences by medications 
There were significant differences between patients in each cluster in terms of the medications 
that patients received 24 hours prior to and after CRI1, as shown in Figure 27. Inter-cluster 
differences per cluster as well as per control group are shown in Table 6.  
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Table 4. Admission characteristics in patients with first instance of cardiorespiratory instability 
(CRI1) event during the course of their stay on the step-down unit (SDU) by cluster. 
 
Variable Total 
(N = 103) 
No. (%) 
Cluster 1 
(n=9) 
No. (%) 
Cluster 2 
(n=61) 
No. (%) 
Cluster 3 
(n=25) 
No. (%) 
Cluster 4 
(n=8) 
No. (%) 
p-value 
       
Age (Mean + SD) 
 
60.1 + 20 46.3 + 23 66.5 + 16 51.1 + 20 54.7 + 25 .001* 
Gender      .549 
Male 50 (51.5) 5 (55.6) 32 (52.5) 9 (36.0) 4 (50.0)  
Female 
 
53 (48.5) 4 (44.4) 29 (47.5) 16 (64.0) 4 (50.0)  
Race      .288 
White 81 (78.6) 5 (55.6) 51 (83.6) 19 (76.0) 6 (75.0)  
Black 9 (8.7) 2 (22.2) 4 (6.6) 3(12.0) 0 (0.0)  
Other 
 
13 (12.6) 2 (22.2) 6 (9.8) 3 (12.0) 2 (25.0)  
Type of Service      .739 
Surgical 57 (55.3) 5 (55.6) 33 (54.1) 13 (52.0) 6 (75.0)  
Medical 
 
46 (44.7) 4 (44.4) 28 (45.9) 12 (48.0) 2 (25.0)  
Hospital Admission 
Diagnosis 
     .450 
Trauma 54 (52.4) 6 (66.7) 32 (52.5) 10 (40.0) 6 (75.0)  
Diseases of 
Circulatory System 
16 (15.5) 0 (0.0) 11 (18) 4 (16.0) 1 (12.5)  
Diseases of 
Digestive System 
15 (14.6) 2 (22.2) 6 (9.8) 7 (28.0) 0 (0.0)  
All other diagnoses 
 
18 (17.5) 1 (11.1) 12 (19.7) 4 (16.0) 1 (12.5)  
SDU Admission 
Source 
     .008** 
Higher intensity 
monitoring unit 
43 (41.7) 8 (88.9) 22 (36.1) 8 (32.0) 5 (62.5)  
Direct Admission, or 
lower intensity 
monitoring unit 
60 (58.3) 1 (11.1) 39 (63.9) 17 (68.0) 3 (37.5)  
Charlson-Deyo 
Comorbidity Index 
     < .01** 
0 49 (47.6) 7 (77.8) 20 (32.8) 15 (60.0) 7 (87.5)  
1 25 (24.3) 1 (11.1) 18 (29.5) 6 (24.0) 0 (0.0)  
> 2 29 (28.2) 1 (11.1) 23 (37.7) 4 (16.0) 1 (12.5)  
*Oneway ANOVA p-value; **Chi-square test p-value 
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Table 5. Outcomes between clusters of patients who developed cardiorespiratory instability 
event (CRI1) during thecourse of their stay on the step-down unit (SDU) length of stay (LOS) by 
cluster. 
 
Variable Total 
(N = 103) 
 
Cluster 1 
(n = 9) 
Cluster 2 
(n = 61) 
Cluster 3 
(n = 25) 
Cluster 4 
(n = 8) 
p-
value 
Hospital LOS, mean, SD 
 
11.8 + 11.1 14.2 + 9.1 10.7 + 10.9 11.8 + 10.2 17.4 + 16.7 .391 
SDU LOS, mean, SD 
 
6.3 + 5.4 6.7 + 6.2 5.8 + 5.1 6.4 + 6.1 8.6 + 4.9 .581 
Transferred from SDU to a 
higher intensity monitoring 
unit 
 n (%) 
 
15 (14.6) 3 (33.3) 9 (14.8) 2 (8.0) 1 (12.5) .315 
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Figure 27. Inter-cluster differences by medication categories.  
There were significant differences between patients in each cluster in terms of the medications 
that patients received 24 hours prior to and after CRI1. 
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Table 6. Inter-cluster differences by medications as compared to the control group 
Drug Category Cluster0 
(n = 50) 
% 
Cluster1 
(n = 9) 
% 
Cluster2 
(n = 61) 
% 
Cluster3 
(n = 25) 
% 
Cluster4 
(n = 8) 
% 
p-value 
Cardiovascular  
Drugs 
7.9 9.1 11.0 6.5 10.9 .003 
Vit/Lytes/Hematinics 9.4 18.5 15.4 11.7 15.6 <.001 
Fluids 7.2 5.9 4.0 4.1 1.6 <.001 
Respiratory  
Drugs 
3.0 1.7 5.2 4.8 2.7 .009 
Narcotics & Sedatives 37.7 35.0 32.3 36.7 31.1 .036 
Anti-Infectives 3.7 5.6 5.2 7.2 6.6 .059 
Other 31.2 24.1 27 29 31 .075 
CRI
1
 Summary 
 of VS 
No CRI Normal HR 
High RR 
Normal 
SpO2 
Normal HR 
Low-Normal 
RR 
Low SpO2 
Normal HR 
Low RR 
Normal 
SpO2 
High HR 
Normal RR 
Normal 
SpO2 
 
 
Table 7. Cluster differences compared to control group 
Control Group. Vs. Cluster p-value 
Cluster 0 – Cluster 1 .002 
Cluster 0 – Cluster 2 .000 
Cluster 0 – Cluster 3 .003 
Cluster 0 – Cluster 4 .000 
Cluster 0 – All Clusters .000 
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6.2 DISCUSSION FOR SPECIFIC AIMS 2 & 3 
This study is the first of its kind to use hierarchical and k-means clustering on the feature space 
of CRI1 epoch to derive the VS pattern clusters of CRI1. The key findings from this study are as 
follows. First, the most common driver of CRI1 was SpO2, Second, four main clusters were 
derived: C1) normal HR and SpO2 but high RR; C2) normal HR, either low or normal RR and 
low SpO2; C3) normal HR, low RR, normal SpO2; and C4) high HR, normal RR and SpO2. 
Third, interactions among the VS suggest predictability of the driver; and finally, admission 
characteristics between patients placed within a cluster differed in regard to age, SDU admission 
source and Charlson Deyo comorbidity index.  
 Using features of mean, median, mode and maximum values for the VS of HR, RR and 
SpO2 for CRI1 epoch and applying clustering techniques, we found that a 4-cluster solution was 
best. An interesting finding was that within three of the clusters, the driver was identical for all 
patients in that cluster. For C2, the driver was SpO2, for C3 RR and for C4 HR. In C1 (normal 
HR and SpO2 and high RR), there were 2 patients whose driver was SpO2, while for the rest it 
was RR. On review of the actual data within the CRI1 epoch for these patients, we discovered 
that these patients’ RR was 32-34 breaths/ min, (i.e. relatively high) similar to other patients in 
the cluster. However, due to our threshold definition (RR > 36), their CRI1 driver was not RR 
but instead was low SpO2 < 85%. Barring this exception, all patients within a cluster had the 
same CRI1 driver.  
 We initially decided to use a total of 24 features derived from the CRI epoch per VS, 
which included the features shown in Table 1, similar to our previous work(M Hravnak et al., 
2014). However, in testing clustering techniques, the only features which were consistently 
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found to contribute to clustering were the mean, median, mode, minimum and maximum value. 
A commonly employed procedure is to use the ANOVA table similar to our approach and only 
retain features which contributed significantly towards clustering (Cellucci, Tyrrell, Twilt, 
Sheikh, & Benseler, 2014; Haldar et al., 2008). Besides this, we also observed that Q-Q plots 
generated for the features of range, variance and standard error of the mean per VS showed fat 
tails and severe departures from normality for the distribution. Further, extremely high kurtosis 
values were observed especially for HR values. Removing outlier cases would have resulted in 
further loss of patients available for clustering. We chose to eliminate(Devaney & Ram, 1997; 
Talavera, 1999) these 9 features instead of the patients, leaving 15 features for cluster analysis.  
 We employed the most commonly used unsupervised machine learning techniques of 
hierarchical and k-means clustering to derive CRI patterns(Hastie, Tibshirani, & Friedman, 
2009) and used them in a complementary way, with each approach giving slightly different 
information. We used hierarchical clustering and visualization of the dendrogram to potentially 
estimate where k-value could be set for k-means clustering. Our choice of a bottom-up approach 
such as agglomerative hierarchical clustering was to ensure that nearby and thus similar cases 
ended up within the same cluster, as opposed to top-down approaches.(Arai & Barakbah, 2007) 
While heuristic techniques exist for deciding on an optimal value for the number of clusters such 
as the use of an elbow plot (Mooi & Sarstedt, 2011) or other techniques,(Milligan & Cooper, 
1985; Tibshirani et al., 2001) our use of hierarchical clustering was primarily to estimate 
potential k-values, similar to others (Cellucci et al., 2014; Hawkins et al., 2015). Our choice of 
Ward’s linkage method was that besides being a commonly used approach (Stuetzle & Nugent, 
2012), it used ANOVA to evaluate distances between clusters in an attempt to minimize sum of 
squares of any two clusters (Ward Jr, 1963), thus a more rigorous approach . Further, since our 
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goal was to use k-means clustering also, Ward’s linkage method was ideal for comparing the two 
procedures. This is because it is also based on the same analysis of the clustering problem as k-
means and usually gives clusters that appear well-defined (Clarke, Fokoue, & Zhang, 2009). 
After visualization of the dendrogram, we decided on limiting the k-value used in k-means 
clustering to between 3 and 5 clusters.  
 We implemented 10-fold stratified cross validation (CV) (Wagstaff, Cardie, Rogers, & 
Schrödl, 2001) to determine if a 4-cluster or 5-cluster solution was better. Given our small 
dataset, stratified cross-validation was used so that all the folds would likely contain at least a 
good proportion of patients even from the smallest cluster. We evaluated the performance of k-
means algorithm by its accuracy, which is the degree of success in classifying correctly new 
instances as shown in Figure 4. While there is no universal algorithm giving the best 
performance in all possible learning situations,(Schaffer, 1994) CV was particularly suited in our 
study given the narrowed down option of two possible cluster solutions, as opposed to other 
boot-strapping procedures (Duda, Hart, & Stork, 2012) to decide the best cluster solution.  
 We used cross-correlations among the VS within the cluster to study the interactions 
within the 3 VS. For instance, a negative cross correlation between RR and SpO¬2 in a particular 
case would indicate that RR and SpO2 were moving in the opposite direction while a positive 
cross-correlation would suggest a synergistic effect. We expected that all patients within the 
cluster would exhibit certain pattern of changes for the three VS, but this was not noticed.  This 
suggests that while there are broad cluster patterns within CRI epoch, there could be subsets of 
patterns within the cluster not captured by our analysis or subtle variations within VS even prior 
to entering into CRI epoch (Clermont, Sileanu, Pinsky, & Ogundele, 2012, 2013). Future studies 
are needed to explore this potential. 
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The only admission characteristics that differed significantly between the patients in each cluster 
were age, SDU admission status and comorbidity Index. In the largest cluster (C2), mean age 
was 66.5 and the driver for CRI1 was SpO2, indicating that older patients were more likely to 
develop CRI1 due to SpO2, with the pattern being normal HR, either low or normal RR and low 
SpO2. Even though we had an overall relatively healthy cohort of patients (greater number of 
patients with Charlson index at 0), we showed that increasing age and comorbidities placed 
patients at greater risk of developing CRI1 due to SpO2. From a clinical perspective, this 
indicates that older patients with increased comorbid conditions and those transferred from a 
higher intensity monitoring unit should be monitored more closely for changes in RR and SpO2.  
Finally, we chose to study only the first instance of CRI (CRI1) in this study. The clinical utility 
of our study is to aid CRI pattern recognition so as to eventually target surveillance and 
intervention based on probable cluster patterns, right from the first occurrence of CRI. While in 
the case of MET syndromes (Jones, Duke, et al., 2006) that eventually result in serious 
deterioration needing a MET call might be identifiable from the outset, CRI occurs with subtle 
changes in VS (Hravnak et al., 2008). Thus, studies of VS pattern recognition such as ours could 
eventually be used for designing intelligent monitoring systems. This study is also a stepping 
stone to identify if patients continue to remain within the same cluster, or if they eventually 
switch to a different pattern, should successive instances of CRI occur. Future studies to track 
cluster progression will explore whether or not patients change clusters during further instances 
of CRI.   
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6.3 LIMITATION FOR SPECIFIC AIMS 2 & 3 
VS analyzed for this study were obtained from the SDU of one Level-1 Trauma Center and may 
not be reflective of other hospitals or patient populations. The thresholds used to define 
abnormality, although commonly used as thresholds for serious instability (Hravnak et al., 2011; 
Hravnak et al., 2008; Smith, Prytherch, Schmidt, Featherstone, & Higgins, 2008), differed from 
normal values remarkably. Use of lower thresholds of lesser instability magnitude might have 
altered our results. Also, we recorded our data at 1/20 Hz for each of the VS. With this recording 
frequency, there were a few instances when all values were not recorded. Nevertheless, we did 
not use missing value imputation or any other procedures commonly employed in time-series 
cross-section data to account for missing data (Honaker & King, 2010; Honaker, King, & 
Blackwell, 2011). We made this decision to insure the data were as accurate and as close to 
normal SDU monitoring practices as possible, yet seek features we could use for clustering.  
However, this may have resulted in loss of patients who could have otherwise been placed in one 
of the clusters. Finally, we employed a limited set of features and results could differ with 
increased features derived from CRI1 epoch, although the parsimonious feature set we used 
enabled testing both clustering approaches with less than 10 iterations of the algorithms. 
6.4 CONCLUSION FOR SPECIFIC AIMS 2 & 3 
Our analysis, the first of its kind to use clustering techniques on the feature space of the VS of 
HR, RR and SpO2 on CRI1 epochs in SDU patients, derived 4 different clusters of VS 
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presentations. The most common driver of CRI1 was SpO2 with the cluster pattern of normal 
HR, low-normal RR and low SpO2. The cluster groups varied on age, number of comorbidities 
and SDU admission source. Inter-cluster differences exist between the medication categories 
administered. Patients within the clusters differed individually from the control group of patients. 
Patients with and without CRI differed by medications administered. There is evidence that there 
may be differences in the physiologic underpinnings of these clusters as demonstrated by 
differences in medication need. Future study will be needed to determine if there are common 
physiologic underpinnings of the VS clusters which might inform clinical decision-making even 
at the point where CRI first manifests. 
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7.0  CONCLUSIONS 
CRI1 most commonly occurred due to SpO2 and was associated with prolonged hospital and 
SDU length of stay. Patients transferred from a higher level of care were more likely to develop 
CRI, suggesting that they are sicker when admitted to the SDU. Four different clusters of VS 
presentations for CRI1 were identified, with C2 (normal HR, low-normal RR and low SpO2) 
most prevalent. The cluster groups varied on age, number of comorbidities and SDU admission 
source. There is some evidence that there may be differences in the physiologic underpinnings of 
these clusters as demonstrated by differences in medication need and some admission 
characteristics. However, this requires future studies using more variables to hone in on disease 
process. 
The clinical utility of our study was to aid pattern recognition so as to eventually target 
surveillance and intervention based on probable cluster patters, right from the first occurrence of 
CRI. While in the case of MET syndromes that eventually result in serious deterioration needing 
a MET call might be identifiable from the outset, CRI occurs with subtle changes in VS. Thus, 
studies of VS pattern recognition such as ours could eventually be used for designing intelligent 
monitoring systems. This study is also a stepping stone to identify if patients continue to remain 
within the same cluster, or if they eventually switch to a different pattern, should successive 
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instances of CRI occur. Future studies to track cluster progression will explore whether or not 
patients change clusters during further instances of CRI. 
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A.1 INTRODUCTION 
Why measure cardiac output (CO)?  There is no “normal value” as its level rises and falls as 
metabolic demand and oxygen (O2) carrying capacity dictate.  Similarly absolute intravascular 
volume status varies widely across cohorts of presumably similar patient subsets.  Clearly, the 
blind measure of either CO or intravascular volume status in isolation is often an unrewarding 
clinical exercise.  However, when coupled with other measures of effectiveness of blood flow, 
pump function and metabolic demand, knowing both CO and volume status allow the bedside 
clinician to precise the cardiovascular state and to a large extent define cardiovascular reserve.  
Thus, the measure of cardiac output, though central to the definition of cardiovascular state is a 
dependent variable and needs to be used and monitored within this limited context.  
Prior Art 
“It is astonishing that no one has arrived at the following obvious method by 
which the amount of blood ejected by a ventricle of the heart with each systole 
may be determined directly…” 
with this introduction Adolf Fick 1 described, in the proceedings of the Wurzburg Physikalische 
Medizinische Gesellschaft on July 9, 1870, how to compute an animal’s cardiac output (CO) 
from arterial and venous blood oxygen measurements. In order to employ the Fick Principle to 
determine blood flow through an organ it is necessary to have a substance which is either 
removed or added to the blood during its period of flow through the organ. The amount which is 
added or removed from the organ by the blood is equal to the difference between the amount 
brought into the organ and the amount carried away from the organ.2 Therefore, one can 
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summarize the above statement by the following equation using oxygen consumption (VO2) as 
the means to alter the arterio-venous O2 content difference (Ca – Cv), as: 
VO2 = CO * Ca – CO * Cv  
And solving for CO one gets: 
CO = VO2/(Ca – Cv) 
Fick’s original principle was later adopted in the development of Stewarts’s indicator-
dilution method in 1897.3 Stewart injected a bolus of a sodium chloride solution into the central 
venous circulation of anesthetized dogs and rabbits, and then collected blood samples containing 
diluted sodium chloride from a femoral artery catheter. An electric transducer on the 
contralateral femoral artery sensed the arrival of diluted injectate. The cardiac output 
measurement by indicator dilution has three principle phases: a) an indicator is brought into the 
circulation (injection). b) the indicator mixes with the blood stream (mixing and dilution) and c) 
the concentration of the indicator is determined downstream (detection). The cardiac output 
would then be obtained using the Stewart-Hamilton formula. To derive the CO, Stewart used the 
following computation: let V0 (mL) denote the initial injectate’s volume and C0 (mg/ml) its 
initial concentration. The circulation dilutes the injectate to a presumed uniform concentration 
C1 occupying a volume V1 where V1 = V0 * (C0 / C1). The heart expels the diluted indicator 
over a period of t (seconds). Because the vascular resistance of the major arterial vessels are 
negligible, t is also the duration over which the downstream collection catheter encounters 
diluted indicator. The blood flow, i.e., the CO F(ml/s) is the blood volume transferred per unit 
time or  
F = V1/t = C0 V0/ C1 t 
 116 
 
However, contrary to his own observations, Stewart assumed in his formula that the 
indicator concentration at the collection site rises and declines in a stepwise manner over the 
collection interval. This technique, using indocyanine green as an indicator and a continuous 
withdrawal of blood into a sensing cuvette was the conventional indicator dilution method used 
to measure cardiac output in the critically ill patient. However, Stewart’s computations excluded 
his own recognition that the indicator concentration at the collection catheter initially increased 
and subsequently decreased in a non-stepwise pattern over the collection interval. The Hamilton 
modification introduced in 1928, accounted for such non-stepwise pattern, substituting in the 
place of uniform concentration C1, the time-averaged concentration of diluted indicator 
traversing the detector. The resulting CO F(ml/s) is calculated using the Stewart-Hamilton 
formula: 
                                                  F =  
Fegler first described the use of thermodilution for measuring cardiac output.4  In 1968, 
this method was then adapted for use in man by Branthwaite and Bradley5 at St. Thomas' 
Hospital in London and then further developed by Ganz and others.6, 7 Following the introduction 
of the pulmonary artery catheter (PAC) into clinical practice, the single-bolus thermodilution 
measurement of CO has been widely accepted as the “clinical standard” for advanced 
hemodynamic monitoring. The ability to monitor CO is a cornerstone of hemodynamic 
assessment for managing critically ill patients and in particular in patients with preexisting 
cardiovascular comorbidities. In critically ill patients, optimizing CO is considered an integral 
part of initial resuscitation approaches to increase O2 delivery because oxygen delivery is 
primarily altered by varying CO.8 
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The introduction of the PAC in 1970 and its subsequent use in performing thermodilution 
CO measurements in humans translated the ability to measure CO from the experimental 
physiology laboratory to multiple clinical settings. Measuring CO by thermodilution using a 
PAC, ever since, has most frequently been used in the clinical setting and has been regarded as 
the de facto reference method. PACs provide CO and other hemodynamic measurements not 
obtainable by clinical examination.9-11 Pulmonary blood flow, using a balloon floatation 
pulmonary artery catheter equipped with a distal thermistor, and transpulmonary blood flow 
using an arterial thermistor, both with a central venous cold volume injection, can be used. 
Cardiac output can be measured intermittently by bolus cold injection or continuously by cold 
infusion or heating coil upstream from the sensing thermistor. The advantage of the continuous 
CO technique and the transpulmonary technique is that neither is influenced greatly by the 
ventilation-induced swings in pulmonary blood flow. Since the PAC measures pulmonary blood 
flow, not aortic flow, variations in pulmonary blood flow will affect its measure.  Thus, 
intermittent measures show profound ventilator cycle-specific patterns.12 By making numerous 
measures at random with the ventilator cycle and then averaging all measures with proper 
thermal decay profiles, regardless of their values, an accurate measure of pulmonary blood flow 
can be derived.13 If ventilatory cycle–specific changes in the proportion of tricuspid regurgitation 
are present, then averaging all thermodilution measures may result in inaccurate estimates of 
cardiac output. In the setting of cor pulmonale and pulmonary hypertension, inspiration- induced 
tricuspid regurgitation may occur. The clinician can easily identify this phenomenon by 
observing the respiratory cycle-specific ‘‘v’’ waves in the right atrial pressure (Pra) trace. If 
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phase-specific tricuspid regurgitation exists, estimates of cardiac output by the thermodilution 
technique will overestimate the actual cardiac output.  
For more than 30 years, single-bolus thermodilution measurement through a pulmonary 
artery catheter for assessment of cardiac output has been widely accepted as the “clinical 
standard” for advanced hemodynamic monitoring.8 The controversy over the use of the PAC in 
the management of critically ill patients continues to rage. Nevertheless, current users of PACs 
rely on an underlying assumption that these changes in management lead to improved patient 
outcomes.14 Since there are no definitive studies, several professional groups have developed 
guidelines for PAC use.15 Proponents of its use cite the physiologic rationale for diagnosis and 
titration of complex treatments that may otherwise be detrimental. Opponents of PAC use cite 
the almost total lack of data showing that its use in the management of critically ill patients 
improves outcome. Pulmonary arterial catheterization allows the measurement of intrapulmonary 
vascular pressures, cardiac output, RV ejection fraction, and SvO2. It is logical that with the 
ability to measure these variables and calculate physiologic parameters such as total O2 delivery, 
whole body O2 consumption, pulmonary and systemic vascular resistance, pulmonary venous 
admixture, and RV and LV stroke work index, the pulmonary catheter would be invaluable in the 
assessment and management of the complex critically ill patient. That usefulness has not been 
documented, however.  
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A.2 MONITORING CARDIAC OUTPUT 
Cardiac output can be estimated by invasive hemodynamic monitoring using the PAC. The 
intermittent thermodilution technique, in which boluses of ice-cold fluid are injected into the 
right atrium via a PAC and the change in temperature detected in the blood of the pulmonary 
artery used to calculate cardiac output, is still widely considered as the standard method of 
reference. Adaptation of the PAC to incorporate a thermal filament (Vigilance™, Edwards Life 
Sciences, Irvine, CA, USA) or thermal coil (OptiQ™, ICU Medical, San Clemente, CA, USA) 
that warms blood in the superior vena cava and measures changes in blood temperature at the 
PAC tip using a thermistor, provides a continuous measure of the trend in cardiac output, with 
the displayed values representing an average of the values over the previous 10 minutes. The 
averaged values have the advantage of eliminating variability in the presence of arrhythmias, but 
the disadvantage of not being real-time values, thus limiting the usefulness of this approach for 
assessing rapid hemodynamic changes in unstable patients. The PAC has a key advantage over 
many other systems in that it provides simultaneous measurements of other hemodynamic 
parameters in addition to cardiac output, including pulmonary artery pressures, right-sided and 
left-sided filling pressures, and SvO2.16 
 
A.2.1 Transpulmonary or ultrasound indicator dilution 
The PiCCO® (Pulsion Medical Systems, Munich, Germany), LiDCO™ (LiDCO Ltd, London, 
UK), VolumeView™ (Edwards Life Sciences), and COstatus® (Transonic Systems Inc., Ithaca, 
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NY, USA) systems allow cardiac output to be investigated less invasively, using a central venous 
(to allow calibration) and an arterial catheter, rather than needing to introduce a catheter into the 
pulmonary artery. The PiCCO® and recently launched VolumeView™ systems require a 
femoral artery catheter. These devices use the same basic principles of dilution to estimate the 
cardiac output as with PAC thermodilution. PiCCO® and VolumeView™ use injections of ice 
cold intravenous fluid as the indicator, measuring change in temperature downstream to calculate 
cardiac output, whereas LiDCO™ uses minute amounts of lithium chloride as the indicator and 
measures levels using a lithium-selective electrode. COstatus® calculates cardiac output by 
using ultrasound technology to measure changes in blood ultrasound velocity and blood flow 
following an injection of warm saline solution. Cardiac output values measured using 
transpulmonary or ultrasound indicator dilution techniques correlate well with those measured 
using PAC thermodilution17-20 and may show less respiratory phase-dependent variation.18 
The PiCCO® and the VolumeView™ systems provide variables in addition to cardiac output, 
such as global end-diastolic volume and measurements of extravascular lung water. The 
COstatus® system also provides some derived variables, including total end diastolic volume 
index.  
 
A.2.2 Arterial pressure trace-derived estimation of cardiac output 
In addition to the intermittent indicator dilution cardiac output measurements discussed above, 
the PiCCO® and LiDCO™ systems can also estimate cardiac output on a continuous basis from 
the arterial pressure waveform with (PiCCO2® and LiDCOplus™) or without (LidCOrapid™) 
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the need for recalibration when changes in vascular compliance may have occurred. The 
PiCCO® system uses a pulse contour analysis and the LiDCO™ system a pulse power analysis. 
In addition to these, Vigileo™ (Edwards Life Sciences) and MostCare™ (Vytech, Padova, Italy) 
using the Pressure Recording Analytical Method (PRAM)) systems have been developed for 
arterial waveform analysis without external calibration. Each of these systems contains a 
proprietary algorithm for converting a pressure-based signal into a flow measurement. The 
specific algorithms have individual characteristics and make different assumptions - for example, 
related to arterial compliance (Vigileo™) or pressure (MostCare™) - which can make them more 
or less accurate depending on the clinical circumstances. The level of accuracy and precision of 
each device needs to be understood as the data cannot be superimposed from one system to 
another. The advantages of these arterial pressure-based cardiac output monitoring systems over 
PAC-derived measurements is primarily their less invasive nature. The major weakness of all 
these devices is the drift in values whenever there is a major change in vascular compliance, as, 
for example, in vascular leak syndrome with increased vessel wall edema leading to decreased 
arterial compliance. Aortic valve regurgitation may further decrease the accuracy of these 
techniques. Over or under-damped arterial pressure waveforms will also decrease the precision 
of these monitors. 
 
A.2.3 Stroke Volume Variation 
If absolute measures of cardiovascular values cannot be used effectively as parameters 
describing cardiovascular status or responsiveness, then more provocative maneuvers need to be 
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employed to improve the utility of these measures. Such provocative approaches comprise the 
broad field of monitoring techniques, referred to as functional hemodynamic monitoring. 
 
Dynamic parameters can predict increases in cardiac output from volume expansion are 
better predictors of fluid resuscitation than static parameters.21 Understanding how dynamic 
measures are predictors of fluid responsiveness requires an understanding of how respiratory 
variation can impact the preload, pulse pressure, and stroke volume. Spontaneous inspiration 
leads to a larger venous return to the right side of the heart but also leads to the displacement of 
the septum and pulmonary vein dilatation leading to reduced preload to the left side of the heart. 
This reduced preload results in less ventricular filling and a lower left ventricular (LV) stroke 
volume. Expiration leads to decreased intrathoracic pressure, higher preload, and larger stroke 
volumes on the left side of the heart. This increase in left cardiac preload occurs at expiration as 
a result of the transmission of the increase in right cardiac preload after the lung transit time. 
Such changes in pulse pressure during spontaneous respiration are otherwise known as pulsus 
paradoxus. Changes in intrathoracic pressure from mechanical ventilation can lead to cyclic 
changes, but reversed—otherwise termed reverse pulsus paradoxus. These small changes in right 
ventricular preload induced by mechanical ventilation can lead to significant changes in stroke 
volume in preload-dependent individuals. On the left side of the heart, if arterial compliance is 
constant through a respiratory cycle then variations in systolic blood pressure and pulse pressure 
(PP) will be reflected in LV stroke volume. 
Positive pressure ventilation (PPV) when applied to a patient at rest and with no 
spontaneous respiratory effort is associated with a cyclic increase in Pra in phase with 
inspiration. Since Pra is the back-pressure to venous return, if upstream venous pressures do not 
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simultaneously increase22 then RV filling will also decrease in a cyclic fashion. This cyclic 
variation in RV filling will induce a cyclic variation in LV filling if both RV and LV are preload 
responsive.23 This cyclic variation in LV filling will induce a cyclic variation in LV stroke 
volume and arterial pulse pressure if the patient is preload responsive. 
Stroke volume variation (SVV) is believed to be less affected by vasomotor tone than 
PPV and is, therefore, likely to be a better measure of fluid resuscitation in mechanically 
ventilated patients.24,25 A study comparing SVV to pulmonary artery catheterization by 
thermodilution (PAC-TD) demonstrated SVV (ROC = 0.82) to be equivalent if not better than 
PPV (ROC = 0.80) in mechanically ventilated patients.26 SVV, much like PPV, is limited to 
mechanically ventilated patients, as preload is highly susceptible to changes in intrathoracic 
pressure. Despite the promising results of studies of PPV and SVV in mechanically ventilated 
patients, limitations exist in these methodologies. In mechanically ventilated patients, a linear 
relationship exists between tidal volume and SVV or PPV; 27 tidal volumes of less than 8 mL/kg 
are no more accurate than traditional measures of preload.28 Recent work has demonstrated that 
lower tidal volumes, impaired contractility, or elevated respiratory rates each independently 
result in lower SVV and PPV errantly leading to an increase in falsely negative tests for fluid 
responsiveness.29,30 Meanwhile, right ventricular dysfunction may cause false positives of PPV31 
a result that could lead to volume overload and deleterious effects in certain populations.32 
Interestingly, increased contractility does not influence PPV or SVV.29 Presently, PPV is easier 
to measure than SVV because it only requires inspection of the arterial pressure waveform over 
time33 whereas SVV can be assessed by either esophageal Doppler echocardiography34 or 
echocardiographic measures of aortic velocity.35Several commercially available technologies 
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have evolved based on arterial waveform analysis that can estimate stroke volume from the pulse 
pressure waveform. 
 
There is a tight correlation between positive-pressure ventilation-induced changes in 
arterial pulse pressure (PP), also called PPV, and fluid responsiveness.36 PPV is calculated as the 
ratio of difference between maximum and minimum PP to their mean as assessed over about 5 
breaths or 20 seconds. The greater the PPV, the greater the CO increase. Not surprisingly, 
subsequent studies showed that similarly calculated SVV, when measured independently, also 
predicted volume responsiveness.37 Theoretically, mean arterial pressure (MAP) and PP should 
co-vary with changes in CO if the heart rate remains constant. We previously predicted that 
PPV/SVV >0.8 would define pressure responsive subjects if CO increased.38  
The FloTrac® device estimates SVV from the standard deviation of the individual 
arterial pressure values over single beats averaged over 20 seconds. Assuming the SV variance 
has a normal distribution, this assumption is valid for calculating SVV. Importantly, SVV as a 
time-series function may not be normally distributed during atrial fibrillation and with vigorous 
spontaneous inspiratory efforts. How much error such non-normal distribution would introduce 
into the SVV calculation is not known, but on theoretical modeling the degree of non-normal 
distribution would need to be great for it to affect SVV by the standard deviation method. 
There also has been renewed interest in the estimation of LV stroke volume from the 
arterial pressure profile over ejection by a process referred to as arterial pulse contour analysis.39 
Because the only determinants of arterial pressure are LV stroke volume and the resistance, 
compliance, and inertance characteristics of the arterial tree and blood, if the arterial components 
are constant, then changes in pulse pressure most proportionally reflect changes in LV stroke 
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volume. Thus, it is not surprising that the aortic flow variation parallels arterial pulse pressure 
variation,40 and pulse contour–derived estimates of stroke volume variation can be used to 
determine preload responsiveness.41,42 However, caution must be exercised when using the pulse 
contour method because it is not validated in subjects with rapidly changing arterial tone, as 
often occurs in subjects with hemodynamic instability, and it requires, at least in the studies that 
used it, the application of abnormally large tidal volumes.41-43  Thus, at present, the pulse 
contour–derived stroke volume variation technique represents a potentially great but still 
unproven clinical decision tool.44 
 
A.2.4 End Diastolic Volume 
Preload is defined as the degree of stretch of the isolated myocardial fiber at the onset of 
contraction. In the intact heart this corresponds to the ventricular volume at end-diastole and, 
although originally derived from experimental conditions, the concept of preload is commonly 
applied to the clinical situation. The determination of right ventricular (RV) end-diastolic volume 
(RVEDV) from a pulmonary artery catheter has been suggested as a more accurate method of 
reflecting right heart preload, 45 but the importance of right ventricular preload is unclear. 
Evaluation of preload status and subsequent volume loading are first-line therapy in the 
hemodynamic management of critically  ill or  injured patients.  Although cardiac filling 
pressures, such  as  the  central venous pressure (CVP) and pulmonary artery occlusion pressure 
(Ppao),  have commonly been  used  to guide  fluid  therapy,  several studies have  shown that 
the  Ppao  may not  provide a reliable guide  to cardiac preload.46-48 Some of the factors thought 
 126 
 
to disturb the  relationship between Ppao and  ventricular end-diastolic volume  include 
myocardial trauma or ischemia, pulmonary injury or  dysfunction, and  increases in  juxtacardiac 
pressure caused by mechanical ventilation and PEEP.46-48 Mechanical ventilation and  PEEP may  
also  cause  movement of the  interventricular septum to the  left to reduce  LV filling  and  alter 
the  relationship between Ppao  and  LV end-diastolic volume  and  cardiac output.49,50 The use 
of the pulmonary artery catheter has allowed thermodilution determination   of RVEF and right 
ventricular volumes at the bedside. Published studies on RVEDV Index51-55 suggest that right 
ventricular volumes provide a better index of cardiac filling than the  Ppao. 
Several studies have emphasized the good correlation between estimates of right 
ventricular end-diastolic volume (RVEDV) by thermodilution-derived right ventricular ejection 
fraction (RVEF) and surrogates of stroke volume.56-59 However, the thermodilution technique for 
assessing RVEDV is still intermittent, and the value of RVEDV as a marker of fluid 
responsiveness in critically ill patients is controversial.59-61 A recently available Swan–Ganz 
catheter with a rapid response thermistor permits nearly continuous assessment of cardiac output 
(CO), RVEF and RVEDV, which should be more applicable in the ICU. The measurement 
variability associated with the intermittent bolus technique is eliminated by this catheter, and 
continuously assessed RVEDV (CEDV) should be more accurate than RVEDV based on 
intermittent thermodilution; therefore, CEDV may be a valuable marker of cardiac preload and a 
predictor of fluid responsiveness. 
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A.2.5 Simpson’s Rule 
The simplest method for estimating left ventriclar (LV) volume is the cube formula, which 
assumes that the LV volume is that of a sphere with a diameter equal to the LV antero-posterior 
dimension. However, this method has proven to be inferior to other volume techniques.62-64 LV 
volume may hence be measured using Simpson’s rule, similar to its application for LV 
measurements, which states that the volume of a geometrical figure can be calculated from the 
sum of the volumes of smaller figures of similar shape. Most commonly, Simpson’s algorithm 
divides the LV into a series of stacked oval disks whose height is “h” and whose orthogonal 
minor and major axes are D1 and D2 (method of disks). The volume of the entire left atrium can 
be derived from the sum of the volume of the individual disks. 65 
Volume =  
The formula is integrated with the aid of a computer and the calculated volume provided 
by the software package. The use of the Simpson’s method in this way requires the input of 
biplane LV planimetry to derive the diameters. Optimal contours should be obtained 
orthogonally around the long-axis of the left atrium using transthoracic echocardiography (TTE) 
apical views. Three-dimensional echocardiography should provide the most accurate evaluation 
of LV volume and has shown promise, however no consensus exists to date on the specific 
method that should be used for data acquisition and there is no comparison with established 
normal values.66-68 
Despite the difficulty in using ultrasound for the measurement of stroke volume and 
cardiac output, focused critical care echocardiography is increasingly being recognized as an 
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important adjunct in the care of critically ill patients because of the wealth of information one 
can obtain. Assessment of right ventricular function by echocardiography is important in certain 
types of shock and may contribute to limited responses to fluid resuscitation.69-70  Currently, 
transesophageal echocardiography (TEE) may be one of the best measures of fluid 
responsiveness.71, 72  
 
A.2.6 Echocardiography and Echo-Doppler 
Echocardiography allows measurement of cardiac output using standard two-dimensional 
imaging or, more commonly, Doppler-based methods. The main interest in echocardiography in 
general is that it can be used not only for measurement of cardiac output but also for the 
additional assessment of cardiac function. Echocardiography is particularly useful as a diagnostic 
tool because it allows the visualization of cardiac chambers, valves and pericardium. Small 
ventricles (‘kissing ventricles’) may incite fluid administration whereas a poorly contractile 
myocardium may suggest that a dobutamine infusion is a better choice. Right ventricular 
dilatation may orient towards the diagnosis of massive pulmonary embolism or myocardial 
infarction whereas the presence of pericardial fluid may suggest a diagnosis of pericardial 
tamponade. Severe valvulopathy can also be recognized promptly. However, echocardiography 
instruments and expertise may not be readily available everywhere; in some institutions, this is 
still the domain of the cardiologists and they need to be called to do the procedure. If an 
ultrasound beam is directed along the aorta using a probe, part of the ultrasound signal will be 
reflected back by the moving red blood cells at a different frequency. The resultant Doppler shift 
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in the frequency can be used to calculate the flow velocity and volume and hence cardiac output. 
Echo-Doppler evaluation can provide reasonable estimates of cardiac output, but this procedure 
is operator dependent and continuous measurement of cardiac output using this technique is not 
possible. Echo-Doppler evaluation may be applied either trans thoracically or transesophageally. 
However, transthoracic techniques do not always yield good images and transesophageal 
techniques are more invasive such that some sedation, and often endotracheal intubation, is 
required in order to obtain reliable measurements. Moreover, the esophageal probe is 
uncomfortable in non-intubated patients, although may be better tolerated if inserted nasally, and 
should be used cautiously in patients with esophageal lesions. The signal produces different 
wave forms that can be used to distinguish to some extent changes in preload, afterload and LV 
contractility. Doppler flow studies focusing on the descending thoracic aorta may not provide a 
reliable measurement of the total cardiac output (for example, with epidural use), and are invalid 
in the presence of intra-aortic balloon pumping. Echo-Doppler cardiac output estimates vary 
considerably for several reasons, including difficulty in assessment of the velocity time integral, 
calculation error due to the angle of insonation, and problems with correct measurement of the 
cross-sectional area. Some training is required when using these techniques. Esophageal-Doppler 
techniques have been shown to be useful for optimizing fluid administration in high risk surgical 
patients.73, 74 Simplified transesophageal Doppler techniques can be convenient as the probe is 
smaller than for standard esophageal echocardiography techniques. Simplified transthoracic 
Doppler systems allow estimation of aortic blood flow and may be even less invasive; however, 
although these techniques can be simple to perform in healthy volunteers, access to good images 
may be more difficult in critically ill patients. Moreover, there is a fairly prolonged learning 
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curve for correct use of this system.75 These methods need further validation in critically ill 
patients. 
A.2.7 CO2 rebreathing 
CO2 rebreathing systems, based on the Fick principle, use a CO2 sensor, a disposable airflow 
sensor and a disposable rebreathing loop. CO2 production is calculated from minute ventilation 
and its CO2 content, and the arterial CO2 content is estimated from end-tidal CO2. Partial 
rebreathing reduces CO2 elimination and increases the end-tidal CO2. By combining 
measurements taken during and without rebreathing, venous CO2 content can be eliminated from 
the Fick equation. However, intrapulmonary shunting of blood and rapid hemodynamic changes 
affect the accuracy of the measurement, so that this technique is not considered to be reliable in 
acutely ill patients. 
A.2.8 Bioimpedance and bioreactance 
Bioimpedance is based on the fact that the conductivity of a high-frequency, low-magnitude 
alternating current passed across the thorax changes as blood flow varies with each cardiac cycle. 
These changes can be measured using electrodes placed on a patient’s chest and used to generate 
a waveform from which cardiac output can be calculated. Bioreactance has developed out of 
bioimpedance and measures changes in the frequency of the electrical currents traversing the 
chest, rather than changes in impedance, potentially making it less sensitive to noise. These 
techniques are non-invasive and can be applied quickly. They have been used for physiological 
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studies in healthy individuals and may be useful in perioperative applications,76 but are less 
reliable in critically ill patients.77 Electrical interference may also occur if patients are placed  in 
an ICU environment. 
 
A.3 ETIOLOGIES OF SHOCK 
Circulatory shock results primarily in inadequate tissue blood flow. Although most forms of 
shock may show some increase in cardiac output initially in response to fluid loading, fully one-
half of all hemodynamically unstable intensive care unit patients are not preload responsive.78 
The etiologies of shock pathophysiology are usually categorized into four broad groups: 
hypovolemic, cardiogenic, obstructive, or distributive, all of which may have different causes 
and treatments. Since the primary goal of the cardiovascular system is to supply adequate 
amounts of oxygen to meet the metabolic demands of the body, calculation of systemic oxygen 
delivery (DO2) and VO2, identifying tissue ischemia (usually monitored by mixed venous 
oxygen saturation [SvO2]) as well as measures of ventricular performance (stroke work) are 
often calculated from such primary variables. At this level, hemodynamic monitoring is used to 
define cardiovascular status, not response to treatments based on assumed pathophysiology, and 
predict outcome. Most of the rationale for hemodynamic monitoring resides at this 
pathophysiology level. The implied assumption here is that restoration of normal hemodynamic 
values will prevent further organ injury and reduce mortality. Unfortunately, this argument may 
not be valid, primarily because hemodynamic monitoring usually only assesses global circulatory 
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status, not organ function or microcirculation, and does not address the mechanisms by which 
disease occurs.79-81 
Circulatory shock causes tissue hypoperfusion, cellular dysfunction, organ injury, and 
death may occur proportional to the degree and duration of tissue hypoperfusion as quantified by 
oxygen debt.82 The four pathophysiologic categories of shock are usually characterized by 
different specific hemodynamic variables, induced by the associated primary hemodynamic 
event and the autonomic response to it. These variables can be measured by a variety of 
noninvasive and invasive means and derived hemodynamic parameters calculated that reflect 
global cardiovascular status. The relation between specific hemodynamic variables is complex in 
health, and even more complex is disease. However, a solid understanding of the cardiovascular 
underpinnings of blood flow homeostasis is required to interpret hemodynamic variables 
effectively. If disease causes cardiac output and DO2 to decrease, mean arterial pressure (MAP) 
decreases as well. Baroreceptors in the aortic arch and carotid body alter vasomotor tone through 
modulation of sympathetic tone to maintain cerebral perfusion pressure (eg: MAP > 65 mm 
Hg).83 The hemodynamic effects of this increased sympathetic tone are tachycardia and 
restoration of MAP toward normal values by reducing unstressed circulatory blood volume and 
increased arterial vasomotor tone. Thus, hypotension reflects failure of the sympathetic nervous 
system to compensate for circulatory shock, while normotension does not insure hemodynamic 
stability.84 Since regulation of blood flow distribution occurs by regional vasodilation of arterial 
resistance vessels, hypotension impairs auto regulated blood flow distribution.85,86 Except in 
conditions of severe hypoxemia and anemia, the primary means by which DO2 is varied to match 
metabolic requirements is by varying cardiac output and tissue oxygen extraction. Since 
metabolic demands can vary widely, there is no normal cardiac output or DO2 value, but rather 
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minimal thresholds for resting conditions and potentially adequate higher levels during stress. 
Operationally, it is better to access cardiac output as being either adequate or inadequate to meet 
the metabolic demands of the body. Inadequate DO2 is presumed to occur if tissue oxygen 
extraction is markedly increased, as manifest by a decrease in SvO2 <70%.87 
 
Of the four categories of shock, only distributive shock states following intravascular 
volume resuscitation are associated with an increased cardiac output but decreased vasomotor 
tone.88 Thus, cardiac output, stroke work, DO2, and SvO2 are decreased in cardiogenic, 
hypovolemic, and obstructive shock but may be normal or even increased in distributive shock. 
However, in all conditions, heart rate increases associated with an increased sympathetic tone. 
Cardiogenic shock represents primary cardiac failure. It can be due to impaired contractility 
(myocardial ischemia/infarction, electrolyte imbalance, hypoxemia, hypothermia, endocrinologic 
diseases, metabolic poisoning, beta-blockers), pump function (valvulopathy, ventriculoseptal 
defect, dyssrythmias), or diastolic compliance (fibrosis, infiltrative cardiomyopathies, 
hypertrophy). The specific cardinal findings of cardiogenic shock are increased back pressure to 
cardiac filling (right atrial pressure [Pra] and pulmonary artery occlusion pressure [Ppao]) and 
upstream edema (peripheral and pulmonary). Hypovolemic shock represents a decrease in 
effective circulating blood volume and venous return. It can be due to primary intravascular 
volume loss (hemorrhage, capillary leak), secondary intravascular volume loss (third-space loss, 
insensible loss through skin with burns, diarrhea, vomiting), and increased unstressed vascular 
volume (loss of sympathetic tone, spinal cord injury, vasodilating drugs). The specific findings 
of hypovolemic shock are decreased filling pressures. Obstructive shock represents a blockage of 
blood flow. It may be due to right ventricular (RV) outflow obstruction (pulmonary embolism, 
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hyperinflation), tamponade (pericardial effusion, hyperinflation), or LV outflow obstruction 
(aortic stenosis, dissecting aortic aneurysm). The specific findings of obstructive shock are often 
more subtle but include decreased LV diastolic compliance (small LV volume with increased 
Ppao) and signs of cor pulmonale (Pra greater than Ppao, tricuspid regurgitation). Distributive 
shock represents loss of normal sympathetic responsiveness resulting in decreased vasomotor 
tone. In the nonresuscitated subject, this presents as hypovolemic shock, 89 but with fluid 
resuscitation blood pressure (BP) does not increase despite an increase in cardiac output. It can 
be due to loss of vascular responsiveness (sepsis, spinal shock, vasodilating drugs, metabolic 
poisons). The specific findings of distributive shock are an increased cardiac output, DO2, and 
SvO2 despite persistent hypotension. Hemodynamic monitoring can aid in determining 
circulatory shock etiology. Since most forms of circulatory shock reflect inadequate tissue DO2, 
a primary goal of resuscitation is to increase DO2.  
A.3.1 Minimally invasive techniques 
Although the PAC measures CO easily at the bedside in critically ill patients,6,90,91 the recent 
trend in intensive care unit (ICU) monitoring is toward minimally invasive methods.92-96Arterial 
pulse contour and pulse power analyses have emerged as less invasive alternatives to PAC-
derived CO measures.97,98  The accuracy of these devices for PAC-derived CO measures has not 
been systematically compared in response to therapies other than volume resuscitation.99,100 
These devices use different calibration schema and model the transfer of arterial pulse pressure 
to stroke volume differently. Thus, their cross-correlations may not be assumed to be similar. 
The LiDCO Plus™ (LiDCO Ltd, London, UK) uses a transthoracic lithium dilution estimate of 
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CO for calibration, whereas the PiCCO Plus™ (Pulsion Ltd, Munich, Germany) uses a 
transthoracic thermodilution approach to compensate for interindividual differences in arterial 
compliance.101-103  
 
The number of novel noninvasive and minimally invasive hemodynamic monitoring 
gizmos currently available and being developed is amazing. Independent of their accuracy in 
measuring what they say they measure, how they are used in clinical decision making is 
potentially more important because monitoring devices will only improve outcome if coupled to 
a treatment that itself improves outcome. Non-invasiveness is not the only goal. Although it is 
always preferable to be less invasive, being non-invasive is not always possible and may even be 
counter effective. For example, continuous monitoring of arterial pressure is more invasive than 
intermittent monitoring but is helpful in hypotensive (or severe hypertensive) states. Likewise, a 
central venous catheter can be helpful to monitor the central venous pressure (CVP) and the 
ScvO2 (and also facilitates the rapid administration of fluids).  Whenever possible, we should of 
course try to be as non-invasive as possible, but arterial pressure monitoring by itself is still 
invasive. Echocardiography must be promoted more for its ability to offer a direct evaluation of 
cardiac function than for its non-invasiveness. Even though it is the most invasive method, the 
PAC is still of value in very sick patients with complex problems, for example, respiratory 
failure with shock and oliguria. At the other extreme, completely non-invasive bioimpedance has 
a place in healthy individuals, but little place in critically ill patients. Other monitoring systems 
are of use in patients with conditions somewhere between these two extremes. The optimal 
device depends on the type of patient, the question being asked, and the condition being 
managed or anticipated. 
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A.4 CONCLUSION 
There is no normal CO. Cardiac output is either adequate or inadequate to meet the metabolic 
demands of the body.  Monitoring of CO alone represents only a single aspect of hemodynamic 
assessment. Therefore, choices for a specific approach to monitoring cardiac performance should 
always reflect the necessity for information that might alter patient management. The diagnostic 
accuracy of preload responsiveness is markedly improved by the use of arterial pulse pressure or 
stroke volume variation, neither of which require pulmonary arterial catheterization. Interest in 
clinically relevant applications of PPV and SVV is growing as these parameters demonstrate 
their influence on patient outcomes. Great care should be taken, however, to ensure that 
limitations of these parameters are understood, because all measures need to be considered 
within the context of their physiological limitations. 
 
No bedside method is available to directly assess cardiac output, so all values obtained 
are estimates. The intermittent thermodilution technique is generally considered as the 
‘reference’ standard, but has its own limitations. A measurement obtained by a less invasive 
technique may be preferable if it can be obtained more rapidly and easily, even if it is slightly 
less accurate. Importantly, the accuracy of absolute values may be less important if one is 
following trends, for example, to track the short-term effects of therapies, such as fluid loading. 
It is important to be familiar with the technology being used, profiting from its advantages but 
recognizing its limitations. Most importantly, one must never forget that it is not the monitoring 
of cardiac output itself that can improve outcomes, but the changes in therapy guided by the data 
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obtained. Monitoring devices can improve outcome only if they are coupled to treatments that 
improve outcomes. 
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B.1 ABSTRACT 
Hemodynamic instability as a clinical state represents either a perfusion failure with clinical 
manifestations of circulatory shock and/or heart failure, or one or more out-of-threshold 
hemodynamic monitoring values, which may not necessarily be pathological. Different types of 
circulatory shock etiologies require different types of treatment modalities making these 
distinctions important. Diagnostic approaches or therapies based on data derived from 
hemodynamic monitoring assume that specific patterns of derangements reflect specific disease 
processes, which will respond to appropriate interventions. Hemodynamic monitoring at the 
bedside improves patient outcomes when used to make treatment decisions at the right time for 
patients experiencing hemodynamic instability. 
B.1.1 Key points 
1) Bedside measures of hemodynamic instability include mean arterial pressure (MAP), 
hypotension and mixed venous oxygen saturation. 1) Bedside measures of hemodynamic 
instability include mean arterial pressure (MAP), hypotension and mixed venous oxygen 
saturation. 
2) Circulatory shock etiologies can be divided into hypovolemic, cardiogenic, obstructive and 
distributive shock, and the hemodynamic patterns are characteristic for each etiology. 
3) The different etiologies of circulatory shock usually require different types of treatment 
modalities, making the correct etiologic diagnosis important. 
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4) Pharmacotherapies for hemodynamic instability include vasopressors, inotropes and 
vasodilators. 
5) Technological advances to restore hemodynamic instability include the use of ventricular 
assist devices and continuous renal replacement therapies. 
B.2 HEMODYNAMIC INSTABILITY 
Hemodynamic instability Hemodynamic instability as a clinical state represents either a 
perfusion failure with clinical manifestations of circulatory shock and/or heart failure, or one or 
more out-of-threshold hemodynamic monitoring values, which may not necessarily be 
pathological. Circulatory shock can be produced by decreases in cardiac output relative to 
metabolic demands, such as decreased intravascular volume (hypovolemic), impaired ventricular 
pump function (cardiogenic), or mechanical obstruction to blood flow (obstructive) or by 
misdistribution of blood flow independent of cardiac output (distributive). The prompt 
identification and diagnosis of the probable cause of hemodynamic instability, coupled with 
appropriate resuscitation and (when possible) specific treatments, are the cornerstones of 
intensive care medicine.(M. R. Pinsky & Payen, 2005) Hemodynamic monitoring plays a pivotal 
role in the diagnosis and management of circulatory shock. 
 
The management of the critically ill patient often requires continual monitoring of 
hemodynamic variables and the functional hemodynamic status owing to the level of 
cardiovascular instability the circulatory shock creates. Patterns of hemodynamic variables often 
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suggest hypovolemic, cardiogenic, obstructive, or distributive shock processes as the primary 
etiologies of hemodynamic instability.  Since these different types of circulatory shock etiologies 
usually require different types of treatment modalities, making these differential distinctions 
important. Diagnostic approaches or therapies based on data derived from hemodynamic 
monitoring in the critically ill patient assume that specific patterns of derangement reflect 
specific disease processes, which will respond to appropriate interventions.(M. R. Pinsky, 2007) 
B.2.1 Mean arterial pressure as a measure of hemodynamic instability 
Organ perfusion is dependent on input organ perfusion pressure and local vasomotor tone. Local 
vasomotor tone varies inversely with local tissue metabolic demand. For most organs except the 
kidneys and heart, independent changes in arterial pressure above some minimal value are 
associated with increased vasomotor tone to keep organ perfusion constant, and are therefore not 
entirely dependent on cardiac function and cardiac output. In such situations, cardiac output is 
only important to allow parallel circuits to maintain flow without inducing hypotension, and 
cardiac function is only important in sustaining cardiac output and a given output pressure 
without causing too high a back pressure in the venous circuits.  Hypotension, on the other hand, 
will decrease blood flow to all organs. Operationally, mean arterial pressure (MAP) is the input 
pressure to all organs other than the heart. Diastolic aortic pressure is the input pressure for 
coronary blood flow. MAP is estimated to be equal to the diastolic pressure plus one-third the 
pulse pressure between diastole and systole. Over a wide range of MAP values, regional blood 
flow to the brain and other organs remains remarkably stable owing to autoregulation of local 
vasomotor tone to keep that local blood flow constant despite changing MAP. However, in a 
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previously normotensive subject, once MAP decreases below ~60 mmHg, then tissue perfusion 
may decrease independent of metabolic demand and local autoregulatory processes. As tissue 
blood flow decreases independent of metabolic demand, then tissue O2 extraction increases to 
keep local O2 consumption and metabolic activity constant. This process occurs routinely in 
most individuals and if transient and is not pathological. However, if tissue blood flow decreases 
further than increased O2 extraction can compensate for, then end-organ ischemic dysfunction 
follows. Despite the lack of sensitivity of a non-hypotensive MAP to reflect hemodynamic 
stability, measures of MAP to identify hypotension are essential in the assessment and 
management of hemodynamically unstable subjects, since hypotension must decrease 
autoregulatory control and increasing MAP in this setting will also increase organ perfusion 
pressure and organ blood flow. 
B.2.2 Hypotension as a measure of hemodynamic instability 
Hypotension directly reduces organ blood flow, is synonymous with hemodynamic instability 
and is a key manifestation in most types of circulatory shock. It also causes coronary 
hypoperfusion, impairing cardiac function and cardiac output. However, the assumption is often 
false that, because MAP is maintained in low cardiac output shock states by sympathetic tone 
mediated peripheral vasoconstriction, the patient is not unstable. Intra-organ vascular resistance 
and venous outflow pressure along with MAP are the two other determinants of organ blood 
flow, and therefore organ perfusion. The normal mechanism allowing autoregulation of blood 
flow distribution is local changes in organ inflow resistance, such that organs with increased 
metabolic demand enact arterial dilation to increase their blood flow. If there is hypotension, 
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then local arterial dilation will not result in increased blood flow because the lower inflow 
pressure will have minimal effect on the organ perfusion pressure. Thus, hypotension impairs 
autoregulation of blood flow distribution.(Kellum & Pinsky, 2002) 
 
In shock states, normal homeostatic mechanisms functioning through carotid body 
baroreceptors vary arterial vascular tone so as to maintain MAP relatively constant despite 
varying cardiac output and metabolic demand. Presumably, this vasoconstriction occurs in low 
cardiac output states to maintain cerebral and myocardial blood flow at the expense of the 
remainder of the body. In subjects with normal renal function, oliguria is the immediate 
manifestation of this adaptive response, reflecting marked reduction in renal blood flow and 
solute clearance despite persisting “normal” MAP. As such, normotension does not insure 
hemodynamic sufficiency of all organ systems simultaneously. Hence, indirect measures of 
sympathetic tone, such as heart rate, respiratory rate, peripheral capillary filling and peripheral 
cyanosis are more sensitive estimates of increases circulatory stress and hemodynamic instability 
than is MAP.(M. R. Pinsky, 1998) 
Although systemic hypotension can be identified non-invasively using a 
sphygmomanometer, in the treatment of hypotension not readily responsive to simple maneuvers 
like recumbency and an initial fluid bolus, invasive arterial catheterization and continuous 
monitoring of arterial pressure is indicated. There is no consensus as to the absolute indication 
for invasive arterial pressure monitoring, but caution should be aired in favor of monitoring as 
opposed to its avoidance in the patient who cannot be rapidly resuscitated. Although peripheral 
radial arterial catheterization is the most common site for arterial access, femoral arterial 
catheterization is also available and has the advantage of greater likelihood of successful arterial 
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cannulation in the setting of profound hypotension and shock. The femoral artery is also the 
preferred site if one specific minimally invasive arterial monitoring device (i.e. PiCCOplus) use 
is being considered. However, these issues are addressed in subsequent chapters in this volume 
on invasive monitoring and minimally invasive and non-invasive monitoring, respectively. 
Importantly, in conditions of marked vasoconstriction associated with profound hypovolemia 
and hypothermia, central arterial pressure may exceed peripheral arterial pressure because of 
increased arterial resistance between these two sites. Thus, assessing end-organ perfusion 
parameters like level of consciousness, urine output and vascular refill are important early 
measures of the effectiveness of blood flow. Finally, though early attention is appropriately 
focused on restoring MAP to some minimal threshold level, organ perfusion pressure is actually 
MAP minus output pressure. Thus, in the setting of increased intracranial or intra-abdominal 
pressures, cerebral and splanchnic/renal perfusion pressures will be less than MAP, respectively 
and these compartment pressures need to be directly measured so as to target an organ perfusion 
pressure of >60 mmHg. 
B.2.3 Mixed venous oxygen saturation as a measure of hemodynamic instability  
One cardinal sign of increased circulatory stress is an increased O2 extraction ratio, which in the 
setting of an adequate arterial O2 content manifests itself as a decreasing mixed venous O2 
saturation (SvO2) in the face of adequate oxygen uptake in the lungs. SvO2 can only be sampled 
using a pulmonary artery catheter (PAC), while central venous (unmixed superior vena cava) O2 
saturation can be assessed using a central venous catheter.  The choice of the type of monitoring 
to be used and how it is interpreted is the subject for the invasive monitoring chapter later in the 
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volume. However, low SvO2 values can also occur if arterial O2 content is low, as is the case 
with anemia and hypoxemia or if O2 consumption is increased as with muscular exercise. 
Muscle activity effectively extracts O2 from the blood because of the set-up of the 
microcirculatory flow patterns and the large concentration of mitochondria in these tissues. Thus, 
normal vigorous muscular activity can be associated with a marked decrease in SvO2 despite 
adequate oxygen uptake and a normal circulatory system and metabolic demand.(M. R. Pinsky, 
2007) Muscular activities, such as moving in bed or being turned, “fighting the ventilator,” and 
labored breathing spontaneously increase O2 consumption. In the patient with an intact and 
functioning cardiopulmonary apparatus, this will translate into an increase in both oxygen 
delivery (DO2) and O2 consumption and a decrease in SvO2 only to the extent that the increased 
DO2 cannot supply the needed O2 for this increased demand. Under normal conditions of 
submaximal exercise, DO2 is the parameter increasing most markedly, although some decrease 
in SvO2 also occurs. However, in the sedated and mechanically ventilated patient, decreased 
SvO2 is a very sensitive marker of diminished circulation. Although muscle activity is minimal, 
the diminished flow permits more time for oxygen extraction across the transversed tissue and 
organ capillary beds. Although there is no level of cardiac output which is ‘normal,’  there are 
DO2 thresholds below which normal metabolism can no longer occur.(M. Pinsky, 2009) 
Nevertheless,  SvO2 can be utilized as a sensitive but nonspecific marker of circulatory stress, 
with values less than 70% connoting circulatory stress, less than 60% identifying significant 
metabolic limitation, and values less than 50% indicating frank tissue ischemia.(Rivers, Ander, 
& Powell, 2001) 
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B.3 PRINCIPLES OF HEMODYNAMIC MONITORING BASED ON SHOCK 
ETIOLOGY 
Weil and Shubin defined circulatory shock in 1968 as a decreased effectiveness of circulatory 
blood flow to meet the metabolic demands of the body.(Weil & Shubin, 1968) The heart, 
vascular integrity, vasomotor tone, and autonomic control all interact to sustain circulatory 
sufficiency. Circulatory shock reflects a failure of this system and results in an inadequate 
perfusion of the tissues to meet their metabolic demand, which can lead to cellular dysfunction 
and death.(Shoemaker, 1996) 
Four basic functional etiologies of circulatory shock can be defined: (1) hypovolemic, 
due to inadequate venous return (hemorrhage, dehydration [absolute hypovolemia]), (2) 
cardiogenic, due to inadequate ventricular pump function (myocardial infarction, valvulopathy), 
(3) obstructive, due to impingement on the central great vessels,  (pulmonary embolism, 
tamponade), and (4) distributive, due to loss of vasoregulatory control (sepsis, anaphylaxis, 
neurogenic shock, adrenal insufficiency [relative hypovolemia])(Table 1). 
Tissue hypoperfusion is common in all forms of shock, with the possible exception of 
hyperdynamic septic shock, and results in tissue hypoxia and a switch from aerobic to anaerobic 
metabolism, inducing both hyperlactacidemia and metabolic acidosis. However, 
hyperlactacidemia is not a reliable marker of ongoing tissue hypoperfusion because lactate 
clearance is often delayed or impaired in shock states, and processes such as exercise (seizure 
activity) and inflammation can induce hyperlactacidemia without cardiovascular 
insufficiency.(James, Luchette, McCarter, & Fischer, 1999) Sustained circulatory shock results 
in cellular damage, not from anaerobic metabolism alone, but also from an inability to sustain 
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intermediary metabolism and enzyme production necessary to drive normal mitochondrial 
performance.(Crouser, 2004) Metabolic failure due to sustained tissue hypoxia may explain why 
surgical preoptimization(Kern & Shoemaker, 2002) and early goal-directed therapy(Rivers, 
Nguyen, Huang, & Donnino, 2004) improve outcome, whereas aggressive resuscitation after 
cellular injury has already occurred is not effective at reducing mortality from a variety of 
insults.(Gruen, Jurkovich, McIntyre, Foy, & Maier, 2006) 
Since most forms of hemodynamic monitoring measure global systemic blood flow 
parameters like arterial pressure, heart rate, other central vascular pressures and cardiac output, 
the assessment of the severity of shock and its initial response to therapy is often limited if 
monitoring is limited to these global variables alone. Since cellular respiration does not cease 
when tissue blood flow decreases until some very low level of blood flow occurs, tissue CO2 
production usually continues at a normal rate, resulting in an increased venous PCO2. 
Potentially, measuring SvO2, or alternatively the difference between tissue PCO2 (PvCO2) and 
arterial PCO2 (PaCO2), referred to as the Pv-aCO2 gap, would allow one to assess effective 
tissue blood flow, since decreases in capillary blood flow initially causes CO2 from aerobic 
metabolism to accumulate.(Silva, De Backer, Creteur, & Vincent, 2004) Currently, global 
measures of circulatory function are being used to determine which of the four shock categories 
is the most likely cause of organ dysfunction  by noting their characteristic patterns or groupings 
of abnormalities, referred to as hemodynamic profile analysis.(FIDDIAN-GREEN, Haglund, 
GUTIERREZ, & SHOEMAKER, 1993). 
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B.3.1 Hypovolemic shock 
Hypovolemia is the cardiovascular state in which the effective circulating blood volume 
is inadequate to sustain adequate venous return and thus cardiac output to support normal 
function without invoking supplemental sympathetic tone or postural changes to provide venous 
return assistance. It is a process of absolute hypovolemia, which can occur through loss of blood, 
such as with hemorrhage and trauma, or with fluid and electrolyte loss, as with diuresis, diarrhea, 
vomiting, or evaporation from large burn surfaces, or with severe fluid intake restriction 
resulting in dehydration.(Piper & Kaplan, 2012) The normal reflex response to absolute 
hypovolemia is increased sympathetic tone causing selective vasoconstriction. Cardiac output is 
often sustained by this vasoconstrictive maneuver, and venous return is maintained by diverting 
blood away from the skin, resting muscles, and gut and into the central circulation. The cardinal 
sign of this circulatory stress is increased heart rate owing to increased sympathetic tone. If the 
hypovolemic state progresses, this vasoconstriction becomes inadequate to sustain venous return 
and cardiac output decreases. Under these conditions, heart rate increases but stroke volume 
decreases more such that cardiac output declines. With tissue hypoperfusion, increased O2 
extraction occurs across the capillary beds, but eventually even increased extraction fails to 
sustain aerobic metabolism, and  lactic acidosis develops as a marker of tissue anaerobic 
metabolism.(M. Fink, 1996) Thus, hypovolemia initiates tachycardia, reduced arterial pulse 
pressure, and (often) hypertension with a near normal resting cardiac output, followed by signs 
of end-organ hypoperfusion (oliguria, confusion) as cardiac output decreases. 
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Hypovolemic shock represents a decrease in effective circulating blood volume and 
venous return. It can be due to primary intravascular volume loss (hemorrhage, capillary leak) or 
secondary intravascular volume loss (third-space loss, insensible loss through skin with burns, 
diarrhea, vomiting). The specific findings of hypovolemic shock are decreased cardiac filling 
pressures (low venous return manifested by low right atrial pressure [Pra] and low left atrial 
pressure [pulmonary artery occlusion pressure or Ppao]) accompanied by low cardiac output and 
high systemic vascular resistance (reflexive or sympathetically induced vasoconstriction 
manifested by high systemic vascular resistance index).(M. R. Pinsky, 2007) Systemic 
hypotension is the final presentation of hypovolemic shock(Parks, Elliott, Gentilello, & Shafi, 
2006) and if the clinician waits for hypotension to identify circulatory shock before intervening, 
ischemic tissue injury is almost always already present. 
 
B.3.2 Cardiogenic shock 
Cardiac pump dysfunction can be due to left ventricle (LV), right ventricle (RV) failure, or both. 
LV failure is usually manifested by an increased LV end-diastolic pressure and left atrial 
pressure, which must exist to sustain an adequate LV stroke volume. Tachycardia is universal in 
the patient who is not β-blocked. The most common cause of isolated LV failure in the critically 
ill patient is acute myocardial infarction.(Menon et al., 2000) However, in post-operative cardiac 
surgery patients, myocardial stunning can also cause transient LV failure. In acute isolated LV 
failure, LV stroke work is reduced and heart rate increased. In chronic heart failure, cardiac 
output may be adequate, or the periphery may have adapted enough to increase O2 extraction 
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such that tissue hypoperfusion is not present, with the only sign of heart failure being peripheral 
edema and increased sympathetic tone. However, in acute LV failure cardiac output may be 
normal or even increased, owing to increased sympathetic tone. However, LV filling pressure 
becomes markedly elevated as the increased sympathetic tone decreases unstressed volume 
increasing mean systemic pressure and augmenting the pressure gradient for venous return. This 
causes a marked increase in intrathoracic blood volume which may induce flash hydrostatic 
pulmonary edema, also known as cardiogenic pulmonary edema. However, neither cardiac 
output nor systemic vascular resistance are sensitive markers of LV failure until after cardiogenic 
shock develops.(M. R. Pinsky, 1998a) 
 
The normal adaptive response of the patient to impaired LV contractile function and 
resulting low organ and tissue perfusion is to increase sympathetic tone, induce tachycardia, 
activate the renin-angiotensin system, retain sodium by the kidneys, and thus increase the 
circulating blood volume. In essence, the body does not differentiate its adaptive response to low 
tissue perfusion caused by either hypovolemic or cardiogenic shock.  Fluid retention as a 
compensatory mechanism, if present, takes time to evolve, whereas acute impairments of LV 
contractility can occur over seconds in response to myocardial ischemia. Thus, the hemodynamic 
profile of acute and chronic LV failure can be different. Acute LV failure is manifest by 
increased sympathetic tone (tachycardia, hypertension), impaired LV function (increased left 
atrial filling pressure and reduced stroke volume), with minimal RV effects (normal central 
venous pressure, unless RV infarction also occurs), and increased oxygen extraction manifested 
by a low SvO2. Cardiac output may not be reduced and may actually  be slightly elevated early 
on, owing to the release of catecholamines as part of the acute stress response.(Sapolsky, 
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Romero, & Munck, 2000) Vascular resistance, therefore, is increased. By contrast, in chronic 
heart failure, although sympathetic tone is elevated, the heart rate is rarely >105 beats/min, while 
filling pressures are elevated in both atria consistent with combined LV failure and fluid 
retention. Importantly, cardiac output is not reduced except in severe chronic heart failure states. 
Importantly, a cardinal finding of heart failure is the inability of the heart to increase cardiac 
output in response to a volume load or metabolic stress state (exercise). Furthermore, owing to 
the increased sympathetic tone, splanchnic and renal blood flows are reduced and can lead to 
splanchnic or renal ischemia.(Gelman & Mushlin, 2004) Although acute heart failure may 
present with shock, more commonly patients with preexisting chronic heart failure develop a 
new illness, or acute exacerbation of their heart failure. Thus, their new pathology is 
superimposed upon the preexisting heart failure. Such mixed process shock states are often 
difficult to treat because of the limitations of the patient’s cardiac response created by the prior 
heart failure, and it is quite easy to induce pulmonary and peripheral edema using routine fluid 
resuscitation. 
Cardiogenic shock represents primary cardiac failure. It can be due to impaired 
myocardial contractility (myocardial ischemia/infarction, electrolyte imbalance, hypoxemia, 
hypothermia, endocrinologic diseases, metabolic poisoning, beta-blockers), pump function 
(valvulopathy, ventriculoseptal defect, dysrhythmias), or diastolic compliance (left ventricular 
hypertrophy, fibrosis, infiltrative cardiomyopathies, asymmetric septal hypertrophy, cor 
pulmonale). The specific cardinal findings of cardiogenic shock are increased back pressure to 
cardiac filling (increased right atrial pressure [Pra] and pulmonary artery occlusion pressure 
[Ppao]) and upstream edema owing to compensatory fluid retention (peripheral and 
pulmonary).(M. R. Pinsky, 2007)The hemodynamic profile pattern therefore seen in cardiogenic 
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shock is as it progresses is low cardiac output, high right atrial pressure [Pra] and pulmonary 
artery occlusion pressures [Ppao], and high systemic vascular resistance (reflexive or 
sympathetically induced vasoconstriction manifested by high systemic vascular resistance 
index).  
B.3.3 Obstructive shock 
Obstructive shock represents a blockage of blood flow in one of the heart’s outflow tracts. It may 
be due to right ventricular (RV) outflow obstruction (pulmonary embolism, lung hyperinflation 
and pulmonary artery compression), LV outflow obstruction (aortic stenosis, dissecting aortic 
aneurysm) or cardiac tamponade (pericardial effusion, lung hyperinflation and atrial 
compression).The specific findings of obstructive shock are often difficult to separate from 
cardiogenic shock, and may be different relative to the ventricle with the obstructive 
pathophysiology. 
The most common cause of obstructive shock is pulmonary embolism and RV outflow 
obstruction leading to acute RV failure (Torbicki et al., 2008). However, isolated RV 
dysfunction can occur in the setting of an acute inferior wall myocardial infarction, and also as a 
consequence of pulmonary vascular disease (chronic obstructive pulmonary disease, primary 
pulmonary hypertension) and hyperinflation. Neither pulmonary vascular resistance nor mean 
pulmonary artery pressure need be grossly elevated for RV failure to be present. Indeed, and 
importantly, if pulmonary arterial pressures are greater than 30 to 35 mmHg, then pulmonary 
hypertension is probably chronic in nature because acute elevations of pulmonary arterial 
pressures above this level are physiologically tolerable. Elevations in central venous pressure of 
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more than 12 mmHg also reflect fluid retention, suggesting further that RV decompensation or 
massive volume overload from LV failure has occurred. The most common hemodynamic 
monitoring pattern in acute pulmonary embolism is that of elevated central venous pressure, 
decreased pulmonary artery occlusion pressures [Ppao] relative to the CVP (since preload to the 
left ventricle is diminished but LV contractility remains normal), and low cardiac output 
accompanied by high systemic vascular resistance (reflexive or sympathetically induced 
vasoconstriction manifested by high systemic vascular resistance index). However, in severe cor 
pulmonale, RV and LV diastolic pressure equalization occurs and it is indistinguishable from 
pericardial tamponade, as indeed acute RV dilation will induce tamponade physiology. 
Echocardiography is extremely useful in making the diagnosis of acute cor pulmonale because it 
can be performed immediately at the bedside and is non-invasive. Echocardiographic studies will 
reveal RV diameters greater than LV diameters and a paradoxical intraventricular septal shift. 
These points are discussed in detail in the chapter on ultrasonography. 
When RV dysfunction predominates and is induced by pulmonary parenchymal disease, 
it is referred to as cor pulmonale, which is associated with signs of backward failure, elevated 
RV volume and pressures, systemic venous hypertension, low cardiac output, as well as reduced 
renal and hepatic blood flow.(M. R. Pinsky, 2007) LV diastolic compliance decreases as the right 
ventricle dilates due to ventricular interdependence, either from intraventricular septal shift or 
absolute limitation of biventricular volume due to pericardial restraint. Thus, Ppao is often 
elevated for a specific LV stroke work, giving the erroneous appearance of impaired LV 
contractility. (M. R. Pinsky, 2006) 
Cardiac tamponade, another cause of obstructive shock, can occur from either (1) 
biventricular dilation limiting biventricular filling due to pericardial volume limitation, (2) acute 
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pericardial fluid accumulation due to either effusion fluid (inflammation, severe uremia) or blood 
(hemorrhage), which needs not be great in quantity, and (3) lung hyperinflation resulting in 
mechanical compression of the heart from without, which acts like pericardial tamponade to limit 
biventricular filling.(Spodick, 1998) The first two etiologies are rarely seen, whereas 
hyperinflation commonly occurs. The cardinal sign of tamponade is diastolic equalization of all 
intrathoracic vascular pressures (CVP, pulmonary arterial diastolic pressure, and Ppao).(Aksoy 
& Rodriguez, 2013) Since RV compliance is greater than LV compliance early on in tamponade, 
there may be selective reduction in RV filling.(M. Pinsky, 2002) 
B.3.4 Distributive shock 
Loss of blood flow regulation occurs as the end-stage of all forms of circulatory shock owing to 
hypotension, but is one of the initial presenting processes seen in sepsis, neurogenic shock, and 
adrenal insufficiency. The hemodynamic profile of sepsis is one of increased cardiac index, low 
right and left filling pressures, elevated SvO2, low mean arterial pressure, and low systemic 
vascular resistance consistent with loss of peripheral vasomotor tone and pooling of blood in the 
vascular system manifesting as a relative hypovolemia. 
Sepsis is a systemic process characterized by activation of the intravascular inflammatory 
mediators resulting in generalized vascular endothelial injury, but it is not clear that tissue 
ischemia is an early aspect of this process.(Hack & Zeerleder, 2001) Acute septicemia is 
associated with increased sympathetic activity (tachycardia, diaphoresis) and increased capillary 
leak with secondary loss of intravascular volume, and inappropriate clotting in the 
microcirculation. Before fluid resuscitation, this combination of processes resembles simple 
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hypovolemia, with decreased cardiac output, normal to increased peripheral vasomotor tone, and 
very low SvO2, reflecting systemic hypoperfusion. LV function is often impaired, but usually in 
parallel with depression of other organs, and this effect of sepsis is usually masked by the 
associated hypotension that maintains low LV afterload.(M. R. Pinsky & Rico, 2000) Initially, 
decreased adrenergic responsiveness and impaired diastolic relaxation characterize septic 
cardiomyopathy.  If sepsis remains ongoing, impaired LV contractile function also occurs. 
However, most patients with such a clinical presentation receive initial volume expansion 
therapy such that the clinical picture of sepsis reflects a hyperdynamic state rather than 
hypovolemia, which has been referred to as ‘warm shock’ in contrast to all other forms of 
shock.(Rabuel & Mebazaa, 2006) 
Neurogenic shock results from an acute spinal injury above the upper thoracic level, 
spinal anesthesia, general anesthesia, neurotoxic poisoning and central nervous system 
catastrophe. All of these states induce a profound loss of sympathetic tone and pooling of blood 
in the vascular compartment causing a relative hypovolemic state. In neurogenic shock, the 
resulting hypotension is often not associated with compensatory tachycardia, hence systemic 
hypotension can be severe  and precipitate cerebral vascular insufficiency and myocardial 
ischemia.(Kiss & Tator, 1993) Since neurogenic shock reduces sympathetic tone, the 
biventricular filling pressures, arterial pressure and cardiac output are all decreased. Treatment 
consists of reversing the primary process and supporting the circulation with volume loading and 
an infusion of an α-adrenergic agonist, such as norepinephrine, dopamine or phenylephrine to 
induce vasoconstriction and reverse vascular pooling of blood.(Müllner et al., 2004) 
Acute adrenal insufficiency can present with hyperpyrexia and circulatory collapse. This 
is more common than might be realized based on the epidemiology of adrenal cortical disease, 
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because many patients in the community are receiving chronic corticosteroid therapy for the 
management of chronic systemic and localized inflammatory states, such as asthma or 
rheumatoid arthritis. In such cases the added stress of trauma, surgery, or infection can 
precipitate secondary adrenal insufficiency, as can the discontinuation of long-term steroid 
treatment.(Sabharwal, Fishel, & Breslow, 1998) Patients typically present with nausea and 
vomiting, diarrhea, confusion, hypotension, and tachycardia. Cardiovascular collapse is similar 
to that seen in neurogenic shock, except that the vasculature is not as responsive to 
sympathomimetic support.(Bouachour et al., 1994) Since systemic hypotension is a profound 
stimulus of the adreno-cortical axis, measures of random cortisol levels in a patient with 
systemic hypotension will show low values in patients with adrenal insufficiency, and an ACTH-
stimulation test is not needed to make the diagnosis. Accordingly, failure to respond to 
vasoactive pharmacological support in a patient who is hypotensive should suggest the diagnosis 
of adrenal insufficiency, while giving stress doses of corticosteroids usually reverses the 
unresponsive nature of the shock process.(CLAUSSEN, LANDERCASPER, & COGBILL, 
1992) Since there is little detrimental effect of providing adrenal replacement levels of 
hydrocortisone in the short term, it is reasonable to start low dose hydrocortisone (60-80 mg 
intravenously every eight hours) while awaiting the response to resuscitation, and results of the 
plasma cortisol test. 
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B.4 CIRCULATORY SUPPORT OF THE PATIENT WITH HEMODYNAMIC 
INSTABILITY 
 
A brief summary of the four main shock states has been provided in Table 1. Of the four 
categories of shock, only distributive shock states following intravascular volume resuscitation 
are associated with an increased cardiac output but decreased vasomotor tone. Thus, cardiac 
output, stroke work, DO2, and SvO2 are decreased in cardiogenic, hypovolemic, and obstructive 
shock, but may be normal or even increased in distributive shock. However, in all conditions, 
heart rate increases associated with an increased sympathetic tone (except in neurogenic shock 
and sympathetic impairment). Hemodynamic monitoring can aid in determining circulatory 
shock etiology and in assessing response to therapy. Since most forms of circulatory shock 
reflect inadequate tissue DO2, a primary goal of resuscitation is to increase DO2.(Moore, 
McKinley, & Moore, 2004) 
If the cause of hypotension is diminished intravascular volume, either absolute or 
relative, then cerebral and coronary perfusion pressures must be maintained while fluid 
resuscitation is begun, otherwise cerebral ischemia and cardiac pump failure may develop and 
limit the effectiveness of fluid resuscitation.(Mehta & Pinsky, 1998) Infusions of vasoactive 
agents with both α and β-1 adrenergic agonist properties will increase both MAP and cardiac 
output at the expense of the remaining vascular beds, hence fluid resuscitation to achieve an 
adequate intravascular blood volume is an essential co-therapy for sustaining organ perfusion 
pressure.  Isolated vasopressor therapy in the setting of systemic hypotension causes worsening 
hypoperfusion of the periphery and organs excluding the heart and brain. Thus, though giving 
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vasopressor therapy in the setting of acute hypotension is often indicated, it is essential to assess 
volume status as well, because the pathologic ischemic effects of hypovolemia will be 
heightened by isolated vasopressor therapy. Many pathological states and acute stress conditions 
are associated with either adrenergic exhaustion or blunted responsiveness to otherwise adequate 
circulating levels of catecholamines (e.g. diabetes, adrenal insufficiency, hypothermia, 
hypoglycemia, and hypothyroidism). Furthermore, acute sepsis and systemic inflammation are 
associated with reduced adrenergic responsiveness or relative adrenal insufficiency.(Hennein et 
al., 1994; Oddis & Finkel, 1997) Thus, even if the patient produces an otherwise adequate 
sympathetic response, the vasomotor and inotropic response may be inadequate, requiring 
transient use of potent sympathomimetic agents to sustain hemodynamic stability, and 
adrenocortical hormone replacement to support relative adrenal insufficiency is also often 
needed. 
B.4.1 Pharmacotherapies for hemodynamic instability 
Pharmacotherapies for hemodynamic instability are directed at the pathophysiological processes 
that either induce or compound it. Hemodynamic monitoring plays a central role in assessing the 
effectiveness of these therapies in an iterative fashion. These therapies can be loosely grouped 
into one of three processes: (1) those that increase vascular smooth muscle tone (vasopressor 
therapy), (2) those that increase cardiac contractility (inotropic support), and (3) those that 
decrease smooth muscle tone (vasodilator therapy). 
Infusion of vasopressor agents are indicated to sustain a MAP greater than 60 mmHg to 
prevent coronary or cerebral ischemia while other resuscitative measures like volume 
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resuscitation and specific treatments of the underlying condition are initiated. This level of MAP 
is clearly arbitrary since some patients maintain adequate coronary and cerebral blood flow at 
lower MAP levels, whereas others, notably those with either pre-existent systemic hypertension 
or atherosclerotic cerebrovascular disease, may not tolerate MAP decreasing more than 30 
mmHg below their baseline value.(M. Pinsky, 2005) Once an “adequate” MAP has been 
achieved and intravascular volume losses corrected, care shifts toward maintaining adequate 
blood flow to perfuse metabolically active tissues in order to sustain organ performance while 
minimizing the detrimental effects of these vasoactive therapies. 
B.4.2 Vasopressor agents for hemodynamic instability 
Vasopressor therapy can reverse systemic hypotension, but at a price: the only means whereby it 
can increase systemic MAP is by reducing blood flow through vasoconstriction. Importantly, 
cerebral vascular circuits have no α-adrenergic receptors, and coronary vascular circuits have 
minimal α-adrenergic receptors, and therefore their facular beds will not constrict in the presence 
of exogenous -adrenergic stimulation. Unfortunately, in hypovolemic states vasopressor 
support may transiently improve both global blood flow and MAP, but at the expense of 
worsening local non-vital blood flow and hastening tissue ischemia. Initial resuscitative efforts 
should therefore always include an initial volume expansion component and fluid challenge 
while  diagnostic approaches that identify shock states ensue, before relying on vasopressors 
alone to support the hemodynamically unstable patient.(M. R. Pinsky, 2005) 
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B.4.3 Phenylephrine 
The only non-catecholamine sympathomimetic used, phenylephrine differs chemically from 
other sympathomimetics by the absence of a hydroxyl group on position 4 of the benzene ring. 
This deletion reduces its potency relative to other sympathomimetics. It acts as a moderately 
potent α1-agonist and is used in those patients in whom hypotension is due to decreased arterial 
elastance (it only activates β-adrenoreceptors at high doses). A modest direct coronary 
vasoconstrictor effect appears to be offset by autoregulatory mechanisms in the absence of flow-
limiting coronary disease. It is not metabolized by catecholamine O-methyltransferase (COMT), 
which metabolizes catecholamines, and therefore its absolute half-life is considerably longer than 
catecholamine sympathomimetics.(Westfall & Westfall, 2006) Thus, if phenylephrine is used to 
treat hypotension, it universally causes cardiac output to decrease. This is because α1-agonist 
activity results in an MAP increase purely on the basis of the associated increase in vascular 
resistance and therefore increased left ventricular afterload, but without by β1 stimulation to 
assist with improved contractility. Accordingly, its prolonged use is potentially detrimental to 
tissue blood flow, though it’s acute use may reverse hypotension and transiently sustain cerebral 
and coronary blood flow. 
B.4.4 Norepinephrine 
Norepinephrine has significant activity at α and β1-adrenoreceptors, resulting in a positive 
vasoconstrictor and inotropic effect. Its accompanying β1 activity makes it the α1-agonist of 
choice in the patient with hypotension and known LV dysfunction.(Skomedal, Borthne, Aass, 
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Geiran, & Osnes, 1997) Its positive vasopressor effect may enhance renal perfusion and indices 
of renal function in hemodynamically stable patients and this effect may also be seen at higher 
doses when norepinephrine is used as a vasopressor in those patients with sepsis. Both effects are 
likely related to elevation of MAP, the input pressure for organ perfusion. If norepinephrine is 
used to treat hypotension and decreased vasomotor tone, then one usually sees MAP increase 
with minimal changes in cardiac output because the increase in afterload is balanced by the 
associated increased contractility. However, this balance is also dependent on the LV being 
responsive to adrenergic stimulation. Maas et al. demonstrated that when post-operative cardiac 
surgery patients had their MAP increased by 20 mmHg by norepinephrine infusion, cardiac 
output increased in those with normal cardiac reserve and decreased in those with impaired 
cardiac reserve.(Maas, Pinsky, de Wilde, de Jonge, & Jansen, 2013) Thus, the cardiac output 
response to increasing MAP with norepinephrine is variable and dependent on baseline cardiac 
contractile reserve. 
B.4.5 Epinephrine 
Epinephrine is a very potent catecholamine sympathomimetic that has markedly increased β2-
adrenoreceptor activity compared with its molecular substrate, noradrenaline. Adrenaline has 
potent chronotropic, inotropic, β2-vasodilatory, and α1-vasoconstrictor properties. Its net 
vasopressor effect is the end result of the balance between adrenaline-mediated β2 and α1 
adrenoreceptors stimulation. At low doses this balance may result in no net pressor effect, with a 
fall in the diastolic blood pressure. Thus, the effects of epinephrine on hemodynamics will be 
variable and dependent on dosage, perhaps more so than other sympathomimetic agents. 
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Epinephrine, like norepinephrine, is known to have potent renovascular and splanchnic 
vasoconstrictor properties.(Mehta & Pinsky, 1998) Clearance rates are variable and mediated by 
both the COMT and monoamine oxidase systems. 
B.4.6 Dopamine 
Dopamine is the most controversial of the clinically utilized catecholamine sympathomimetics. 
This stems largely from claims for selective, dose-dependent, splanchnic and renovascular 
vasodilatory properties. Its dopaminergic properties do not reduce the incidence of renal failure 
in patients with shock when compared to noradrenaline.(Perdue, Balser, Lipsett, & Breslow, 
1998) Dopamine stimulates the release of norepinephrine from sympathetic nerve terminals in a 
dose-dependent manner, with this indirect norepinephrine effect accounting for up to half of 
dopamine’s clinically observed physiological activity.(A. Smith, 1973) Cardiomyocyte 
norepinephrine stores are finite, accounting for tachyphylaxis to the positive inotropic effects of 
dopamine observed after approximately 24 h in patients with acute myocardial 
infarction.(Parissis, Farmakis, & Nieminen, 2007) 
 
Recent clinical trials showing norepinephrine beneficial effects over dopamine 
Consensus guidelines and expert recommendations suggest that either norepinephrine or 
dopamine may be used as a first-choice vasopressor in patients with shock.(Antman et al., 2004; 
Dellinger et al., 2008; Hollenberg et al., 2004) However, observational studies have shown that 
the administration of dopamine may be associated with mortality rates  that are higher than those 
associated with the administration of norepinephrine in patients with septic shock.(Boulain et al., 
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2009; Martin, Viviand, Leone, & Thirion, 2000; Sakr et al., 2006) The Sepsis Occurrence in 
Acutely Ill Patients (SOAP) study, which involved 1058 patients with shock, demonstrated  that 
administration of dopamine was an independent risk factor for death in the intensive care unit. In 
a recent multicenter, randomized, blinded trial comparing dopamine and norepinephrine as the 
initial vasopressor therapy in the treatment of shock,(De Backer et al., 2010) there was no 
significant difference in mortality at 28 days between patients who received dopamine and those 
who received norepinephrine, although  dopamine was associated with more severe arrhythmic 
events than was norepinephrine. Other studies in patients with cardiogenic shock have shown 
that the mortality rate was significantly higher in the dopamine group than in the norepinephrine 
group,(LOEB, WINSLOW, RAHIMTOOLA, ROSEN, & GUNNAR, 1971; Ungar et al., 2004; 
Winslow, Loeb, Rahimtoola, Kamath, & Gunnar, 1973) with higher heart rates in patients who 
received dopamine as a potential contributor to the occurrence of ischemic events. Clinical trials 
in critically ill patients at risk for renal failure have also shown no renal vascular saving-effect of 
low dose dopamine. (R. Bellomo, Chapman, Finfer, Hickling, & Myburgh, 2000; D. Jones & 
Bellomo, 2005)In summary, recent clinical trials have raised serious concerns about the safety 
and efficacy of dopamine therapy in the treatment of hypotensive circulatory shock.  
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B.4.7 Inotropic agents 
B.4.8 Dobutamine 
Dobutamine is a synthetic analogue of dopamine. It is utilized by continuous infusion as 
a positive inotrope, with the improvement in cardiac output noted to potentially increase renal 
blood flow, creatinine clearance, and urine output. Dobutamine also induces vasodilation that 
can cause profound hypotension in the hypovolemic patient. As a β1-agonist it increases 
myocardial oxygen consumption, although autoregulatory increases in coronary blood flow 
usually fully compensate in the absence of flow-limiting coronary artery disease. A noted 
problem with dobutamine is the development of tachyphylaxis with prolonged (as little as 72 
hours) infusions, suggested to be due to the down-regulation of β1-adrenoreceptors. (Klein, 
Siskind, Frishman, Sonnenblick, & Lejemtel, 1981; O'Connor et al., 1999; Unverferth, Blanford, 
Kates, & Leier, 1980) A recent randomized, double blind, placebo-controlled clinical trial in 
septic shock patients with low cardiac output and persistent hypoperfusion showed that 
dobutamine failed to improve sublingual microcirculatory, metabolic, hepatosplanchnic or 
peripheral perfusion parameters despite inducing a signiﬁcant increase in systemic hemodynamic 
variables.(Hernandez et al., 2013) Thus, changes in measures of macrocirculatory flow may not 
be translated into changes in microcirculatory tissue blood flow.  This unfortunate potential 
dissociation between macrocirculatory and microcirculatory is not unique to dobutamine, but 
may be seen in response to volume resuscitation and both vasopressor and vasodilator therapies. 
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B.4.9 Dopexamine 
Dopexamine is a synthetic dopamine analogue with significant β2-adrenoreceptor agonist 
activity. Its splanchnic blood flow effects and positive inotropic activity have led to enthusiasm 
for potential utility outside its primary indication—decrease of afterload in acute heart failure 
syndromes with hypertension and oliguria. Randomized controlled clinical investigations have 
demonstrated improvement in morbidity and mortality outcomes when dopexamine was utilized 
as the pharmaceutical of choice in achieving goal-oriented oxygen delivery values in 
perioperative critically ill patients. (Boyd, Grounds, & Bennett, 1993; Hayes et al., 1994) 
Though widely utilized outside of North America, it is not licensed for use in North America.  
B.4.10 Phosphodiesterase inhibitors 
Although these agents are not widely used in the management of circulatory shock, but the two 
most commonly employed agents in this class are amrinone and milrinone. Both are bipyridines, 
and the class of drugs is otherwise known as ‘inodilators’ with reference to the two predominant 
dose-dependent modes of action—inotropy and vasodilation .(Dei Cas, Metra, & Visioli, 1989) 
Milrinone has a shorter half-life and is a more potent (10–15-fold) inotropic agent than 
amrinone, but from all other aspects they are similar agents.(Alousi & Johnson, 1986; Earl, 
Linden, & Weglicki, 1985) Both are eliminated by conjugation, with amrinone’s biological half-
life known to be extended in the presence of congestive heart failure. Their mechanism of action 
is not precisely known, but at least part of their activity is related to inhibition of 
phosphodiesterase type 3, found in high concentrations in cardiomyocytes and smooth muscle 
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cells, and they may activate a sodium-dependent calcium channel. The end result is an increase 
in intracellular cAMP and calcium, with the physiological effect being an improvement in 
diastolic myocardial function, and for this reason these agents are felt to be positive 
lusiotropes.(Lipskaia, Chemaly, Hadri, Lompre, & Hajjar, 2010) Clinically, they are used as 
positive inotropes, given by continuous intravenous infusion following a loading dose, with their 
catecholamine-independent mechanism of action making them theoretically attractive as an 
inotropic support of choice in patients with potential β1-adrenoreceptor down-regulation. 
B.4.11 Levosimendan 
Levosimendan, as a pharmacological agent, exerts positive inotropic effects by binding to 
cardiac troponin C, thus sensitizing the myofilaments to calcium(Haikala, Kaivola, et al., 1995; 
Haikala, Nissinen, Etemadzadeh, Levijoki, & Lindén, 1995) and increasing the effects of 
calcium during systole, thereby improving contraction. During diastole, it causes calcium 
concentration to decline, allowing normal or improved diastolic relaxation.(Follath et al., 2002) 
Levosimendan also has vasodilatory properties due to its facilitation of an adenosine 
triphosphate-dependent potassium channel opening(Yokoshiki, Katsube, Sunagawa, & 
Sperelakis, 1997) as well as anti-ischemic effects.(Kersten, Montgomery, Pagel, & Warltier, 
2000) In clinical studies, levosimendan increased cardiac output and lowered cardiac filling 
pressures and was associated with reduced cardiac symptoms, risk of death, and hospitalization 
in patients . (Moiseyev et al., 2002; Nieminen et al., 2000; Slawsky et al., 2000) Unlike other 
positive inotropic agents, the primary actions of levosimendan are independent of interactions 
with β-adrenergic receptors. (Haikala, Kaheinen, Levijoki, & Lindén, 1997) In the 
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Levosimendan Infusion versus Dobutamine (LIDO) study(Follath et al., 2002), levosimendan 
was shown to exert superior hemodynamic effects compared with the β-adrenergic agonist 
dobutamine, and in secondary and post hoc analyses was associated with a lower risk of death 
after 31 and 180 days. 
B.4.12 Vasodilators 
Afterload reducing vasodilators act via vascular smooth muscle relaxation. Vascular dilatation is 
mediated by both nitric oxide (NO) and non-NO-based mechanisms, NO being a powerful, 
locally acting vascular smooth muscle relaxant. Among commonly used vasodilators in 
hemodynamically unstable patients, both sodium nitroprusside and glyceryl trinitrate 
(nitroglycerine) function as NO donors. Numerous other non-NO donor vasodilating agents are 
available, with hydralazine, clonidine, and inhibitors of the renin-angiotensin system being the 
most commonly employed non-NO-based vasodilators in patients with hemodynamic instability. 
Although uncommonly needed in the management of circulatory shock, their use in combination 
with vasopressor therapy has recently been advocated to increase microcirculatory flow since 
nitrate releasing agents cause microcirculatory flow to increase even in the setting of 
vasopressor-induced arteriolar vasoconstriction.(Trzeciak et al., 2008) However, this is an 
approach still under investigation and not ready yet for general clinical use. (De Backer et al., 
2007)   
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B.5 VENTRICULAR ASSIST DEVICES 
Ventricular assist devices (VADs) are artificial pumps that take over the function of the damaged 
ventricle so as to restore hemodynamic stability and end-organ blood flow. These devices are 
useful in two groups of patients. The first group consists of patients who require ventricular 
assistance to allow the heart to rest and recover its function. In such situations, it is critical to 
obtain complete drainage of the ventricle so as to unload the ventricle, diminish myocardial 
work, and maximize subendocardial perfusion.(EMERY & JOYCE, 1991) The second group 
consists of patients with myocardial infarction, acute myocarditis, or end-stage heart disease who 
are not expected to recover to adequate cardiac function and who require mechanical support as a 
bridge to transplantation.(Frazier et al., 1992; Pae & Pierce, 1981) Patients on VAD support 
often require hemodynamic monitoring to assess their cardiovascular state both in the 
perioperative state and afterward.  
B.5.1 Left Ventricular Assist Device (LVAD)  
Left ventricular assist devices (LVADs), which are rapidly evolving, are used to treat patients 
with advanced stages of heart failure. While the main goals of LVAD therapy are to improve 
symptoms of heart failure and quality of life, they also reverse pulmonary vascular hypertension 
in the setting of venous back-pressure induced increased pulmonary vasomotor tone, thus 
reversing right ventricular dysfunction.(Lund, Matthews, & Aaronson, 2010) 
Patient selection is a crucial consideration that determines the ultimate outcome of 
patients who receive a LVAD. In general, patients who receive LVADs have end-stage heart 
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disease without irreversible end-organ failure. For patients who are too ill to undergo heart 
transplantation, such as those who cannot be weaned from cardiopulmonary bypass, use of a 
short-term extracorporeal LVAD is a first-line therapy. For patients who are suitable candidates 
to receive a heart transplant but are unlikely to survive the wait required before transplantation, 
LVADs are an effective bridge to transplantation.(Goldstein, Oz, & Rose, 1998) 
 
Complications that could occur in the post-implant period include infection, 
thromboembolism and failure of the device. The most common causes of early morbidity and 
mortality after placement of a LVAD include air embolism, bleeding, right-sided heart failure, 
and progressive multisystem organ failure.(Potapov, Stepanenko, Krabatsch, & Hetzer, 2011) In 
general, complications are less with the smaller pumps and drivelines, and in those that use axial 
rather than pulsatile flow. Pump thrombosis, a complication with high mortality or one requiring 
a pump change, can occur causing an obstruction of the pump,(Frazier et al., 1992; Lund et al., 
2010) but can be treated with tirofiban/tissue plasminogen activator.  
Since 60-70% of RV systolic power comes from LV contraction,(Damiano, La Follette, 
Cox, Lowe, & Santamore, 1991) acute cor pulmonale can occur post LVAD insertion. This can 
be corrected by applying therapies aimed at sustaining coronary blood flow (i.e. increased MAP) 
and minimizing any increased pulmonary vasomotor tone (i.e. intravenous prostacyclin or 
inhaled nitric oxide). Hemodynamic monitoring often requires echocardiographic support, as 
described later in this volume. Importantly, the unsupported right ventricle will be minimally 
responsive to positive inotropic drug infusion since most of the beneficial effects of increased 
inotropy on the right ventricle are derived from increased LV contraction.  Thus, volume 
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overload and acute RV dilation are serious concerns and need to be closely monitored using 
echocardiographic techniques.  
B.5.2 Right ventricular assist device (RVAD) 
Right ventricular (RV) dysfunction occurs in clinical scenarios such as RV pressure overload due 
to increased pulmonary vascular resistance, cardiomyopathies, arrhythmias, RV ischemia, 
congenital or valvular heart diseases, and sepsis.(Simon & Pinsky, 2011) The most common 
cause of increased pulmonary vascular resistance  is pulmonary arterial hypertension (PAH), 
which is defined as the mean pulmonary artery pressure > 25 mmHg with a Ppao, left atrial 
pressure or LV end-diastolic pressure < 15 mmHg.(McLaughlin et al., 2009) The critical 
determinant of patient outcomes in PAH is the functioning of the right ventricle, and has been 
recognized as an important avenue for further research.(Voelkel et al., 2006)  Historically, long-
term outcomes for patients with PAH are poor. Progressively increasing PAH results in severe 
RV failure, since the RV, in an attempt to adapt to the pressure overload, becomes hypertrophied 
and eventually dilated, with diminished systolic and diastolic function.  RV failure is the end 
result of PAH and the cause of at least 70% of all PAH deaths.(D'Alonzo et al., 1991) 
Mechanical support for the RV may be appropriate in etiologies where it is likely to be reversed 
(i.e. acute vasospastic disease) or as a bridge to definitive treatment (i.e. lung transplantation). 
RVADs may be used in primary RV dysfunction(Giesler, Gomez, Letsou, Vooletich, & 
Smalling, 2006) and have been used with coexisting PAH.(Fonger et al., 1985; Nagarsheth et al., 
2008) In patients with PAH,  however, there is concern that pulsatile devices may cause 
pulmonary microcirculatory damage.(Berman, Tsui, Vuylsteke, Klein, & Jenkins, 2008) 
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Although theoretically an RVAD may be beneficial for decreasing right-side atrial and 
ventricular filling pressures, decongesting the liver, and increasing LVAD flow, the RVAD itself 
has complications, with the current RVAD technologies requiring external pumps with a 
cumbersome drive system, making  hospital discharge  difficult to achieve.(Chen et al., 1996; 
Farrar et al., 1997) Furthermore, it is difficult to assess volume status in RVAD patients because 
the RV is the primary balance in between volume and volume response. Thus, no clear 
guidelines as to minimal CVP values can be made even when individualized to a given patient’s 
cardiac output, since unstressed intravascular volume can vary widely. 
B.5.3 BiVentricular Assist Device (BiVAD) 
 
The rationale for the use of a BiVAD in patients with heart failure is still controversial. 
These patients are typically more severely ill preoperatively, have a higher serum creatinine, and 
a greater proportion of them are ventilator dependent before VAD insertion.(Farrar et al., 1997; 
Tsukui et al., 2005) While the selection of patients for BiVAD support is crucial to obtaining 
successful outcomes, criteria for predicting the need for a BiVAD have not been well established 
and remain a major focus for future research. While rates of survival to discharge have been 
shown to be similar to LVAD when used post transplantation,(Tsukui et al., 2005) patient 
survival to transplantation is much lower with BiVAD than LVAD.(Farrar et al., 1997) Patients 
on BiVAD therapy are at a greater risk of complications with higher incidences of infection, 
thromboembolism and failure of the device due to twice as many cannulae and pumps. 
(Pennington et al., 1990) As may be expected, BiVAD patients are monitored more by their 
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VAD-displayed cardiac output estimates and measures of MAP than central venous O2 
saturation. Volume status and need for vasopressor therapy are usually accomplished through 
therapeutic trials to observe if changes in cardiac output and MAP occur, rather than on 
predefined physiological conditions. 
B.6 ACUTE KIDNEY INJURY 
Fluid resuscitation together with attention to DO2 are the cornerstones of resuscitation in all 
critically ill patients.(M. R. Pinsky & Payen, 2005) However, acute kidney injury (AKI) is a 
common complication of circulatory shock, and is associated with high mortality.(Rinaldo 
Bellomo, Kellum, & Ronco, 2001; Chertow et al., 1998) Circulating fluid deficits can occur as a 
result of absolute or relative hypovolemia, resulting in inadequate blood flow to meet the 
metabolic requirements of the kidneys. Low cardiac output, either as a primary mechanism in 
cardiogenic shock or a secondary mechanism in the other forms of shock also decreases kidney 
perfusion. Both of these volume and flow problems must be treated urgently if AKI is to be 
avoided.(Blow, Magliore, Claridge, Butler, & Young, 1999; Claridge et al., 2000) Although the 
importance of fluid management is generally recognized, the choice and amount of fluid, and  
fluid status end-points are controversial,(Michard et al., 2000; M. R. Pinsky, 2012; M. Pinsky, 
2002) requiring special attention to monitoring hemodynamic patterns of fluid resuscitation in 
patients at risk for AKI. 
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B.6.1 Risk of starches to cause AKI 
Hydroxylethyl starches (HES) are identified by three numbers corresponding to concentration, 
molecular weight, and molar substitution (e.g.: 6% HES, 130/0.4). According to the number of 
hydroxyethylations at carbon positions C2, C3, or C6 (degree of substitution), the HES are more 
or less resistant to degradation by plasma α-amylase. Molar substitution is the most clinically 
significant number since it relates to the rate of enzymatic degradation of the starch polymer. 
(Westphal et al., 2009) Pharmacokinetic characteristics of HES solutions are based upon the 
molecular weight, and degree of substitution and C2/C6 hyrdoxyethylation ratio.(Ragaller, 
Theilen, & Koch, 2001) Renal toxicity of HES depends on the level of molar substitution, 
although a meta-analysis of randomized clinical trials in surgical patients failed to show any 
difference in the incidence of renal impairment between patients who received low substituted 
HES and other forms of fluid therapy.(Van Der Linden, James, Mythen, & Weiskopf, 2013) 
However, in the intensive care units, renal toxicity has been reported even with low substituted 
HES, due to concurrent sepsis and distributive shock,(Sear, 2005) with the initiation of renal 
replacement therapies significantly greater in patients who received HES than those who 
received saline for fluid management.(Rahbari et al., 2009)  
 
B.6.2 Continuous Renal Replacement Therapies 
In general, critically ill patients receive high daily amounts of volume infusions: continuous 
infusions, vasopressors, blood or fresh frozen plasma. Patients with renal failure and in septic 
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shock continue to receive large amounts of fluid resuscitation thus leading to fluid overload. The 
consequent positive fluid balance necessitates water removal, with a major consequence of rapid 
fluid removal being hemodynamic instability.(Ronco, Bellomo, & Ricci, 2001)  
Daily or every other day conventional hemodialysis (HD) is the standard dialysis regimen 
for hemodynamically stable patients with renal failure. However, hypotension during HD due to 
rapid fluid and solute removal is the most common complication of this therapy, and can prolong 
renal insufficiency in critically ill AKI patients. The rapid rate of solute removal during HD 
results in an abrupt fall in plasma osmolality which induces further extracellular volume 
depletion by promoting osmotic water movement into the cells. This reduction in plasma 
osmolality may contribute to the development of hypotension. Severe hypotension still 
accompanies 20-30% of HD sessions in patients with AKI.(Hakim, Wingard, & Parker, 1994) It 
was for that reason that continuous renal replacement therapy (CRRT) was developed. With 
CRRT, volume control is more gently continuous and immediately adaptable to changing 
circumstances (e.g. the immediate need for blood or blood products in a patient at risk for 
ARDS). Because of this adaptability, volume overload can be immediately treated or prevented, 
and volume depletion avoided.  
The ideal renal replacement therapy would be one that achieves slow yet adjustable fluid 
removal, in order to easily meet the highly variable required daily fluid balance. At the present 
time, by mimicking urine output, CRRT slowly and continuously removes a patient’s plasma 
water. It must be emphasized, however, that the protection afforded by CRRT is relative and not 
absolute, since hypotension can still occur if too much fluid is removed or if fluid is removed too 
quickly, irrespective of the therapy name. Studies comparing CRRT to HD in patients with AKI 
have not shown a survival benefit for one approach versus the other.(Jun et al., 2010) It remains 
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a controversial matter as to which clinical parameter (dry weight, MAP, Ppao, SvO2, etc.) or 
currently available invasive monitoring (central venous catheter, pulmonary artery catheter, etc.) 
should be utilized in order to define the concept of ‘fluid overload’ and subsequent therapies 
thereof to be employed for fluid removal.(Vincent, Abraham, Kochanek, Moore, & Fink, 2011) 
B.7 CONCLUSION 
Hemodynamic monitoring at the bedside improves patient outcomes when used to make 
treatment decisions at the right time for patients experiencing hemodynamic instability. For 
monitoring to provide any benefit, the clinician must be able to use the information to guide 
management within the context of known physiological principles and an understanding of the 
pathological processes that may be in play. Three basic guiding principles could be used to 
effectively manage patients with hemodynamic instability associated with signs and symptoms 
of tissue hypoperfusion. If blood flow to the body increases with fluid resuscitation, then 
treatment must include volume expansion. If the patient is also hypotensive and has reduced 
vasomotor tone, then vasopressor therapy might be initiated simultaneously.  If the patient is 
neither preload responsive nor exhibiting reduced vasomotor tone and is hypotensive, then the 
problem is the heart, and both diagnostic and therapeutic actions must be initiated to address 
these specific problems. Protocolized management, based on existing hemodynamic monitoring 
technologies at the bedside, is both pluripotential (different monitoring devices can drive the 
same protocol) and scalable (can alter the resuscitation intensity) and thus lends itself to 
automation. 
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Table 1. Categorization of Shock States based on the Weil and Shubin8 Nosology 
 
 
Abbreviations: right atrial pressure, Pra; pulmonary artery occlusion pressure, Ppao; cardiac 
output, CO; systemic vascular resistance, SVR; mean arterial pressure, MAP, central venous 
pressure, CVP, venous oxygen saturation, SvO2. 
Shock state Pathophysiology Disease States Hemodynamic 
Monitoring Pattern 
Hypovolemic Decrease in 
effective circulating 
blood volume and 
venous return 
 Primary intravascular volume loss (hemorrhage, capillary leak) 
 Secondary intravascular volume loss (third-space loss, burns, 
diarrhea, vomiting) 
↓ filling pressures (↓Pra 
and Ppao) 
↓ CO 
↑ SVR 
Cardiogenic Primary cardiac 
failure 
 Impaired contractility (myocardial ischemia/infarction, 
electrolyte imbalance, hypoxemia, hypothermia, endocrinologic 
diseases, metabolic poisoning, beta-blockers) 
 Pump function (valvulopathy, ventriculoseptal defect, 
dysrhythmias) 
 Diastolic compliance (left ventricular hypertrophy, fibrosis, 
infiltrative cardiomyopathies, asymmetric septal hypertrophy, 
cor pulmonale) 
↑ back pressure to cardiac 
filling (↑Pra and Ppao) 
↓ CO 
↑ SVR 
Obstructive Blockage of blood 
flow in heart’s 
outflow tracts 
 RV outflow obstruction (pulmonary embolism, lung 
hyperinflation and pulmonary artery compression) 
 LV outflow obstruction (aortic stenosis, dissecting aortic 
aneurysm) 
 Cardiac Tamponade (pericardial effusion, lung hyperinflation 
and atrial compression) 
↑CVP 
↓ Ppao relative to CVP  
↓ CO 
↑ SVR 
Distributive Loss of blood flow 
regulation 
 Sepsis (increased capillary leak with secondary loss of 
intravascular volume, and inappropriate clotting in the 
microcirculation) 
 Neurogenic shock (acute spinal injury above the upper thoracic 
level, spinal anesthesia, general anesthesia, neurotoxic poisoning 
and central nervous system catastrophe) 
 Acute adrenal insufficiency (hyperpyrexia and circulatory 
collapse) 
↓CVP 
↓ filling pressures (↓Pra 
and Ppao) 
↑ SvO2  
↓ MAP  
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Psychometric Analysis of the Charlson Comorbidity Index Deyo Method 
Eliezer Bose, Marilyn Hravnak, Lauren Terhorst 
 
Introduction: The Charlson Comorbidity Index (CCI) Deyo method is widely employed in 
acute care. This scoring system uses abstraction from administrative databases, with 17 
comorbidities assigned a score (1-6 based on risk of dying associated with the condition) and 
summed for a mortality risk score. Since CCI items were empirically derived, this study sought 
to provide psychometric information about the CCI Deyo through exploratory factor analysis 
(EFA).  
Hypothesis: EFA of CCI items will expose factor structure of items and construct validity. 
Methods: CCI items and scores were electronically abstracted from 634 neurotrauma step-down 
unit patient records. Univariate analyses of individual items were explored. Inter-item 
correlations, multivariate outliers with Mahalanobis distance, and KMO and Bartlett’s tests were 
verified for EFA application. Principal component analysis (PCA) using promax rotation, 
assuming associations among the factors, produced form factors and subscales. Cronbach’s alpha 
for factors reliability was computed. Pearson correlation of each subscale score was compared to 
overall CCI scores testing construct validity.  
Results: The sample mean age was 57 yrs, and 49% had a CCI score of 0 (24%=CCI 1, 
15%=CCI 2, 6%=CCI 3, 6% CCI ≥4). Diabetes (DM) was the most prevalent comorbidity (21%) 
followed by COPD (18%), then MI, PVD and CHF (10% each) and cerebral vascular disease 
(6%), and the other 11 comorbidities prevalence ≤4%. A KMO value of 0.546 and Bartlett’s 
p<0.001 denoted adequate sample size for EFA, and no multicollinearity (no inter-item 
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correlation >0.68). PCA with eigenvalues>1 extracted 7 factors which explained 59% of the 
variance. Pearson correlation of Factor 2 loaded items (CHF, MI, COPD, DM and PVD) had the 
highest value of 0.707 with overall CCI score, indicating strong predictive relationship of this 
factor. However, all 7 subscales scores obtained p<0.01 compared to overall CCI score. 
Conclusion: EFA revealed co-occurrence of certain disease items, indicating common 
underlying pathologic mechanisms, as well as propensity of multiple comorbidity groupings. 
However, as a scoring mechanism the composite CCI Deyo may be only moderately helpful as 
construct validity was poor. 
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D.1 ABSTRACT 
Background and Purpose: Since the Charlson Comorbidity Index Deyo–method (CCI-D) is 
widely used in nursing research, this study examines the internal structure of the CCI-D method. 
Methods: CCI-D scores were obtained from 634 in-patients. Principal component analysis 
(PCA) was utilized to investigate the internal structure and identify subscales. Results: Four 
factors had eigenvalues >1 and accounted for 49.4% of the extracted variance. The four 
subscales were not strongly correlated, providing evidence of dimensionality within CCI-D. 
Conclusions: Even though CCI-D is commonly used as a variable in nursing research and can be 
easily obtained from administrative data, its internal structure is multidimensional. The subscales 
may provide more information than the overall index. Further complex psychometric testing of 
CCI-D is warranted to interpret utility.  
 
Keywords: comorbidity; principal component analysis; ICD-9-CM; hospital mortality 
D.2 INTRODUCTION 
Patient co-morbidity is a variable that must be taken into account when assessing the impact of 
nurse characteristics or nursing interventions upon patient care and outcomes. The Charlson 
Comorbidity Index has been frequently employed in nursing research to account for a patient’s 
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pre-existing comorbid conditions when  studying nurse staffing (Rafferty et al., 2007; Rochefort, 
Ward, Ritchie, Girard, & Tamblyn, 2012; Xue, Aiken, Freund, & Noyes, 2012), and the impact 
of nurses upon hospital mortality (Aiken et al., 2014; Schubert, Clarke, Aiken, & De Geest, 
2012; Sermeus et al., 2011), and post-surgical outcomes (Carthon et al., 2012). Nurse researchers 
as well as clinicians operate under the assumption that ‘true comorbidity’ is correlated with 
worse health outcomes. Methods that evaluate comorbidity generally assign scores to all relevant 
comorbid conditions, with the “comorbidity index” obtained by the summation of these scores. 
Charlson et.al developed a weighted index of comorbidity, known as the Charlson Comorbidity 
Index or CCI (Charlson, Pompei, Ales, & MacKenzie, 1987). A few years later, with the wide-
spread use of electronic health records, Deyo et al. (Deyo, Cherkin, & Ciol, 1992) developed an 
electronic version of the CCI which we refer to as  CCI-Deyo or CCI-D, which has been used 
more commonly in nursing literature (Aiken et al., 2014; Collins et al., 2013; Hravnak, Chen, 
Dubrawski, Bose, & Pinsky, 2015; Ott et al., 2012; Yousef, Pinsky, DeVita, Sereika, & Hravnak, 
2012). Nurse researchers should become more aware of this method of measuring comorbidity, 
particularly as the use of large electronic databases and “big” data become more prevalent. The 
overall purpose of this study was to examine the internal structure of the CCI-D. With the recent 
shift towards ICD-10 coding system and few studies (Sundararajan et al., 2004; Sundararajan et 
al., 2007; Thygesen, Christiansen, Christensen, Lash, & Sørensen, 2011) already having 
validated the CCI as a valuable predictive tool for hospital mortality, nurse researchers and 
nurses using that research to develop evidence-based practice will only find its use much more 
widespread for assessing in-hospital comorbidities and mortality. 
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D.3 BACKGROUND 
The comorbidity index developed empirically by Charlson and colleagues was based on 1-yr 
mortality from a cohort of 604 patients admitted to a particular service at one hospital during one 
month in 1984 (Charlson, Pompei, Ales, & MacKenzie, 1987). This empirically derived CCI had 
a list of 19 comorbid conditions. Charlson et al. assigned each condition an associated weight 
from 1 to 6 according to their associated risk for 1-year mortality. The overall CCI was obtained 
by the summation of the weights for the existing comorbid conditions that a patient had. The CCI 
was then validated for its ability to predict mortality in a cohort of 685 patients who were treated 
for primary breast cancer. Its performance was compared to the method of classifying comorbid 
disease previously developed by Kaplan and Feinstein (Kaplan & Feinstein, 1974). The relative 
risk of 1-year mortality for each increasing point of the CCI was 2.3 (95% CI 1.9-2.8) and CCI 
was a highly significant predictor of mortality (p<.0001) (Charlson et al., 1987). In a much later 
study, similar results were obtained when the CCI was used as a predictor for measuring post-
operative survival in patients with hypertension or diabetes (Charlson, Szatrowski, Peterson, & 
Gold, 1994), thus establishing the validity of the instrument. However, in order for CCI to be 
computed, each patient’s hospital record had to be reviewed manually for the comorbid 
conditions. Deyo et al. used a method whereby the comorbid conditions were determined, not by 
manual review of hospital records, but by electronically assigning ICD-9-CM codes for 17 
comorbid conditions used in the CCI. They used the method for medical record abstraction of 
administrative databases in 27,111 Medicare beneficiaries who underwent lumbar spine surgery 
in order to identify the comorbidities, assign the weighted scores and thus compute CCI-D (Deyo 
et al., 1992).  
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Across the nursing and other healthcare literature, the accuracy of an index such as CCI or CCI-
D depends on how well the index separates the two groups of patients compared (e.g. those with 
mortality/died vs. those without mortality/lived). In order to do so, a commonly employed 
procedure includes the use of Area under receiving operator characteristics (AUROC) curves. 
AUROCs are designed to plot the false positive rate of a score (1-specificity) on the x-axis and 
the true positive rate (sensitivity) on the y-axis. In terms of discrimination between the groups, 
an AUROC value between 0.7 and 0.8 indicates fair while a value between 0.8 and 0.9 indicates 
good and a value > 0.9 is excellent. CCI-D demonstrated good discrimination of in-hospital 
mortality with AUROC values of .86 - .87. Few subsequent studies validated the CCI-D 
(Kieszak, Flanders, Kosinski, Shipp, & Karp, 1999; Melfi, Holleman, Arthur, & Katz, 1995; 
Poses, Smith, McClish, & Anthony, 1995). 
D.4 PURPOSE 
While the CCI-D has been extensively utilized and its performance validated in samples of 
patients with breast cancer, hypertension and diabetes, lumbar spine surgery etc. as described in 
a systematic review by Sharabiani et al. (Sharabiani, Aylin, & Bottle, 2012), it has never been 
examined using a sample of patients in a step down unit (SDU). According to the American 
Education Research Association’s standards, when an instrument is utilized in a new or different 
population, its performance with the new population should be examined. The purpose of the 
current study was to examine the internal structure of the CCI-D using a sample of 634 patients 
admitted to the SDU of a Level I trauma center. Principal components analysis (PCA) was used 
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to analyze and discover simple pattern of relationships among the list of comorbid conditions of 
the CCI-D. This study, about the internal structure of a commonly used comorbidity index in 
nursing literature, will offer nurse researchers, and nurses utilizing that research, an overview of 
the relationship among the different comorbid conditions within the CCI-D. Such information 
can be invaluable for nurse researchers working on large databases and “big” data, thereby 
reducing the risk of the “curse of dimensionality” when gathering data related to comorbid 
conditions. 
D.5 METHODS 
D.5.1 Sample 
This study was approved by the local institutional review board (IRB PRO12070002). The unit 
providing the data was a 24 bed trauma/surgery step-down unit (SDU). Demographic 
information was obtained from the medical record for all patient admissions (N = 634; 73% 
white, 60% male). Entry criteria for the parent study required that the patients were >21 years of 
age during the study periods (11/06-8/07; 16 weeks). There were no special efforts to direct 
patient admissions to the study unit. 
D.5.2 Instrument 
The CCI-D was calculated electronically using the ICD-9 CM codes for each of the 17 CCI 
items—myocardial infarction (MI), congestive heart failure (CHF), peripheral vascular disease 
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(PVD), cerebral vascular disease (CVD), dementia (DEM)  , chronic pulmonary disease (CPD), 
rheumatoid disorder (RMD), peptic ulcer disease (PUD), mild liver disease (MLD), diabetes 
(DIAB), diabetes with complications (DIABCC), hemiparesis (HEMIPARA), renal (RENAL), 
metastatic tumor (METATUMR), malignant tumor (MALIG), severe liver disease (SLD) and 
acquired immune deficiency syndrome  (AIDS). Individual items were coded as either 0 or 1. If a 
patient had a particular disease in the list of CCI items, it was scored as 1 for that item while if 
the patient did not have the disease, it was scored as a 0 for that item. 
D.6 ANALYSIS 
All statistical analyses were conducted on the data from 634 participants using Statistical 
Packages for the Social Sciences (SPSS) version 21. The assumptions for PCA should first be 
verified ensuring that the data can be analyzed using PCA. These assumptions included testing 
for sampling adequacy using the Kaiser-Myer-Olkin (KMO) and Bartlett’s test of sphericity as 
well as a check to assess for individual item distributions, which in this sample was the list of 17 
comorbid conditions of the CCI-D.  
Item Distributions and Preliminary Analyses. The responses for each of the 17 CCI-D items for 
each patient, and their overall prevalence of occurrence in the total sample were examined. If 
items were not endorsed by at least 2% of the patients in the sample, they were considered non-
representative and were dropped from further analysis.  
Next, we proceeded to assess for sampling accuracy. Tabachnick’s rule-of-thumb suggests 
having at least 300 cases for performing PCA (Tabachnick & Fidell, 2007). The classic Kaiser-
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Myer-Olkin (KMO) statistic (Kaiser, 1974) and Bartlett’s test of sphericity (Bartlett, 1950) were 
computed to establish the appropriateness of performing the factor analysis. The KMO index 
ranges from 0 to 1, with .50 considered suitable for PCA. A KMO value < .5 would render the 
data unsuitable for PCA, according to Kaiser Criterion. Bartlett’s test of sphericity was also 
tested and must be significant for PCA to be suitable. Next, a correlation matrix was computed to 
investigate the interrelationships among the individual items, and to identify possible clusters of 
items. Generally, the correlation matrix is inspected to check for correlation coefficients over .30 
(Tabachnick & Fidell, 2007) to identify item patterns. Items with correlations higher than .8 may 
be redundant and should be inspected further. 
Principal Component Analysis. PCA is a statistical technique in which the interrelationship 
among many correlated variables may be reproduced, and the data represented by a smaller 
number of variables or principal components (Nunnally & Bernstein, 1994). The components are 
arranged in a decreasing order of the percentage of the total variance accounted for by each of 
the components. PCA searches for the fewest number of components that could explain the 
variance in the items and outputs the variance in terms of a combination of both unique and 
shared variance (Costello & Osborne, 2005).  
The rationale for the use of principal components analysis (PCA) was to examine the internal 
structure of the CCI-D. Reduction into components established underlying dimensions between 
the items used for measuring the construct of comorbidity. In order to make the pattern of factor 
loadings clearer, researchers commonly employ the use of two types of rotation procedures—
either orthogonal or oblique. Orthogonal rotation assumes that the factors in the analysis are 
uncorrelated while oblique rotation assumes that the factors are correlated. The internal structure 
was examined using both orthogonal (Varimax) rotation as well as oblique (Promax) rotation; 
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however only Promax results were reported. This is because, from a physiological standpoint, 
there seemed to be a correlation between the various comorbid conditions and oblique rotation 
accounts for such correlations.  
 PCA was then performed by extracting components with eigenvalues > 1, which meant 
that  a component was dropped unless it extracted at least as much as the equivalent of one 
original item, as per Kaiser criterion (Kaiser, 1974). A Cattell scree plot, a 2 dimensional plot 
with the components on the X axis and their corresponding eigenvalues as the Y-axis (Catell, 
1978) was also examined. Upon examination of component loadings, items with component 
loadings > .32 were retained to form subscales (Tabachnick & Fidell, 2007). Items with loadings 
higher than .32 on more than one component were considered cross-loaders. The magnitude and 
direction of the relationships among the emergent subscales, and between the subscales and the 
total CCI score were then inspected to further examine the internal structure of the CCI. 
Once subscales were confirmed, labels were created based on the prominent pathophysiological 
mechanisms of the comorbid conditions, in consultation with members of the research team. 
Labels were assigned primarily with the intent of reflecting the theoretical and conceptual intent 
of the constructs. Conventionally, variables that have a loading of .32 or greater within a 
particular component are considered to be its major contributors, and subscales are usually given 
names relating to their main emphasis (Tabachnick & Fidell, 2007). 
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D.7 RESULTS 
D.7.1 Sample Demographics 
The demographic characteristics of the sample are provided in Table 1. There were 634 subjects 
with CCI scores obtained using the Deyo Method. About 48.6% of the patients had age ranges 
over 59, placing them at potentially greater risk of comorbidities. The median length of hospital 
stay for the sample was five days. The resulting sample had a median CCI total score = 0 and 
inter quartile range = 1, indicating a population with a low risk of 1-yr mortality. Table 2 
provides the frequencies of each of the CCI items as well as the means and the standard 
deviations. Although there were 17 initial items, it was discovered that dementia (DEM)  was a 
constant (all 0’s); so it was removed from the analysis, as none of the sample of patients either 
had or were recorded as having  dementia. Additionally, several items were not endorsed by at 
least 2% of the patients: these were hemiparesis, metastatic tumor, renal, mild liver disease, 
severe liver disease, and AIDS. These items were also dropped from further analyses, resulting 
in 10 items for the PCA. 
 
D.7.2 Analysis 
Preliminary Analyses. The correlation matrix displaying the relationships between the 10 items 
has been provided in Table 3, and indicated that the items may be clustering to form factors. No 
inter-item correlations exceeded r =.24, thus indicating no problems with multicollinearity. The 
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item-to-total scale correlations ranged from .077 (MALIG) to .350 (CHF). This range of item-
total correlations was considered to be acceptable (Bernstein & Nunnally, 1994) . The sample of 
634 subjects and 10 items, revealed a KMO statistic (.636) and a Bartlett’s test of sphericity (χ 2 
(45) = 188.6 with p< .001) both indicating that PCA was acceptable.  
Principal Component analysis. Table 4 reports pattern matrix item loadings, communalities, and 
total variance explained from the PCA solution. Four components explained 49.38% of the total 
variance. Communalities, which provide information on how much item variance is explained by 
the extracted components, ranged from .334 (CVD) to .702 (DIABCC). Two items were 
considered cross-loaders with component loadings greater than .32 on more than one component. 
CHF had a higher loading on component 1 (.557) and a lower loading on component 2 (.369), 
while MALIG had a higher loading on component 4 (.528) and a lower loading on component 2 
(.350). Cross-loading items were retained on the component on which they had the highest 
loading for interpretation and further analysis. Correlations from the extracted components 
ranged from r =.003 to r =.206, providing evidence that the subscales were somewhat related. 
The strongest relationship was between component 1 and component 2 (r=.206, p<.001), while 
the weakest relationship occurred between components 3 and 4 (r =.003, p=.931). The 
relationship between components 2 and 3 was also weak (r =.065, p =.105). Components 1 and 3 
were not strongly correlated (r =.079, p=.048), but it was noted that the relationship was 
significant. The relationship between components 1 and 4 was also significant (r =.102, p =.011), 
providing evidence that component 1 was related to all other emergent components. 
Additionally, each of the four components was significantly related to the overall comorbidity 
score. Component 1 had the strongest correlation with the overall score (r =.742, p <.001), and 
component 2 also had a strong correlation with the CCI score (r =.563, p <.001). Components 3 
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and 4 had moderate correlations with the overall CCI score, r =.284, p<.001 and r =.369, p<.001, 
respectively. Subscale labels were formed with consideration of the particular items that formed 
the four components. Component 1 was labeled as “cardiovascular;” component 2 was labeled 
“hypertensive;” component3 was labeled “rheumatic/peptic;” and component 4 was labeled 
“malignancies.”   
D.8 DISCUSSION 
The purpose of the study was to explore the internal structure and relationships among the items 
of the CCI-D using a sample of 634 patients admitted to the SDU of a Level I trauma center. The 
majority of patients (71%) had a CCI-D score of 0. PCA with oblique rotation revealed four 
subscales which explained 49.38% of the variance. The four emergent subscales were not 
strongly correlated, providing evidence of dimensionality within the CCI-D. 
The finding that most patients had a CCI-D score of 0 probably reflects the nature of the patient 
population on this trauma-SDU. The population was relatively young and victims of an acute 
accident or injury, and thus was relatively healthy prior to hospitalization. Therefore, the range 
of comorbidity scores was relatively small, with very few patients having a score of three or 
more. In order to accurately reflect the type of patient that would receive services in the SDU, all 
patients were retained in the analysis.  
 Seven of the 17 CCI items were endorsed by less than 2% of the 634 patients, indicating 
that a smaller set of items may address the comorbidities experienced by the patients in the step 
down units. Using an instrument with fewer items reduces participant burden in research and 
 207 
 
therefore this finding should be further investigated to determine the best set of items to be used 
in studies of comorbidities in patients placed in SDUs. However, this may also be a reflection of 
the young age and acute-onset illness in this unit. A population of older patients on a medical 
specialty unit might have yielded different results. 
An inspection of the item loadings on the four components led to a few considerations. Firstly, in 
prior research, patient responses to CCI items have been generally summed to provide an overall 
score (Deyo et al., 1992), which implies unidimensionality. In this study, all four components 
were significantly related to the total score, providing evidence that they do measure an overall 
similar construct. However, the findings of this investigation imply that the internal structure of 
the CCI is multidimensional, and that the subscale scores may be utilized to provide additional 
information by which to assess patient comorbidities. 
The subscale labeled Rheumatic/peptic which contained both Rheumatic disease and Peptic ulcer 
disease was an interesting finding of this project. Upon discovering that both of these items 
loaded on a subscale, which at first seemed to be a disparate finding, a literature search was 
conducted to examine the physiological relationship, if any, that existed between the two items. 
Surprisingly, the correlation of these two diseases with a common underpinning of physiologic 
stress has been a well-known fact established in medical literature with the findings provided as 
early as 1988 in the Annals of Rheumatic Disease (Farah, Sturrock, & Russell, 1988). 
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D.9 LIMITATIONS 
There were several limitations associated with the current investigation. Most of the patients in 
the SDU did not have comorbidities and thus did not contribute to the variability in responses. 
Also, only 10 of the 17 CCI items were assigned to the patient sample, thus the full range of 
conditions available within the CCI were not represented. The 10 items that were used in the 
analysis did not provide a clean solution, with two cross-loading items. Further investigation into 
the cross-loading items to determine appropriate component placement is warranted. The current 
study was exploratory in nature, and the results should be confirmed using a different sample of 
patients placed in a SDU. More detailed investigation into item level performance should be 
undertaken using psychometric methods such as a Rasch analysis or confirmatory factor 
analysis. 
D.10 CONCLUSIONS 
This study explored the internal structure of the CCI Deyo method in a sample of patients in a 
SDU of a Level-1trauma center. Findings revealed that most patients were healthy; indicating 
that a smaller set of items could capture the common comorbidities experienced by this 
population. PCA revealed co-occurrence of certain disease items, indicating common underlying 
pathologic mechanisms, as well as propensity of multiple comorbidity groupings. The finding of 
a multidimensional internal structure implies that subscale scores could provide more detailed 
information on patient comorbidities than an overall index. Future, more confirmatory studies are 
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needed to support the results of the current investigation. Nevertheless, this study about the 
internal structure of a widely used comorbidity index in nursing literature can offer nurse 
researchers an overview of the relationship among the different comorbid conditions within the 
CCI-D. Since CCI-D is multidimensional, the use of subscales can prove to be invaluable for 
nurse researchers, thereby reducing the risk of the “curse of dimensionality” when gathering data 
related to comorbid conditions, especially when tapping into large databases and “big” data to 
answer nursing questions. 
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Table 1:  Demographic Characteristics of the Sample (N = 634) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VARIABLE N % 
AGE (YEARS) 57.68 + 
19.94   
 
     < 21 17 2.7 
     21-30 67 10.6 
     31-39 36 5.7 
     40-49 82 12.9 
     50-59 124 19.6 
     59 AND OVER 308 48.6 
ETHNICITY   
     WHITE/CAUCASIAN 461 72.7 
     BLACK/AFRICAN 
AMERICAN 
85 13.4 
     HISPANIC 81 12.8 
     NATIVE AMERICAN 3 .5 
     ASIAN 2 .3 
     OTHER 2 .4 
HOSPITAL LENGTH OF STAY   
     MEAN 9.05 days  
     MEDIAN 5 days  
     MODE 2 days  
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Table 2: Table of means and standard deviations of all items in 634 patients 
CHARLSON/DEYO COMORBIDITY 
INDEX INDIVIDUAL ITEM 
N  MEAN SD 
MYOCARDIAL INFARCTION (MI) 66  .10 .306 
CONGESTIVE HEART FAILURE (CHF) 67  .11 .308 
PERIPHERAL VASCULAR DISEASE (PVD) 68  .11 .310 
CEREBRAL VASCULAR DISEASE (CVD) 36  .06 .232 
DEMENTIA 0  .0 .00 
CHRONIC PULMONARY DISEASE (CPD) 115  .18 .386 
RHEUMATOID DISORDER (RMD) 27  .04 .202 
PEPTIC ULCER DISEASE (PUD) 13  .02 .142 
MILD LIVER DISEASE (MLD) 12  .02 .136 
DIABETES 128  .20 .402 
DIABETES WITH COMPLICATIONS (DIABCC) 19  .03 .171 
HEMIPARESIS (HEMIPARA) 3  .00 .069 
RENAL (RENAL) 7  .01 .105 
METASTATIC TUMOR (METATUMR) 5  .01 .089 
MALIGNANT TUMOR (MALIG) 16 .03 .157 
SEVERE LIVER DISEASE (SLD) 8  .01 .112 
AIDS (AIDS) 2  .00 .056 
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Table 3: Correlation Matrix, Means, and Standard Deviations for the 10-Item Charlson 
Comorbidity Index-Deyo Method 
 
 
MI= Myocardial infarction, CHF = congestive heart failure, PVD = peripheral vascular disease, 
CPD = chronic pulmonary disease, CVD = cerebral vascular disease, RMD = rheumatoid 
disease, PUD = peptic ulcer disease, DIAB = diabetes, DIABCC = diabetes with complications, 
MALIG = malignant tumor 
Item MI CHF PVD CPD CVD RMD PUD DIAB DIABC MALIG 
MI 1.000          
CHF .236 1.000         
PVD .166 .163 1.000        
CPD .161 .184 .088 1.000       
CVD .028 .093 .047 .026 1.000      
RMD .005 .055 .028 .043 .050 1.000     
PUD .024 .023 .058 .076 .013 .135 1.000    
DIAB .112 .211 .080 .069 .097 .011 .038 1.000   
DIABCC .061 .120 .118 .013 -.003 .009 -.025 .004 1.000  
MALIG .011 .043 -.023 .029 .004 .066 .048 .094 .031 1.000 
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Table 4: Principal Component Analysis Solution of the Charlson Comorbidity Index-Deyo 
method (CCI-D). 
 
                                COMPONENTS 
ITEM I II III IV COMM 
MI .631    .418 
CHF .557 .369   .491 
PVD .589    .387 
CPD .516    .356 
CVD  .580   .334 
DIAB  .720   .530 
RMD   .707  .504 
PUD   .754  .567 
DIABCC    .794 .702 
MALIG  .350  .528 .648 
Total Variance Explained (49.38%) 16.99 11.64 10.55 10.20  
Eigenvalues 1.70 1.17 1.05 1.02  
 
 
MI= Myocardial infarction, CHF = congestive heart failure, PVD = peripheral vascular disease, 
CPD = chronic pulmonary disease, CVD = cerebral vascular disease, RMD = rheumatoid 
disease, PUD = peptic ulcer disease, DIAB = diabetes, DIABCC = diabetes with complications, 
MALIG = malignant tumor, COMM = communalities 
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APPENDIX E 
EARLY PHYSIOLOGIC PREDICTORS OF CARDIORESPIRATORY INSTABILITY 
IN STEP-DOWN UNIT PATIENTS 
Poster Presented at the Eastern Nursing Research Society, Boston, MA, Summer 2012 
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Early Physiological Predictors of Cardiorespiratory Instability in Step-Down Unit Patients 
Eliezer Bose, Marilyn Hravnak 
 
Background: Patients hospitalized on step-down units (SDUs) undergo continuous 
physiological monitoring due to presumed risk for cardiorespiratory instability (CRI), which 
occurs in only a subset of patients but is associated with significant morbidity and mortality. 
Early detection and recognition of CRI is crucial. Purpose: To: 1) identify and compare the 
characteristics of SDU patients who develop CRI (unstable) with patients who never develop 
CRI (stable), 2) identify interactive differences in dynamic physiologic patterns of stable and 
unstable patients, and 3) develop models to predict CRI before its overt manifestation. Methods: 
Prospective, longitudinal evaluation of a retrospective convenience sample of SDU patients over 
8 weeks (n=646; 32,000 monitoring hours). An amalgamated database containing patients’ 
continuous physiologic data streams, clinical characteristics (age, gender, race, diagnoses, 
comorbidities), and CRI class will be created. A MATLAB filter will be applied to the 
continuous physiological signals to identify and tag CRI, defined as 1) HR <40 or >140 bpm, 2) 
RR <8 or >36 bpm, 3) systolic BP <80 or >200 mmHg, 4) diastolic BP >110 mmHg or 5) SpO2 
<85%. Patients who at any point cross a CRI threshold are classified as unstable, and patients 
who never did as stable. Stable and unstable patients will be compared to identify which 
characteristics are either singly or in combination associated with instability. Rolling 5-minute 
time windows of the physiologic data will be assessed for emerging interactive pattern 
differences leading to overt CRI using a weighted threshold test based on standard deviation of 
the changes. Regression models incorporating various iterations of physiologic and clinical data 
to dynamically predict instability will be developed, and prediction accuracy evaluated in 30% of 
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the sample not used for calibration. Implications: Study findings will provide direction for 
improved CRI detection and prediction, to shift CRI care from a reactive to preemptive 
approach. 
 220 
 
APPENDIX F 
DIURNAL VARIATION IN VITAL SIGN ALERTS ACCORDING TO MEDICAL 
EMERGENCY TEAM (MET) TRIGGER CRITERIA IN CONTINUOUSLY 
MONITORED STEP-DOWN UNIT (SDU) PATIENTS 
Eliezer Bose, Lujie Chen, Michael Pinsky, Marilyn Hravnak 
Poster presented at the Rapid Response Systems (RRS) Conference, Summer 2014—Best 
posters final list 
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Diurnal variation in vital sign alerts according to Medical Emergency Team (MET) trigger 
criteria in continuously monitored step-down unit (SDU) patients. 
Background: MET calls are made more frequently during mid-day hours. It is unknown if this is 
due to true diurnal variation in instability incidence, or a product of having more staff in the 
presence of the patient during those hours to recognize instability. We hypothesize the latter, and 
that real vital sign (VS) variations indicating instability according to MET trigger criteria occur 
consistently around the clock, representing missed opportunity to deploy the MET. Methods: 
This is a retrospective analysis of prospectively collected data in 634 patients (41,635 monitoring 
hours total; 80 mean monitoring hours/patient; 55 median monitoring hours/patient) who 
underwent continuous noninvasive VS monitoring (heart rate [HR], respiratory rate [RR; 
bioimpedance], and noninvasive oscillometric (systolic [SysBP] and diastolic [DiaBP]) blood 
pressure, and peripheral oximetry (SpO2) recorded at a 1/20Hz frequency. VS deviations beyond 
our local MET trigger values (HR< 40 or >140, RR< 8 or >36, SysBP < 80 or >200, DiaBP>110, 
SpO2< 85%) for 80% of a 5-min moving window were visually annotated by two expert 
clinician reviewers as real alerts or artifacts. Artifacts were discarded, leaving 1,399 MET 
threshold alerts (50% RR, 30% SpO2, 10% HR and 10% BP). Alerts were tallied according to 
hour of the day, and then calculated as the probability of incurring an alert for each hour of the 
day.  R open source statistical software (Version 2.15.2) was used to test if differences existed in 
alert probability for each of the 24 hours of the clock (test for equality in proportions).   
Results: The sample was primarily male (59%) and white (73%), with a mean age of 58 
years, and a mean length of days on SDU 3.1+ 3.1 days. Admissions were highest from 1400 to 
2400. The probability for a MET threshold alert per hour of the clock ranged from a low of 0.019 
+ 0.003 at 0400, to a high of 0.034 + 0.004 at 2200 (Table 1), and there were no significant 
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differences in alert probability by hours of the clock (p=0.4072). When examining MET 
threshold alerts by categorized time blocks (Probability 0000-0800= 0.026 ± 0.003, probability 
0801-1600= 0.027 ± 0.003, probability 1601-2359 = 0.029 ± 0.003) there were no statistical 
differences in probability (p=0.361). Conclusions:  Patients become unstable and meet MET 
trigger criteria throughout the clock without specific clustering relative to time of the day. 
Methods to improve clinicians’ detection of patient instability are needed.  
Table 1. Probability of instability fulfilling MET trigger alert threshold by hour of the clock. 
Hour 0000 0100 0200 0300 0400 0500 0600 0700 
Probability ± 
SD 
.0030 ±. 0038 .0271 ± .0036 .0285 ±. 0037 .0275 ±. 0036 .0189 ± .0030 .0279 ±. 0036 .0025 ±. 0035 .0219 ±. 0033 
Hour 0800 0900 1000 1100 1200 1300 1400 1500 
Probability ± 
SD 
.0233 ± .0034 
 
.0288 ± .0037 .0232 ± .0033 .0301 ± .0038 .0286± .0037 .0286± .0037 .0271± .0036 .0277 ± .0036 
Hour 1600 1700 1800 1900 2000 2100 2200 2300 
Probability ± 
SD 
.0259 ± .0035 .0247 ± .0035 .0278 ± .0037 .0227 ± .0033 .0264  ± .0036 .0327 ± .0040 .0345 ± .0041 .0343 ± .0040 
The authors have no conflicts of interest to disclose. Funding NIH R01NR013912, National 
Institute of Nursing Research. 
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APPENDIX G 
VECTOR AUTOREGRESSIVE (VAR) MODEL FOR EXPLORING CAUSAL 
DYNAMICS OF CARDIORESPIRATORY INSTABILITY 
Eliezer Bose, Marilyn Hravnak, Gilles Clermont 
Poster presented at the Society of Critical Care Medicine (SCCM), Spring 2015 
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Vector Auto-regressive (VAR) model for exploring causal dynamics of cardiorespiratory 
instability 
Introduction: Patients undergo continuous physiologic monitoring of vital signs (heart rate 
[HR], respiratory rate [RR], pulse oximetry [SpO2]). Vital signs undergo inter-related changes in 
situations of stress, and upon recovery from stress. Patterns of this cross-talk could portend 
impending cardiorespiratory instability (CRI). We proposed using VAR modeling and Granger 
causality to explore causal dynamics across the vital signs time-series (VSTS) in patients prior to 
overt CRI. We hypothesize that patient-specific VAR modeling of VSTS will expose Granger 
causal dynamics in evolving CRI. Such information could help target surveillance monitoring. 
Methods: CRI was defined as vital signs beyond normality thresholds (HR=40-140/min, RR=8-
36/min, SpO2>85%) and persisting for 4-mins of a 5-min moving window. A 6-hr window prior 
to first CRI onset was chosen in 25 CRI patients. The uniform time series (freq=1/20 Hz) for 
each vital was assessed for stationarity, followed by: VAR model construction and diagnostics 
such as significant lags, LM test for residual autocorrelation, AR roots and Wald test. With the 
final stable model, Granger causality/block exogeneity Wald chi-square test assessed for 
significance of the lagged variable on the dependent variable. Results: The primary cause of CRI 
was SpO2 (48% cases), followed by RR (28%) and HR (24%). Within CRI cases, Granger 
causality revealed that HR Granger-caused (GC) RR (28%) (i.e. HR changed before RR 
changed) more often than RR GC HR (13%). Similarly, HR GC SpO2 (20%) was more common 
than SpO2 GC HR (15%). For RR and SPO2, RR GC SPO2 (17%) was more common than 
SpO2 GC RR (6%). Conclusions: VAR modeling indicates that, within this sample, HR changes 
seem to occur before those in RR. It is unclear if this means that HR is causative, or if HR is a 
more nimble vital sign and able to attempt compensation in response to subtle abnormalities in 
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RR or SpO2 before overt CRI. Nevertheless, our data suggests that contextual assessment of HR 
changes as the earliest sign of CRI is warranted. More rigorous testing of causal dynamics in a 
larger sample is needed. 
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APPENDIX H 
VECTOR AUTOREGRESSIVE (VAR) MODEL AND GRANGER CAUSALITY IN 
TIME SERIES ANALYSIS OF VITAL SIGNS FOR NURSING RESEARCH  
Eliezer L. Bose, Susan M. Sereika, Marilyn Hravnak 
Paper submitted to Nursing Research, Summer 2015 
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H.1 ABSTRACT 
Background-- Patients undergoing continuous physiologic monitoring of vital signs (heart rate 
[HR], respiratory rate [RR], pulse oximetry [SpO2]) display inter-related vital sign changes in 
situations of physiologic stress. Patterns in this cross-talk could portend impending 
cardiorespiratory instability (CRI). 
Objective-- We proposed using vector autoregressive (VAR) modeling and Granger causality to 
explore causal dynamics across the vital sign time series (VSTS) in patients prior to overt CRI. 
Method-- CRI was defined as vital signs beyond normality thresholds (HR=40-140/min, RR=8-
36/min, SpO2<85%) and persisting for 3 minutes (60%) of a 5 minute moving window. A 6-hour 
window prior to first CRI onset was chosen for time-series modeling in 20 patients. The uniform 
time series for each vital sign was assessed for stationarity, followed by VAR model construction 
and stability check of the VAR system. With the final stable model, Granger causality was 
assessed for the lagged predictor variable on the dependent variable. 
Results-- The primary cause of CRI was SpO2 (60% of cases), followed by RR (30%) and HR 
(10%). Granger causality testing revealed that RR caused HR (21%) (i.e., RR changed before HR 
changed) more often than HR causing RR (15%). Similarly, that RR caused SpO2 (15%) was 
more common than SpO2 causing RR (9%).  
Discussion-- Within this sample of acutely ill patients with CRI, VAR modeling indicates that 
RR changes tend to occur before changes in HR and SpO2. Our findings suggest that contextual 
assessment of RR changes as the earliest sign of CRI is warranted, with more modeling and 
testing in a larger sample being advisable. 
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Keywords: Time series analysis, vector autoregressive modeling, vital sign time series, 
physiological nursing research 
H.2 MANUSCRIPT 
H.2.1 BACKGROUND 
Physiologic nursing research often depends on the collection of time series data to be used in 
various statistical models (Knobel, Levy, Katz, Guenther, & Holditch-Davis, 2013; Tsai, 
Barnard, Lentz, & Thomas, 2010). Vital sign time series (VSTS) usually involve the collection 
of monitored physiologic vital signs (VS), such as heart rate (HR), respiratory rate (RR) or pulse 
oximetry (SpO2). Physiologically, there are constant interactions among the VS indicative of the 
patient’s effort to compensate and attain homeostasis when threshold values exceed normal 
limits (Chester & Rudolph, 2011), the failure of which leads to cardiorespiratory instability 
(CRI). Patient-specific multivariate time series modeling approaches (Schulz et al., 2013) can be 
used to study the causal characteristics of the changes in physiological variables as they progress 
in time towards the development of CRI. The vector autoregressive (VAR) model, a type of 
time-series modeling approach, is one of the most flexible models for the analysis of causality in 
multivariate time series (Lütkepohl, 2011). The general structure of the VAR model used in 
multivariate time series is that each variable is a linear function of past lags of both itself and the 
other variables. The vector autoregressive model of order 1 with 3 variables (HR, RR, SpO2) is 
denoted as VAR (1) and is as follows 
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This model has been widely employed in econometric analyses (Granger & Newbold, 2014) and 
in neurobiology (Tang, Bressler, Sylvester, Shulman, & Corbetta, 2012) for elucidating 
underlying causal mechanisms using Granger causality, but, to the best of our knowledge, has 
never been implemented in studying causality in physiologic time-series variables of HR, RR 
and SpO2 as inputs to the development of CRI. The purpose of this study was to develop a 
patient-specific multivariate time series VAR model using HR, RR and SpO2 in a sample of 
acutely ill monitored step-down unit (SDU) patients in order to study the Granger casual 
dynamics among the VS leading up to CRI. Since CRI can occur at different times during the 
hospitalization of unstable patients, we decided to consider only their first instance of CRI, 
which we called CRI1 for the purposes of this study.  
H.2.2 METHODS 
Research Design 
This is an analysis of prospectively collected physiologic data in patients who underwent 
continuous noninvasive VS monitoring (heart rate [HR], respiratory rate [RR; bioimpedance], 
peripheral oximetry [SpO2; plethysmography]) recorded once every 20 seconds (δ t = 20 
seconds) for the entire monitoring period of their hospitalization on the SDU. VS deviations 
beyond local instability threshold limits 40-140 beats per minute for HR, 8-36 breaths per minute 
for RR and SpO2< 85%, any of which persists for 3-minutes (60% duty cycle) of a 5-minute 
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moving window denote instability epochs. These instability epochs were then visually annotated 
by two expert critical care clinician reviewers as real CRI or monitoring artifacts. We created a 
.csv subset from the first instances of the real CRI, CRI1, using VSTS prior to the onset of CRI1, 
to up to a maximum of 6-hours prior to the start of CRI1.  
Sample and Setting 
The study was approved by the University of Pittsburgh Institutional Review Board (IRB). The 
sample for the study (N=20) was recruited from a 24-bed trauma SDU, located in a tertiary 
academic medical center. For the study, data were extracted from input obtained from beside 
monitors (model M1204, Philips Medical, Bothell, WA) and included noninvasive monitoring of 
continuous HR (3-lead ECG), RR (bioimpedance signal), and plethysmographic peripheral blood 
oxygen saturation (SpO2) signal (model M1191B, Philips Medical Systems). Patient entry 
criteria for the study were: 1) admitted to a monitored bed on the SDU and 2) age >21 years 
during the study periods (11/06-8/07; 8 weeks). All patients were admitted to the study unit 
according to the usual standard of care for monitored bed admission and utilization. This 
methodology yielded a convenience sample of 20 patients, whose ages ranged from 35 to 92 
years, and was equally male and female (50% each) and mostly of white race (80%). 
Data Analysis  
Data analysis consisted of the following steps: data pre-processing, testing the stationarity of the 
VSTS individually for each of the variables, lag-length selection criteria, building a VAR model 
with appropriate lags, assessing the residual autocorrelation with the Lagrange Multiplier (LM) 
test, assessing the stability of the VAR system with the autoregressive (AR) roots graph and 
Granger Causality test. All data analysis was performed using EViews® 8 Student version. 
Data Pre-processing 
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The first point in the patient’s streaming data where the patient develops CRI (CRI1) –i.e. any 
VS first crosses the instability threshold- denotes the start of the epoch, and the point at which all 
VS return within the normal threshold denotes the end of the epoch. Using the beginning of the 
CRI1 epoch, a 6-hour window period prior to that time was chosen for VAR analysis. This was 
because Hravnak et al., in the same group of patients, revealed that vital sign changes occur at 
least 6 hours prior to the onset of CRI (Hravnak et al., 2008). The first step was to pre-process 
the data to verify that a data value existed at every 20 seconds. There were certain portions 
within the data stream where gaps were noticed, likely due to poor signal capture. Gaps in the 
data stream were populated using linear interpolation between the points (Lehman, Nemati, 
Adams, & Mark, 2012), to make the data stream continuous, for each of the 3 variables. We 
employed the use of this strategy since linear interpolation assumes that the unknown value of 
any given physiologic variable lies on the line between the two known values, similar to that of 
normal physiological mechanisms.  
Testing the stationarity of the VSTS individually for each of the variables 
The time series data for each of the individual VS variables were first visualized by a graphical 
line plot of each of the variables to assess for any trends as well as to assess for stationarity. 
From a visual perspective, it verifies that the series looks flat, without any upward or downward 
trend and with no periodic fluctuations over time. To test stationarity mathematically, we used 
the most commonly employed test called the Augmented Dickey-Fuller test (Wai & Ismail, 
2014). An autogregressive model can be represented as Xt = α + ρXt-1+ ἐt or ΔXt = α + (ρ-1) 
Xt-1+ ἐt , where ΔXt = Xt – Xt-1. If δ = ρ-1, then ΔXt = α + δXt-1+ ἐt. The null hypothesis for 
the Augmented Dickey-Fuller (ADF) test is that the time series is non-stationary (H0 : ρ=1) and 
the alternative hypothesis (H1 : ρ<1) is that the series is stationary. In this case, if the null 
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hypothesis holds, then ΔXt = α + ἐt. Using the Dickey-Fuller table and a t-statistic on δ, if we 
can conclude that the t-value is less than the DFcritical, then we can reject the null hypothesis 
(p<0.05), thus proving that the series is stationary (Dickey, 2011). This test was performed 
individually for each of the 3 VS variables for each patient. If the VS time series was not 
stationary, the series was differenced and the ADF test applied again on the differenced time 
series to check for stationarity. Figure 1 illustrates the ADF test for differenced HR for a 
particular patient (Pt ID #1 in the sample). 
Lag-length selection criteria 
Once stationarity of a series was determined, we proceeded with lag-length selection criteria, 
using EViews® lag length selection criteria to identify the order of the lag to be chosen. An 
example illustrating a series of lags as well as the different selection criteria for a particular 
patient is shown in Figure 2. The most commonly employed criteria is the Akaike Information 
Criteria, which (similar to minimizing the error term in regression), chooses the lag order with 
the lowest value of AIC (Vrieze, 2012). In the example in Figure 2, the lowest AIC is starred (*) 
by Eviews®, and is shown in this example on the 12th lag, indicated with gray shading.  
Building a VAR model with appropriate lags 
The VAR model was next constructed in order to include the number of lags from 1 until the 
specified lag as described above. Figure 3 shows the example of a VAR model with lags from 1 
to 12 for HR for one patient (Pt ID #1). The same was done correspondingly to represent RR as 
well as SpO2, and the significance of their coefficients assessed to decide whether another VAR 
model should be constructed so as to minimize the non-significant coefficients.  
Assessing the residual autocorrelation with the LM test 
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We next applied the Lagrange Multiplier (LM) test to check for residual serial correlation, where 
the null hypothesis is that there is no serial correlation up to the specified lag order. If a proper 
VAR system is obtained from the previous step, then the coefficients of the LM-Stat are not 
significant, thus accepting the null hypothesis up to the specified lag. This means that the past 
values of a variable do not affect the future value of the variable until the specified lag value. 
This is illustrated in Figure 4 for one patient (Pt ID #1). 
Assessing the stability of the VAR system with the autoregressive (AR) roots graph 
As the next step, we assessed the stability of the VAR system by evaluating the roots of the 
characteristic polynomial with the endogenous variables of HR, RR and SpO2 and the lag 
specification as per above criteria. If no root lies outside the unit circle as shown in Figure 5 for 
one patient (Pt ID #1), then VAR system satisfies the stability condition, indicating model 
stability. This evaluation was performed on a patient-by-patient basis. 
H.2.3 RESULTS 
Granger causality is a commonly employed method for the investigation of dynamic 
interrelationships in multivariate time series (Eichler, 2013). It is based on the common-sense 
concept that causes precede their effects in time. Granger causality treats one of the VS variables 
as a dependent variable (DV) and the others as independent variables (IVs). It assesses for 
causality between the DV and the IV (including all significant lags of the IV) as shown in Figure 
6. A p-value < .05 is suggestive of causality. Unidirectional causality is assumed if the IV 
Granger causes (<0.05) the DV. Figure 6 shows an example for one patient (Pt ID #1) where RR 
with all of its lags causes HR. This demonstrates that there is unidirectional causality running 
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from RR to HR, with changes in RR causing changes in HR in the patient’s time series prior to 
CRI1. However, if both IV causes DV, and DV causes IV, then bidirectional causality with 
feedback effect among the variables is assumed. Table 1 contains three cases Pt ID # 8, 14 and 
18 where bidirectional causality occurred.  
The final results of the Granger Causality Test, as shown in Table 1, indicate that the first VS 
over threshold to begin the CRI epoch was SpO2 in 60% cases, followed by RR (30%) and HR 
(10%). Within CRI1 cases, Granger causality revealed that RR caused HR (21%) (i.e. RR 
changed before HR changed) more often than HR causing RR (15%). Similarly, RR caused 
SpO2 (15%) was more common than SpO2 causing RR (9%). For HR and SpO2, HR caused 
SpO2 (18%) and SpO2 caused HR (18%). 
H.2.4 DISCUSSION 
The purpose of this study was to develop a stable patient-specific multivariate time series VAR 
model using HR, RR and SpO2 in a sample of SDU patients in order to study the Granger casual 
dynamics among the monitored vital signs leading up to a first CRI. Our results suggest that 
using this information may be helpful to determine causality in VS threshold deviations, and 
determine a physiologic cause. For example in our 20 cases, SpO2 falling below threshold was 
the first indicator of CRI. SpO2 itself was generally not the cause for changed RR or HR, but 
rather RR and HR tended to be the cause for the fall in SpO2. This suggests that SpO2 is a later 
VS change, and is led by more subtle changes in other VS which in turn caused changes in 
SpO2.  
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From an analysis standpoint, there were 2 cases where the patient developed CRI1 before 
a 6-hour window period of his/her arriving on the SDU was complete. In such cases, we only 
considered the entire period back starting with the start time of CRI1. One patient (Pt ID # 6) had 
a 2-hour window period preceding CRI1, while another (Pt ID # 11) had a 4-hour window period 
prior to CRI1, Also, there were 2 cases where we could only obtain VSTS from two variables--
HR and RR VSTS prior to CRI1 (Pt ID # 3) and HR and SpO2 prior to CRI1 (Pt ID # 8). We 
encountered few instances where patients were not monitored (the reasons for the patients being 
off the monitor were not known) for a brief window period of at least 3 hours, within the 6-hour 
period prior to CRI1. Fortunately, there were only 2 instances where the above was the case (Pt 
IDs #9 and #16). In such cases, we used the Markov Chain Monte Carlo (MCMC) approach to 
impute missing values to the dataset, since it was not possible to fill the data stream with linear 
interpolation. For a continuous variable with missing values, MCMC uses the non-missing 
values to find the variable’s sample mean and standard deviation and then fills in the missing 
values with random draws from a normal distribution with mean and standard deviation equal to 
the sample values, limited within the range of the observed minimum and maximum values 
(Brooks, Gelman, Jones, & Meng, 2011; Young, Weckman, & Holland, 2011). 
There were no smoothing or other filtering approaches used to remove artifacts in our 
dataset—this was done by prior expert review before data pre-processing. Florin et al. showed 
that filtering approaches disturb the information content, leading to spurious and missed 
causalities (Florin, Gross, Pfeifer, Fink, & Timmermann, 2010). Hence, no filtering approaches 
were used, but the series was differenced to maintain stationarity, a prerequisite for Granger 
causality. Finally, there were two cases (Pt ID #12 and #20) where the VAR model could not be 
stabilized for reasons that are unclear. Interestingly, both cases were those of HR crossed the 
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threshold first. It is possible that HR is less likely to induce compensatory changes than other 
VS, but this would require further exploration. 
  A major disadvantage of our study is the absence of continuous streaming data from these 
SDU patients for the entire 6-hour period, whereby we could avoid the use of linear interpolation 
or MCMC. We implemented these imputation procedures so as to maintain continuity of the 
VSTS for VAR modeling. Even though the VAR model is quite rich in capturing the temporal 
dynamics of highly complex hemodynamic responses, one must be careful not to over-interpret 
Granger causal relationships as truly causal. 
H.2.5 FUTURE DIRECTIONS 
Our study, the first to use patient-specific VAR modeling approach and the testing of Granger 
causality in multivariate VSTS in a small sample of SDU patients, has shown that the VAR 
modeling approach is able to expose Granger causal dynamics in evolving CRI. Future studies 
with much larger samples and longer VSTS monitoring to study casual dynamics are warranted. 
Such information could help target surveillance monitoring, enabling nurses to better recognize 
impending CRI. 
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Table 1: Granger Causality—unidirectional indicated with () and bidirectional with 
() 
Patient 
ID (Pt. 
ID) 
Data presence First VS over 
Threshold in CRI1  
Granger Causality (GC) 
1  All 3 VS, all 6 hours pre CRI SpO2 RR HR 
 
2  All 3 VS, all 6 hours pre CRI SpO2 RR HR 
RR  SpO2 
3  Only HR and RR VS, all 6 hours pre 
CRI 
RR RR HR 
4  All 3 VS, all 6 hours pre CRI SpO2 HR SpO2 
RR HR 
RR  SpO2 
5  All 3 VS, all 6 hours pre CRI RR No causal structure noticed 
among the variables 
6  All 3 VS, only 2 hours pre CRI SpO2 HR RR 
7  All 3 VS, all 6 hours pre CRI SpO2 RRHR 
RR  SpO2 
HR SpO2 
8  Only HR and SPO2 VS, all 6 hours 
pre CRI 
SpO2 HR SPO2 
 
9  All 3 VS, all 6 hours pre CRI RR RR  SpO2 
10  All 3 VS, all 6 hours pre CRI SpO2 No causal structure noticed 
among the variables 
11  All 3 VS, only 4 hours pre CRI SpO2 SpO2 RR 
HR  SpO2 
12  All 3 VS, all 6 hours pre CRI HR Unable to achieve a stable 
VAR model 
13  All 3 VS, all 6 hours pre CRI SpO2 SpO2HR 
14  All 3 VS, all 6 hours pre CRI RR HR  RR 
 
15  All 3 VS, all 6 hours pre CRI RR No causal structure noticed 
among the variables 
16  All 3 VS, all 6 hours pre CRI SpO2 HR  SpO2 
HR  RR 
SpO2  RR 
 
17  All 3 VS, all 6 hours pre CRI SpO2 SpO2  HR 
18  All 3 VS, all 6 hours pre CRI RR HRRR 
 
19  All 3 VS, all 6 hours pre CRI SpO2 HR  RR 
SpO2 RR 
SpO2  HR 
 
20  All 3 VS, all 6 hours pre CRI HR Unable to achieve a stable 
VAR model 
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Figure 1: Augmented Dickey Fuller test for assessing stationarity of the individual time 
series in one patient. 
Null Hypothesis: D(IPHR) has a unit root  
Exogenous: None   
Lag Length: 5 (Automatic - based on SIC, maxlag=21) 
     
        t-Statistic  Prob.* 
     
     Augmented Dickey-Fuller test statistic -19.78943  0.0000 
Test critical values: 1% level  -2.567115  
 5% level  -1.941118  
 10% level  -1.616501  
     
     *MacKinnon (1996) one-sided p-values.  
     
     
Augmented Dickey-Fuller Test Equation  
Dependent Variable: D(IPHR,2)   
Method: Least Squares   
   
Sample (adjusted): 8 1082   
Included observations: 1075 after adjustments  
     
     Variable Coefficient Std. Error t-Statistic Prob .  
     
     D(IPHR(-1)) -1.773697 0.089628 -19.78943 0.0000 
D(IPHR(-1),2) 0.790138 0.077616 10.18009 0.0000 
D(IPHR(-2),2) 0.508490 0.065739 7.735011 0.0000 
D(IPHR(-3),2) 0.325283 0.051871 6.271053 0.0000 
D(IPHR(-4),2) 0.168148 0.039054 4.305545 0.0000 
D(IPHR(-5),2) 0.087524 0.028581 3.062339 0.0023 
     
     R-squared 0.522789 Mean dependent var -0.000930 
Adjusted R-squared 0.520557 S.D. dependent var 2.646465 
S.E. of regression 1.832461 Akaike info criterion 4.054763 
Sum squared resid 3589.609 Schwarz criterion 4.082558 
Log likelihood -2173.435 Hannan-Quinn criterion 4.065290 
Durbin-Watson stat 2.013721    
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Figure 2. VAR Lag Order Selection Criteria 
VAR Lag Order Selection Criteria     
Endogenous variables: HR RR 
SPO2      
Exogenous variables: C      
     
Sample: 1 1082      
Included observations: 1066     
       
        Lag LogL LR FPE AIC SC HQ 
       
       0 -4409.508 NA   0.790567  8.278627  8.292619  8.283928 
1 -4058.505  699.3724  0.416170  7.636970  7.692936  7.658175 
2 -3895.079  324.7059  0.311489  7.347240  7.445181  7.384348 
3 -3845.196  98.83015  0.288490  7.270536  7.410452  7.323549 
4 -3765.865  156.7268  0.252828  7.138583  7.320474  7.207500 
5 -3729.862  70.92546  0.240339  7.087921  7.311786  7.172741 
6 -3688.072  82.08909  0.226001  7.026402  7.292242*  7.127126 
7 -3660.948  53.12992  0.218446  6.992397  7.300212  7.109025 
8 -3635.782  49.15075  0.211922  6.962068  7.311857  7.094599* 
9 -3622.142  26.56326  0.210087  6.953362  7.345126  7.101797 
10 -3610.422  22.75931  0.209020  6.948258  7.381997  7.112597 
11 -3598.588  22.91200  0.207915  6.942942  7.418656  7.123185 
12 -3574.577  46.35551*  0.202145*  6.914779*  7.432467  7.110925 
13 -3567.614  13.40285  0.202924  6.918601  7.478264  7.130651 
14 -3562.765  9.307612  0.204516  6.926388  7.528026  7.154342 
15 -3559.000  7.205468  0.206540  6.936210  7.579822  7.180067 
       
        * indicates lag order selected by the criterion    
 LR: sequential modified LR test statistic (each test at 5% 
level)   
 FPE: Final prediction error     
 AIC: Akaike information criterion     
 SC: Schwarz information criterion     
 HQ: Hannan-Quinn information criterion    
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Figure 3: Illustration of a VAR model with 12 lags for HR as the dependent variable for 
one patient. 
VAR Model: 
=============================== 
HR = C(1,1)*HR(-1) + C(1,2)*HR(-2) + C(1,3)*HR(-3) + C(1,4)*HR(-4) + C(1,5)*HR(-5) + 
C(1,6)*HR(-6) + C(1,7)*HR(-7) + C(1,8)*HR(-8) + C(1,9)*HR(-9) + C(1,10)*HR(-10) + 
C(1,11)*HR(-11) + C(1,12)*HR(-12) + C(1,13)*RR(-1) + C(1,14)*RR(-2) + C(1,15)*RR(-3) + 
C(1,16)*RR(-4) + C(1,17)*RR(-5) + C(1,18)*RR(-6) + C(1,19)*RR(-7) + C(1,20)*RR(-8) + 
C(1,21)*RR(-9) + C(1,22)*RR(-10) + C(1,23)*RR(-11) + C(1,24)*RR(-12) + C(1,25)*SPO2(-1) 
+ C(1,26)*SPO2(-2) + C(1,27)*SPO2(-3) + C(1,28)*SPO2(-4) + C(1,29)*SPO2(-5) + 
C(1,30)*SPO2(-6) + C(1,31)*SPO2(-7) + C(1,32)*SPO2(-8) + C(1,33)*SPO2(-9) + 
C(1,34)*SPO2(-10) + C(1,35)*SPO2(-11) + C(1,36)*SPO2(-12) + C(1,37) 
 
 
Figure 4: VAR Residual Serial Correlation with LM Tests 
 
 
VAR Residual Serial Correlation 
LM Tests 
Null Hypothesis: no serial 
correlation at lag order h 
 
Sample: 1 1082  
Included observations: 1069 
   
   Lags LM-Stat Prob 
   
   1  9.495643  0.3928 
2  9.068058  0.4310 
3  7.579804  0.5770 
4  13.56391  0.1387 
5  4.095677  0.9050 
6  14.69532  0.0997 
7  8.875476  0.4488 
8  6.233729  0.7163 
9  6.032959  0.7366 
10  8.505331  0.4841 
11  17.01417  0.0485 
12  10.74452  0.2936 
      Probs from chi-square with 9 df. 
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Figure 5: VAR System Stability Condition check for one patient. 
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Figure 6: Granger causality after a stable VAR model in one patient 
VAR Granger Causality/Block Exogeneity Wald 
Tests 
  
Sample: 1 1082   
Included observations: 1069  
    
        
Dependent variable: HR  
    
    Excluded Chi-sq df Prob. 
    
    RR  21.67892 12  0.0413 
SPO2  17.56553 12  0.1295 
    
    All  42.08405 24  0.0126 
    
        
Dependent variable: RR  
    
    Excluded Chi-sq df Prob. 
    
    HR  16.74601 12  0.1594 
SPO2  5.447528 12  0.9413 
    
    All  23.00000 24  0.5198 
    
        
Dependent variable: SPO2  
    
    Excluded Chi-sq df Prob. 
    
    HR  17.94254 12  0.1174 
RR  20.26748 12  0.0622 
    
    All  37.59647 24  0.0381 
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I.1.1 ABSTRACT 
Unrecognized in-hospital cardiorespiratory instability (CRI) risks negative or fatal patient 
outcomes. Even though step down unit patients have continuous non-invasive physiologic 
monitoring of vital signs and a ratio of 1 nurse to 4 or 6 patients, detection of CRI is still 
suboptimal. Nursing surveillance alone is unable to detect CRI. Telemedicine and rapid response 
teams have been tested as possible approaches to prevent CRI with mixed outcomes, while the 
problem still persists. Technology-enabled early warning scores, though rigorously studied, may 
not detect subtle instability. Existing monitoring systems hold the promise of better detection and 
recognition of CRI, but nursing surveillance still remains the key to reliable early detection. 
Research directed towards improving nursing surveillance and facilitating decision-making is 
needed to ensure safe patient outcomes and prevent CRI. 
Keywords: Death, Sudden, Cardiac, Vital Signs, survival 
 
I.1.2 Introduction 
Unrecognized cardiorespiratory instability (CRI) risks negative or fatal patient outcomes. CRI, 
defined as abnormalities in heart rate (HR), respiratory rate (RR), blood pressure (BP), and/or 
peripheral oxygenation by pulse oximetry (SpO2) that precede an adverse event, may not be 
detected until late in the course of instability or until cardiopulmonary arrest. Nursing 
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surveillance alone has not been successful in detecting CRI early enough to prevent negative 
outcomes (Henneman, Gawlinski, & Giuliano, 2012). Telemedicine and rapid response systems 
have been advocated as possible approaches to prevent adverse events, with mixed outcomes 
(Kerlin et al., 2013; Venkataraman & Ramakrishnan, 2015; Winters et al., 2013). Utilization of 
early warning scoring systems, with or without automated calculation and notification, has 
resulted in improvement, but these systems also have deficiencies (Alam et al., 2014). Even 
mature rapid response systems, with track-and-trigger systems based on intermittent patient 
evaluation, miss avoidable cardiopulmonary arrests (Trinkle & Flabouris, 2011). The purpose of 
this review is to describe the current state-of-the science regarding approaches nurses may 
potentially use for detecting CRI and identify strategies that may lead to improved detection. 
I.1.3 Unrecognized CRI risks negative or fatal patient outcomes 
Over 80% of in-hospital cardiac arrests (IHCA) are preceded by serious vital sign (VS) 
abnormalities 6-8 hours before the arrest (Buist, Bernard, Nguyen, Moore, & Anderson, 2004; 
Rozen et al., 2014). Survival after IHCA is poor. In one report of 14,720 adult IHCA patients 
with evolving CRI, only 44% had return of spontaneous circulation and only 17% survived to 
discharge (Perberdy, Kaye, & Ornato, 2003). Long-term survival after IHCA with preceding CRI 
is also poor. In a study that reported outcomes following IHCA in 732 patients, 6.6% lived to 
discharge, 5.2% for 1 year, and 3% for 3 years (Bloom et al., 2007). These outcomes illustrate 
why it is crucial that nurses detect CRI early and initiate supportive or corrective action prior to 
progression to cardiopulmonary arrest. 
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I.1.4 Nursing surveillance alone is unable to detect CRI 
Nursing surveillance, a process wherein nurses assess patients on a routine or as-needed basis to 
evaluate and act on emerging indicators of a status change, is a central nursing function that 
directly impacts patient outcomes (Bulechek, Butcher, Dochterman, & Wagner, 2013). Nursing 
surveillance includes assessment using sight, touch and hearing, or technological assistance, 
ranging from information acquired via thermometers, stethoscopes and sphygmomanometers to 
continuous physiologic data. Although technology can improve assessment sensitivity, failure to 
notice subtle changes in VS over time prevents nurses from intervening to reverse the process.  
 
Several reasons have been posed to explain why subtle changes may go undetected. Patient 
mortality has been shown to be higher as a nurse’s patient caseload increases (Aiken et al., 2011; 
Beaudoin & Edgar, 2003; Ebright, Patterson, Chalko, & Render, 2003; Needleman et al., 2011; 
Patrician et al., 2011). However, staffing level alone does not appear to influence CRI detection 
but, rather, staffing in combination with other nurse characteristics, such as education level and 
familiarity with the care required (Aiken et al., 2011; Blegen, Goode, Park, Vaughn, & Spetz, 
2013). In one study, CRI was less likely to be detected when patients were admitted to units 
where nurses were less familiar with their care, e.g., agency or “pulled” staff  (Schmid-
Mazzoccoli, Hoffman, Wolf, Happ, & Devita, 2008). As well, frequent interruption of nurses 
during care provision   negatively impacts ability to recognize a patient’s changing condition 
(Page, 2004; Potter et al., 2005). 
An additional factor that may contribute to unrecognized CRI lies within the very nature 
of the evolving CRI process. Unless due to an abrupt catastrophic event, such as pulmonary 
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embolism, stroke, or sudden arrhythmia, CRI is more commonly due to processes that evolve 
slowly over time, such as sepsis, respiratory insufficiency, or hypovolemia. In these cases, 
patients demonstrate VS changes that wax and wane between normal and abnormal (Figure 1). 
With only intermittent evaluation, patients may be seen by a nurse during periods of seeming 
stability when, in fact, CRI is present and progressing. This waxing and waning may also 
contribute to nurses feeling unsure that the patient is truly unstable and in need of care 
escalation. Although it is crucial that nursing surveillance provide timely recognition of VS 
changes signaling deterioration, current mechanisms for nursing surveillance and decision-
making may not be sufficient (Dresser, 2012; Henneman, Gawlinski, & Giuliano, 2012; Hillman 
et al., 2005).  
I.1.5 Telemedicine and Rapid Response Terms 
Attempts to provide earlier treatment of CRI focus on two approaches. The first--telemedicine--
provides continuous monitoring, teleconferencing, quick-consultation and advice from 
experienced physicians and advanced practice nurses around the clock to sites without 
specialized resources, with the goal of more promptly and appropriately managing any acute 
change in patient status. To date, this model of surveillance has most commonly been deployed 
in intensive care units (ICUs). Adoption of ICU telemedicine increased rapidly within US 
hospitals at an average of 101% per year from 2002 to 2005, but then slowed to 8.1% per year 
from 2006 to 2010. Hospitals adopting this system were typically large ( > 400 beds), teaching 
and urban (Kahn, Cicero, Wallace, & Iwashyna, 2014). However, telemedicine is expensive, 
with start-up costs ranging from $45,000-$50,000 per bed and annual costs between $28,000-
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$32,000 per bed (Ries, 2009) that may not be reimbursed by insurance (Alverson et al., 2004; 
Kumar et al., 2013). Benefits of ICU telemedicine are conflicting (Wootton, 2012) with some 
experts positing that expenditures are regained by reductions in ICU length of stay and in-
hospital complications (Breslow, 2007) and others reporting no cost offset. Additional concerns 
relate to medical liability (Hoffmann & Rowthorn, 2011; Sao, Gupta, & Gantz, 2012; Whitten & 
Mackert, 2005), loss of privacy (Sao et al., 2012), lack of control over remote physician practices 
(Alverson et al., 2004), and unclear investment return (Moehr et al., 2006). To date, telemedicine 
continuous surveillance is generally not used in patient wards or other areas where patient to 
nurse ratios are higher than in ICUs and instability is more likely to be unrecognized. 
 
A second option involves utilizing a rapid response system (RRS) and medical emergency team 
(MET) to address needs of unstable non-ICU patients (DeVita et al., 2010). The MET is usually 
a multidisciplinary team composed of medical, nursing, and respiratory therapy staff who can be 
summoned immediately to the patient’s bedside at any time and regardless of location for prompt 
evaluation, triage, and treatment of clinical deterioration (Chan, Jain, Nallmothu, Berg, & 
Sasson, 2010). The RRS consists of an “afferent arm” consisting of  some system for  “track and 
trigger,” meaning an established set of conditions or rules whereby unstable patients can be 
identified (tracked) and then an organized system whereby the clinician (or family member) can 
place a call for help (trigger) as shown in Table 1. This component is accompanied by the 
“efferent arm”, i.e., MET deployment, organization, membership, systems, equipment, and 
protocols. The MET can assess and treat patients in whom respiratory, neurologic, or cardiac 
deterioration is in process (Jones, DeVita, & Bellomo, 2011) versus a “code team” whose goal is 
to resuscitate patients once a cardiopulmonary arrest has developed (Litvak & Pronovost, 2010).  
 250 
 
 
In the most comprehensive evaluation of benefit, a multicenter cluster-randomized controlled 
trial called the Medical Early Response Intervention and Therapy (MERIT) study failed to 
demonstrate a reduction in mortality (Hillman et al., 2005) with MET use. However, post-hoc 
analysis (Chen et al., 2009) showed that the study reported deaths associated with all RRS calls, 
some of which occurred after cardiopulmonary arrest had developed. When these patients were 
excluded and only unstable patients prior to an arrest state were included, there was a benefit.  
 
Notably, a MET team can only be deployed when called to help. In one setting with a long-
standing RRS and clear call guidelines, of 108 MET calls on medical-surgical units, 44% were 
delayed (documented evidence that pre-established criteria for a MET call were present for > 30 
minutes) (Schmid-Mazzoccoli et al., 2008). In a second study conducted on a SDU in the same 
institution, of 326 continuously monitored patients, MET activation criteria were achieved in 59 
patients, but the MET was activated in only 7 cases (Hravnak et al., 2008). Several reasons have 
been posed for failure to recognize CRI, including episodic or abbreviated recording of VS, e.g., 
RR monitored for 15 seconds and multiplied by 4 (Ludikhuize, Smorenburg, de Rooij, & de 
Jonge, 2012), failure to recognize the significance of VS changes, and the belief that the problem 
can be managed without additional support (Galhotra, DeVita, Simmons, & Dew, 2007; 
Ludikhuize, Dongelmans, et al., 2012; Trinkle & Flabouris, 2011). 
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I.1.6 Technology enabled early warning scores 
Early warning scoring (EWS) systems and modified early warning scores (MEWS) have been 
developed and utilized to calculate a single composite score from multiple noninvasively 
acquired VS parameters which are then weighted and summed to identify patients who pass a 
“concern threshold” that designates possible CRI. EWS objectively quantify concern to intervene 
or request additional support and are therefore less influenced by individual opinion (DeVita et 
al., 2010; Gardner-Thorpe, Love, Wrightson, Walsh, & Keeling, 2006; Sharpley & Holden, 
2004; Subbe, Gao, & Harrison, 2007). EWS are typically designed to be bedside scoring systems 
for use by nurses or other clinicians who collect data via handwritten score cards or, more 
recently, personal digital assistants (PDAs). Technologically assisted EWS, also known as 
aggregate weighted track and trigger systems (AWTTS), are available from a variety of 
manufacturers,e.g.VitalPACTM,The Learning Clinic 
(http://www.thelearningclinic.co.uk/vitalpac.html). PDA-based applications allow VS data to be 
linked by a wireless network to the hospital’s information system. When this system is used, data 
is integrated with other patient information, e.g., lab results, and programmed to make direct 
contact with the MET team through an automated alerting system (Smith et al., 2006).  
Since 2012, the National Health Service in the United Kingdom has been mandated to use the 
National Early Warning Score (NEWS), a commercially available EWS, nationally. Prior to 
making this decision, NEWS was tested to discriminate patients at risk of IHCA and various 
other outcomes with 33 other AWTTS (excluding ViEWS described below) using a database of 
198,755 observations. Data (RR, HR, SpO2, supplemental oxygen [Yes/No], temperature [oC], 
systolic blood pressure [mmHg] and level of consciousness using the Alert-Verbal-Painful-
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Unresponsive [AVPU] system), were entered whereupon VitalPAC® software automatically 
computed the score as shown in Table 2. The NEWS was then assessed to determine its ability to 
derive scores that identified patients with or without cardiac arrest. In order to perform this 
comparison, they used a measurement process termed area under receiving operator 
characteristics (AUROC) curves. AUROCs plot the false positive rate of a score (1-specificity) 
on the x-axis against the true positive rate (sensitivity) on the y-axis. In terms of discrimination, 
an AUROC value between 0.7 and 0.8 indicates fair, a value between 0.8 and 0.9 indicates good 
and a value > 0.9 is excellent. When assessed in this manner, NEWS achieved an AUROC value 
of 0.722 (95% CI 0.685-0.759) for cardiac arrest discrimination which was better than any other 
EWS system evaluated. (Smith, Prytherch, Meredith, Schmidt, & Featherstone, 2013).  
Another EWS--VitalPACTM EWS—(ViEWS) has been tested in a similar manner. ViEWS is 
used to enter data that includes HR, RR, temperature, systolic BP, SpO2, fraction of inspired 
oxygen (FiO2),  and level of consciousness (AVPU scale), as recommended by the National 
Institute for Health and Clinical Excellence (Armitage, Eddleston, & Stokes, 2007). Using 
ViEWS, the authors were able to predict in-hospital death within 24 h of a given observation 
with a much higher AUROC (0.888) compared to 33 other AWTTS whose AUROCs ranged 
from 0.803 to 0.850 (Prytherch, Smith, Schmidt, & Featherstone, 2010).  
This literature is rapidly evolving. Churpek et al. reported upon a cardiac arrest risk triage score 
(CART) was more accurate than ViEWS for predicting cardiac arrest (CART AUROC  0.88 vs. 
ViEWS 0.78, p<0.001) (Churpek, Yuen, Park, Gibbons, & Edelson, 2014). Ludikhuize et al. 
evaluated use of a three-times-a-day protocolized measurement of EWS and reported that it 
resulted in better (90 MET calls intervention vs. 9 MET  calls control) detection of physiological 
abnormalities and more reliable MET activation (Ludikhuize et al., 2014). However, in a 
 253 
 
randomized trial, Kollef et al. (Kollef et al., 2014) reported that alerts calculated by EWS and 
sent to the RRS did not reduce in-hospital mortality (odds ratio = 0.944, 95% CI: 0.509-1.764).  
Although EWS tools can amalgamate intermittently determined VS data and determine when a 
threshold value is reached, such systems do not interface with continuous monitoring and 
therefore may not detect subtle instability, a factor that may explain conflicting study findings. 
Romero-Brufau et al. concluded that the most widely used AWTTS do not offer good predictive 
capabilities and called for better criteria to be developed and validated (Romero-Brufau et al., 
2014). A more ideal goal would be a system that could continuously and in “real-time” predict 
patients likely to become unstable in the future allowing for preemptive, rather than reactive, 
intervention. In addition, there may be benefit to adding “static” patient information, such as 
demographics and comorbid conditions, to EWS to improve assessment (DeVita et al., 2010). 
Smith et.al showed that adding age to a single VS parameter tracking system improved mortality 
prediction (Smith et al., 2008). Possibly incorporating more variables such as gender, 
comorbidities, diagnoses and procedures could further improve CRI-model prediction 
capabilities. 
I.1.7 Future directions 
Collecting continuous physiologic monitoring data in SDUs opens the door for refining systems 
at the bedside that can more sensitively and specifically detect overt CRI or, ideally, predict its 
occurrence without caregiver presence. Cao et al. analyzed the MIMIC II database of ICU 
patients, which consists of capture of minute-by-minute heart rate (HR) and arterial blood 
pressure (BP) monitoring data, in over 1875 adult ICU patients. They reported that entering 
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continuous and streaming input of HR and invasive BP measurements into a logistic regression 
model allowed prediction of CRI, defined as patients needing vasopressor augmentation to 
maintain normal blood pressure at least two hours before its overt manifestation (Cao et al., 
2008). Although this and other models and clinical algorithms have been developed to predict 
CRI in the ICU (Eshelman et al., 2008), tools have not been adapted for SDU patients, in part 
due to only intermittent recording of vital signs (VS), and use of noninvasive monitoring 
parameters.  
Hravnak et al. used an integrated monitoring system (IMS) which continuously integrates 
HR, RR, BP and SpO2 using a previously trained neural network (Tarassenko, Hann, & Young, 
2006) which generated a single-parameter IMS index value (INDEX) ranging from 0 (no CRI) to 
10 (severe CRI) to determine if use of such a system was able to decrease the length of time that 
patients were in an unstable state on an SDU (Hravnak et al., 2008). An alert was generated if the 
INDEX was > 3.2 which, per their implementation algorithm, called for the nurse to go 
immediately to the bedside and evaluate the patient. Nurses could then decide whether they 
should activate the MET, perform further evaluation and nursing interventions, or call upon the 
provider. This IMS INDEX correlated significantly with CRI concern criteria, usually occurring 
before overt instability and demonstrated use of the IMS resulted in a 60% decrease in the 
overall duration of SDU patient instability and decreased the number of patients progressing 
from mild instability to serious instability by 58% (Hravnak et al., 2011). 
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I.1.8 Implications for Clinical Practice 
Newly developed technology and EWS offer the promise of better detection and recognition of 
CRI, but are imperfect. MET activation presents the advantage of bringing a skilled team 
immediately to the bedside to assist in care triage, but can only act when summoned. Despite a 
vast literature devoted to identifying ways to detect CRI sooner, and extensive resources 
dedicated to developing technology designed to reliably detect CRI, problems continue to persist. 
Absent a “perfect” solution, nurse surveillance continues to be a critical factor. To encourage 
best practices in recognizing CRI at the bedside, the following are recommended: 
 
Establish clear guidelines for initiating a MET call: METs have been driven by the belief that 
they make hospitals safer by preventing adverse events that lead to CRI. To fully embrace this 
system, nurses need clear and established unit-based guidelines for initiating a MET. Nurses 
within a particular unit can develop a form to record and organize information about the patient’s 
condition prior to every MET activation, as well as interventions needed. Such information could 
be used for quality-improvement team-based interventions as well as a repository for staff 
education.  
 
Provide education regarding adverse outcomes: Staff must be educated about the importance of 
accurate VS measurements and adverse outcomes. There must be proper training and strict 
adherence to standards especially by care technicians and early notification of the primary nurse 
or other care providers (or MET activation) when CRI is detected.  
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Avoid behaviors that discourage prompt notification: Since nurses value access to MET 
activation and RRS, barriers to MET activation such as criticism of actions, their expertise in 
providing care, etc. should be avoided. Nurses who believe their actions positively impact patient 
outcomes are more likely to implement them. 
 
Share positive outcomes following CRI detection with the team as a way of promoting best 
practices. Staff nurses need verification of the positive results of their actions. Too often, the 
focus is on what did not succeed, rather than success.  
 
Regardless of the approach used, nursing surveillance is critically important in detecting CRI. 
Research directed towards improving and enhancing the ability of nurses to monitor caseloads of 
patients and recognize evolving CRI earlier in SDUs will ensure better patient outcomes. 
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Table 1: Example of thresholds of vital sign abnormalities of changes in patient condition used 
to “track” for instability and the “trigger” deployment of the Medical Emergency Team (Hravnak 
et al., 2008) 
Cardiorespiratory system 
Respirations < 8/min or > 36/min 
New onset of breathing difficulty 
New pulse oximeter reading < 85% for > 5 minutes, unless patient is known to have chronic 
hypoxemia 
Heart rate < 40 beats/min or >140 beats/min with new symptoms or any rate > 160 beats/min 
Blood pressure: systolic < 80 or >200 mm Hg or diastolic 110 mm Hg with symptoms 
(neurologic change, chest pain, or breathing difficulty) 
Neurologic system 
Acute loss of consciousness 
New onset of lethargy or difficulty in waking 
Sudden collapse 
Seizure (outside of seizure monitoring unit) 
Sudden loss of mobility (or weakness) of face, arm, or leg 
Other criteria 
More than 1 stat page required to assemble MET needed to respond to a crisis 
Patient report of (cardiac) chest pain (unresponsive to nitroglycerine or physician unavailable) 
Color change in patient or extremity to pale, dusky, gray or blue 
Unexplained agitation for > 10 min 
Suicide attempt 
Uncontrolled bleeding 
Bleeding into airway 
Naloxone hydrochloride use without immediate response 
Large volume of short-term blood loss 
Crash cart must be used for rapid delivery of medications 
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Table 2: The National Early Warning Score (NEWS) (adapted from Smith et al., 2013) 
 
Physiological 
Parameters 
3 2 1 0 1 2 3 
Respiration 
Rate (bpm) 
< 8  9-11 12-20  21-24 > 25 
Oxygen 
Saturation (%) 
< 91 92-93 94-95 >96    
Any 
Supplemental 
Oxygen 
 Yes  No    
Temperature 
(oC) 
< 35.0  35.1-36.0 36.1-38.0 38.1-39.0 > 39.1  
Systolic BP 
(mm Hg) 
< 90 91-100 101-110 111-219   > 220 
Heart Rate < 40  41-50 51-90 91-110 111-130 > 131 
Level of 
Consciousness 
   A   V,P,U 
Definition of abbreviations: A = alert; V = responds to voice; P = responds to pain; U = 
unresponsive 
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Figure 1: Waxing and waning of vital signs over time between normal and abnormal as patients 
proceed to overt cardiorespiratory instability (CRI). 
Patient 1: This patient’s CRI evolves progressively over 23 hours. Between 0300 and 0500, 
there is increasing respiratory rate(RR) with mild changes in pulse oximetry(SpO2). Patient 
remains stable from 1100 to 1630, after which increasing RR is accompanied by low SpO2. 
Around 1930 patient develops increasing RR with drop in SpO2. An hour later, at 2030, there 
is a significant drop in both RR and SpO2 until past 2230, the patient developed overt CRI. 
 
Patient 2: This patient is stable until 1200, after which there is increasing heart rate (HR), 
increasing RR and a drop in SpO2. Between 1330 and 1430, the patient experienced waxing 
and waning of SpO2 with increasing RR, until finally around 1530, the patient developed overt 
CRI. 
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